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ABSTRACT 
The centrosome is the microtubule organising centre of animal cells and is 
composed of a pair of centrioles surrounded by an electron-dense mass of proteins, 
called the pericentriolar material (PCM). Several proteins of the PCM exhibit a 
dynamic association with the centrosome in a cell cycle-dependent manner. The 
centrosome duplicates during S-phase of the cell cycle and may play an essential role 
during the transition from G  to S phase of the cell cycle. 
In order to better understand the mechanism of centrosome duplication and the 
role of the centrosome at the GuS transition, we decided to investigate the overall 
changes occurring in the PCM between GI and S phase by comparing the composition 
of the PCM at these two cell cycle stages. Therefore, we isolated centrosomes from 
unsynchronised (mainly in GI) Jurkat cells and from cells arrested in early S phase. 
Centrosomes were further fractionated by salt extraction with potassium iodide into 
soluble and insoluble material. Comparative gel electrophoresis of the soluble fractions 
in GI and S phase allowed us to detect several differences in the protein composition. 
Using MALDI-tof mass spectrometry, we identified eight different proteins specifically 
accumulating in either phase. Among those accumulating in S-phase, some were known 
proteins whereas others were novel uncharacterised proteins. Thus, our results led to 
the identification of new proteins potentially recruited to the centrosome in S phase 
where they may play a specific role in cell cycle-dependent centrosome functions. We 
started the study of HCA66, one of the novel proteins. We cloned its full-length cDNA 
by RT-PCR from Jurkat cells, expressed a recombinant portion of the protein in 
bacteria and raised a polyclonal antibody. A protein of -60kDa corresponding to the 
predicted molecular weight of HCA66 was enriched in the PCM from S phase 
centrosomes. Thus, we laid the basis for further investigation on the function of HCA66 
at the centrosome. 
The protein 4.1R, previously characterised as a component of the plasma 
membrane skeleton, is also localised at the centrosome. We investigated the role of this 
protein at the centrosome and found that the carboxy terminus of 4.1R bears similarities 
to a short motif in 13-tubulin. 
xv 
INTRODUCTION 
Mitosis is the process by which a cell divides, forming two identical daughter 
cells. The correct segregation of chromosomes is essential to ensure the propagation of 
cells and species, as errors of segregation lead to aneuploidy and promote tumor 
development and progression. The mitotic spindle, a complex superstructure composed 
of microtubules, associated proteins and a pair of centrosomes, mediates chromosome 
segregation. The centrosome, named after its central position in the cell, was first 
discovered more than a century ago and thought to be "the organ of cell division par 
excellence" (Wilson 1895). The revolution of molecular biology, the use of genetics, 
biochemistry and advanced microscopy led to a better understanding of centrosome 
ultrastucture, to the discovery of many centrosomal proteins and shed light on other 
important functions of the centrosome. 
Structure of centrosomes and spindle 
pole bodies 
Microtubules organising Qentres (MTOCs) are a morphologically diverse group 
of organelles which fulfil related functions. They are basal bodies in green algae, the 
centrosome in higher eukaryotes, and spindle pole bodies (SPB) in yeast. We will focus 
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on the biological role of the centrosome and its ultra-structure and will give a brief 
overview of the current knowledge of spindle pole bodies. 
A - Centrosome structure 
The centrosome is a very small membrane free organelle (1-2/Am') sitting near 
the centre of the cell, close to the nucleus to which it is anchored. In most animal cells, 
centrosomes consist of two centrioles associated with a cloud of electron-dense material 
called the pericentriolar material (PCM) (Figure 1A, 113). The two centrioles are close 
together, generally in an orthogonal orientation, and are linked to each other by 
filamentous and amorphous material (Bornens et al. 1987). The PCM is an 
interconnected meshwork of —12-15 nm fibres and protein aggregates forming a lattice, 
known as the centromatrix. The centromatrix is an organised structure tightly associated 
with the centriole which directs the recruitment of other centrosomal components such as 
the y-tubulin ring complex, responsible for microtubule nucleation. 
A centriole exhibits a barrel shape of -400 nm in length with its sides made of 
microtubules. The arrangement of these microtubules is complex. At the extremity where 
the two centrioles are the closest (proximal end), the barrel wall consists of nine triplets 
of microtubules (tubules A, B, Q. This organisation changes towards the distal end 
(where the two centrioles are the farthest apart), where the wall of the centriole consists 
of nine doublets (tubules A, B) (Figure 1C). 
The two centrioles are not structurally identical. One, called the mother centriole, 
has sub-distal and distal appendages at its distal end. These appendages are absent from 
the other centriole, which is called the daughter centriole (Figure JC). Electron 
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microscopy studies on isolated centrosomes revealed that distal appendages are oriented 
with a nine-fold symmetry around the centriole and appear as rigid sticks probably 
attached to the tubule B of the centrioles (Paintrand et al. 1992). The sub-distal 
appendages show more variability in their number and distribution than the distal 
appendages. They have a broad base allowing them to interact with two sets of adjacent 
microtubules (Vorobjev and Chentsov 1980). Furthermore, sub-distal appendages 
disappear in the G2 phase of the cell cycle in mammalian somatic cells and reform in 
early G  on the mother centriole (Vorobjev and Chentsov Yu 1982). 
The exact function of these appendages remains unclear. The tip of the sub-distal 
appendages has been described as a nucleation site and/or a binding site for microtubules 
in PE and PtK2 cells and also in vitro from isolated centrosomes (Vorobjev and 
Chentsov Yu 1982; De Brabander et al. 1986; Chretien et al. 1997). Ninein, a candidate 
for microtubule anchoring at the centrosome, was recently located at the sub-distal 
appendages, suggesting a role of these appendages in the anchoring mechanism 
(Mogensen et al. 2000). 
Not all centrioles are as complex in their structure. For instance, centrioles in 
Drosophila melanogaster embryo are composed of nine singles or doublets of 
microtubules arranged in a ring and connected to the centre via spokes (Moritz et al. 
1995; Callaini et al. 1997). This simpler centriole structure might be a result of rapid 
mitosis occurring in the embryo, therefore limiting the available time for building a more 
complex structure (Moritz et al. 1995). 
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Figure 1: Structure of the centrosome. 
A, Schematic representation of a centrosome. Pericentriolar material is in green and microtubules are in 
light blue. B, Electron micrograph showing a longitudinal section of the two centrioles surrounded by 
the pencentriolar material. Top right shows a cross-section of a centriole (from de Harven 1994). C, 
Schematic representation of a centrosome model (adapted from Bornens 2002). Mother and daughter 
centrioles are linked by microtubule-binding proteins. They are able to bind proximal minus end of 
centrioles (black) or centriole walls through interaction with polyglutamylated tubulin (green and blue 
respectively). These two types of proteins are linked together by other proteins (grey) forming the fully 
assembled matrix (black dotted line). Microtubules (blue cylinder) are nucleated by nucleating 
complexes (red) in the vicinity of both centnoles. After nucleation, microtubules are either anchored by 
the mother centriole f®] or released into the cytoplasm [®I. 	 4 
Centrioles are structurally similar to basal bodies. In some organisms, such as 
Chiamydomonas reinhardtii, the same structure acts as a basal body in interphase and a 
centriole in mitosis (Coss 1974). Moreover, in most animals, after fertilisation the basal 
body of the sperm becomes the centriole of the egg's centrosome (see Schatten 1994 for 
review). 
In some cell types, the mother centriole can elongate the microtubules of its distal 
end to produce the primary cilium (see Wheatley et al. 1996 for review). 
Centrioles are not responsible for microtubule nucleation since cells from higher 
plants or some meiotic cells, lacking centrioles, are able to form acentriolar MTOCs 
which can nucleate and organise microtubules. Bobinnec and co-workers demonstrated 
that centrioles are more likely to play a role in centrosomal organisation (Bobinnec et at. 
1998). Microinjection of an antibody against glutamylated tubulin (found mainly at the 
centriole) results in centriole disassembly and PCM disorganisation. Moreover, after 
removal of this antibody the PCM reformed around the centrioles. Furthermore, SAS-4, 
a centriolar protein recently identified in Caenorhabditis elegans, has been implicated in 
the control of centrosome size: the amount of PCM recruited by the centrioles is 
proportional to the quantity of SAS-4 present (Kirkham et at. 2003). These data suggest 
that centrioles are required for the proper organisation of the centrosome by focussing 
the PCM. 
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B - Spindle pole body: an overview 
The spindle pole body, the yeast equivalent of the centrosome, is much smaller than 
its higher eukaryote counterpart (0.01 tm'). Electron microscopy, yeast genetics and 
biochemical approaches on purified SPBs made the Saccharomyces cerevisiae's SPB the 
most extensively MTOC characterised to date. 
1) Ultrastructure of the spindle pole body of 
Saccharomyces cere visiae 
The spindle pole body of Saccharomyces cerevisiae is a multilayered cylindrical 
entity anchored in the nuclear envelope throughout the cell cycle (Figure 2). Electron 
microscopy analysis revealed that the SPB consists of an outer plaque facing the cytoplasm, 
a central plaque, and an inner plaque directed towards the nucleus (see Adams and Kilmartin 
2000 for review). Moreover, a structure called half-bridge is adjacent to the SPB. The half 
bridge is a one-sided extension of the central plaque layered on top of the nuclear envelope 
that functions in the cell cycle dependent duplication of the SPB. Other structures (namely 
ILl, 1L2, IP1 and 1P2) were detected on isolated SPBs using cryo-electron microscopy and 
image processing (Bullitt et al. 1997; see Helfant 2002 for a review). ILl and 1L2 
(intermediate lines 1, 2) are two thin layers which separate the central and the outer plaques. 
IP1 (inner plaque 1), a beaded layer, and 1P2 (inner plaque 1), containing the tips of 
microtubules, form the inner plaque. The spindle pole body organises two arrays of 
microtubules: the cytoplasmic microtubules, which originate from the cytoplasmic side of 
the SPB and are directed towards the cortex of the cell and the nuclear microtubules, which 
originate from the nuclear side of the SPB and are directed towards the nucleoplasm. The 
cytoplasmic microtubules are implicated in the positioning, alignment and movement of the 
nucleus. The nuclear microtubules are implicated in SPB separation, spindle formation and 
chromosome segregation. 
2) Molecular composition of the SPB 
Several strategies were used to identify the components of the SPB. Rout and 
Kilmartin raised monoclonal antibodies against partially purified spindle pole bodies and 
identified several SPB components including Spc97p and Spc98p, two proteins of the yeast 
Tub4p complex (see below and section 11-B-1, Rout and Kilmartin 1990). More recently 
ID-gel electrophoresis of purified spindle pole bodies followed by mass spectrometry, was 
used to identify additional components (Wigge et al. 1998). Other spindle pole components, 
such as Cdc3lp or Karip, were identified using genetic analyses (Byers 1981a; Byers 
1981b; Conde and Fink 1976; Schild et al. 1981, see Table 1 for a list of spindle pole 
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Figure 2: Schematic representation of the budding yeast spindle pole body and 
localisation of its components. Ndc8Op, and Spc's lOSp, 34p, 25p, 24p, 19p are presumably 
associated with the spindle. ILl and 11-2: intermediate lines 1 and 2. Adapted from Wigge et al., 
1998. 
Protein MW (kDa) Location Function 
Stuip 174 Pole and spindle Mitotic spindle assembly 
Spcl lOp 110 SPB CP/OP Anchor site for the Tub4 complex at IP 
SpclOSp 105 Pole  
Stu2p 100 SPB OP/ spindle pole Mitotic spindle elongation in anaphase 
Spc98p 98 SPB OP/IP Associates with Tub4 complex as part of MT 
attachment site of SPB 
Spc97p 97 SPB OP/IP Associates with Tub4 complex as part of MT 
attachment site of SPB 
Nudip 94 SBP OP Nuclear division 
Ndclp 74 SPB CP Nuclear envelope insertion of the SPB 
Spc72p 70 SPB OP Docking protein for Tub4p complex at the OP 
Cnm67p 67 SPB OP Nuclear migration 
Tub4p 52 SPB OP Part of Tub4p complex, MT nucleation 
Karip 51 SPB HB SPB duplication 
Bbplp 45 SPB CP Mitotic cell cycle 
Spc34p 34 Pole and spindle  
Spc29p 29 SPB CP SPB duplication 
Spcl9p 19 Pole and spindle  
Cdc3lp 19 SPB HB Centrin involved in SPB duplication 
Cmdlp 16 SPB CP Nuclear division, chromosome maintenance. 
Table 1: Spindle pole components of Saccharomyces cerevisiae. CP: central plaque, HB: half-bridge, IP 
inner plaque, MT: microtubules, MW: molecular weight, OR outer plaque, SPB: spindle pole body. (adapted 
from Helfant 2002). 
3) Tub4p and the Tub4p complex 
The y-tubulin gene, named TUB4, was identified by the yeast genome-sequencing 
project (Goffeau et al. 1996). The protein was identified at the inner and outer plaques of the 
SPB. Analysis of Tub4p-depleted cells and TUB4 mutants demonstrated the importance of 
this protein in microtubule nucleation (Sobel and Snyder 1995; Marschall et al. 1996). 
Tub4p associates with Spc97p and Spc98p in the yeast Tub4p complex (also known 
as the y-TuRC (-tijbulin ring Qomplex). This complex is localised in the inner and outer 
plaques of the SPB. It is anchored to these substructures via the binding of Spc97p and 
Spc98p to the SPB proteins Spc72p and SpcllOp. 
The role of the Spcl 1 Op protein 
SpcllOp was originally identified by Rout and Kilimartin (Rout and Kilmartin 
1990). The protein localises at the nuclear face of the SPB and its amino- and carboxy-
terminal ends are anchored at the inner and central plaque respectively (Spang et al. 1996; 
Sundberg et al. 1996). Besides a role of spacer protein between the inner and outer plaques, 
SpcllOp has been described as a Tub4p complex-binding protein. It interacts with Spc97p 
and Spc98p, but not with Tub4p, anchoring the Tub4p complex to the inner plaque. 
Spc72p anchors the Tub4p complex at the outer 
plaque 
Whereas SpcllOp anchors the Tub4p complex at the inner plaque, another protein 
called Spc72p, identified as a SPB component interacting with Spc97p and Spc98p, targets 
it to the outer plaque (Fields and Song 1989). More recently, a Spc72p-GFP fusion protein 
was identified at the half-bridge in early Gi cells (Adams and Kilmartin 1999). It is 
consistent with the notion that cytoplasmic microtubules are in initiated from the half-bridge 
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during this time, implying that the Tub4p complex is also present at the half bridge during 
GI (Byers and Goetsch 1975; Knop and Schiebel 1998). The anchoring of Spc72p to the 
half-bridge depends on Karip whereas its anchoring to the outer plaque depends on Nudip. 
The ability of the SPB to nucleate microtubules from different regions at different times in 
the cell cycle (half bridge in early GI, outer plaque in S) could be linked to variation of 
Spc72p localisation. Such variations have previously been described for Gi and mitosis. In 
mitosis Spc72p was predominantly located at the outer plaque, whereas in early GI it was 
located at the half bridge (Pereira et al. 1999; Adams and Kilmartin 1999). 
Biological roles of the centrosome 
For a long time, centrosomes were considered as the microtubule organising centre 
of animal cells. In recent years, new biological roles of the centrosome have been 
discovered; in addition to microtubule nucleation, it is involved in spindle positioning and 
cell cycle progression. 
A - The centrosome as a microtubule organising 
centre 
Microtubules are hollow tubes of -25 nm in diameter consisting of 13 
protofilaments arranged in a cylinder. A protofilament is composed of a and 3-tubulin 
heterodimers organised in a head to tail manner. In vitro, studies have shown that 
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microtubules are dynamic structures, exchanging their tubulin with the soluble pool of 
tubulin. Two mechanisms have been proposed to explain these dynamics: treadmilling 
and dynamic instability. Treadmilling relies on the fact that one microtubule end (termed 
the plus end) predominantly incorporates tubulin dimers, whereas the other end (termed 
the minus end) predominantly loses them. Treadmilling results in an apparent movement 
of the microtubule or, when the microtubule is stationary, in an apparent flux of tubulin 
molecules travelling through the microtubule (Margolis and Wilson 1981). However, the 
treadmilling model is inconsistent with measured rates of microtubule dynamics and fails 
to explain the observation that microtubule polymers can fluctuate in length (sometimes 
to zero), at equilibrium condition. The dynamic instability model describes microtubule 
dynamics as a result of stochastic transitions between assembly and disassembly of 
microtubule ends (Mitchison and Kirschner 1984b). Transitions from assembly to a 
sudden disassembly are named "catastrophe", whereas transitions from disassembly to 
assembly are referred to as "rescue". 
It has been noted that microtubules polymerised in vitro, have a variable number 
of filaments, whereas in vivo the number of filaments is constant, suggesting the presence 
of a template for microtubule assembly. In vivo, the cellular concentration of tubulin is 
below the concentration allowing self-assembly and nucleation occurs mainly from the 
centrosome by plus end addition of tubulin subunits (McIntosh and Euteneuer 1984; 
Mitchison and Kirschner 1984a; Mitchison and Kirschner 1984b). In vivo, many 
microtubules minus ends are capped by the centrosome preventing "catastrophe" events 
and microtubule minus end disassembly, hence limiting the phenomenon to the plus ends 
(Kirschner and Mitchison 1986). 
One role of the centrosome is to nucleate and organise the interphase microtubule 
network and the mitotic spindle. However, an interphase microtubule array can be formed 
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in the absence of centrosomes (Rodionov and Borisy 1997). Microtubules are nucleated 
"randomly" within the cytoplasm and are organised in an array by the action of molecular 
motor proteins such as cytoplasmic dynein (Rodionov and Borisy 1997). The centrosome 
is the main site of microtubule nucleation in the cell and, when present, act in a dominant 
way. If microtubules are artificially depolymerised using drugs or cold treatement, they 
grow back from the centrosome when the drug is washed out or the cells warmed up. The 
nucleation activity of the centrosome is located in the PCM; centrioles do not directly 
participate in the nucleation of cytoplasmic microtubules since they are unable to 
nucleate microtubules in vitro (Gould and Borisy 1977). 
B - The role of y-tubulin and the y-tubulin ring 
complex in microtubule nucleation 
y-Tubulin was first identified in the fungus Aspergillus nidulans as a result of a 
genetic screen designed to identify proteins that interact with 3-tubulin (Oakley and 
Oakley 1989). y-Tubulin is 30% identical to a- and 3-tubulin. It has been described in a 
wide variety of organisms and is likely to be present in all eukaryotes. y-Tubulin is 
present in the pericentriolar material of centrosomes where it plays an important role in 
nucleation of microtubules (Steams et al. 1991; Zheng et al. 1991; Moritz et al. 1998). 
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1) The y-tubulin ring complex 
y-Tubulin and other proteins called y-tubulin ring proteins (grips) assemble in a 
2.2x106  Da complex seen as an open lock washer-shaped ring of 25 nm (the same 
diameter as microtubules) covered by a cap on one face. The complex is found at the 
minus end of centrosomal microtubules, and in the cytoplasm (Stearns and Kirschner 
1994). The complex, called the -tubulin ring Qomplex (y-TuRC), varies in size and 
complexity between species. The y-TuRC composition is conserved among higher 
eukaryotes (Zheng et al. 1995). Drosophila y-TuRC contains y-tubulin, two high 
molecular weight proteins (Dgrip163 and Dgripl28), two proteins of a molecular weight 
near 100 kDa (Dgrip9l and Dgrip84) and a??group of three or four proteins with 
molecular masses around 75 kDa (Dgrip75s) ADDIN ENRfu (Oegema et al. 1999, 
see Table 2 for composition of y-TuRC in Xenopus laevis and mammals). 
Drosophila Melanogaster Xenopus laevis Mammals 
Dgrip 163 Xgrip2 10 (Xgrip 195) GCP6 
Dgrip128 Xgripl33 GCPS 
Dgrip9l Xgrip109 GCP3 
Dgrip84 Xgrip104 GCP2 
Dgrip75s Xgrip75s GCP4 
y-tubulin y-tubulin y-tubulin (GCP1) 
Table 2: The y-TuRC composition in different species (Zheng et al. 1995; Murphy et al. 1998; Murphy 
et al. 200 1) 
The molecular mechanism by which the y-TuRC nucleates microtubules is subject 
to controversy. Two different models have been proposed: the template and the 
protofilament models. 
In the first model, supported by recent publications (Keating and Borisy 2000; 
Moritz et al. 2000; Wiese and Zheng 2000), the y-TuRCs would act as template at the 
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minus end of the microtubule, initiating each of the 13 protofilaments through 
longitudinal contacts with the y-tubulin subunits. In this model, each of the 13 
protofilaments is bound to one of the y-tubulin subunits in the y-TuRC, allowing capping 
of the microtubule and blocking assembly and disassembly at the minus end (Figure 3A). 
In the protofilament model, y-TuRC provides a short segment of preformed 
protofilament, nucleating a second protofilament by lateral contact to a-tubulin and/or 3-
tubulin (Figure 313, (Erickson and Stoffler 1996; Erickson 2000). 
2) The y-tubulin small complex 
In addition to y-TuRC, a smaller complex containing y-tubulin was found in several 
organisms such as Drosophila melanogaster or Saccharomyces cerevisiae (Knop et al. 
1997; Moritz et al. 1998; Oegema et al. 1999). This -jjbu1in small complex (y-TuSC) 
consists of y-tubulin, Dgrip84 (Spc97/GCP2) and Dgrip9l (Spc98/GCP3), and is likely to be 
a structural core subunit of the y-TuRC (Moritz et al. 1998). In vitro experiments, using 
isolated Drosophila y-TuSC, showed that the complex can nucleate microtubules, although 
less efficiently than the y-TuRC (Oegema et al. 1999). Cryoelectron miroscopy analysis 
suggested that the y-TuRC contains 6 y-TuSC forming the ring wall of the y-TuRC (Oegema 
et al. 1999; Wiese and Zheng 1999 for review). The cap structure is made of the non y-TuSC 
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Figure 3: Models of microtubule nucleation by the y-TuRC. 
A, In the template model the y-TuRC mimics the end of a microtubule where tubulin dimers bind 
and a microtubule assembles. B, In the protofilament model tubulin dimers bind to the y-TuRC 
creating a sheet which grows and curls to form the microtubule (adapted from Job et al. 2003). 
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3) How is the y-TuRC recruited to and anchored at 
the centrosome? 
The way y-TuRCs are recruited and anchored at the centrosome is not fully 
understood. In budding yeast, SpcllOp interacts with Spc98p/GCP3 and Spc97p/GCP2 and 
mediates the attachment of the yeast yTuRC to the spindle pole body (Knop and Schiebel 
1997). In mammalian cells, where the y-TuRC is more complex, pericentrin has been 
implicated in the recruitment of y-TuRC to the centrosome possibly through interactions 
with GCP2 and GCP3 (Dictenberg et al. 1998; Doxsey 2001). Moreover, pericentrin B, a 
larger splice variant of pericentrin, shares homology with the ca!modulin domain of 
SpcllOp and might be its mammalian counterpart, suggesting that pericentrin B plays a role 
in y-TuRC anchoring (Flory et al. 2000). Some grip proteins such as Xgrip21O 
(Dgripl63/GCP6) in Xenopus have also been involved in the anchoring of the y-TuRC to the 
centrosome though the mechanism has not yet been solved and might involve other proteins 
(Zhang et al. 2000). For instance, in Drososphila Asp (Abnormal spindle) mutants, y-tubulin 
does not concentrate on centrosomes but is found dispersed throughout the spindle, 
supporting the notion that Asp is involved in the recruitment of y-tubulin at the centrosome 
(Donaldson et al. 2001). 
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C - Anchoring microtubules to the centrosome 
In some cells, such as monocytes or fibroblasts, most microtubules originate from the 
centrosome whereas in others, such as neurons or skeletal muscle cells, most microtubules 
are not anchored at the centrosome. This raises the question of how some microtubules are 
anchored at the centrosome, whereas others are free. 
Epithelial cells have anchoring sites at their apical domain which bind microtubule 
minus ends (Mogensen et al. 1997). These sites lack centrosomal proteins involved in 
microtubule nucleation (i.e y-tubulin, pericentrin), although they contain ninein, a protein 
associated with the sub-distal appendages of the mother centriole, demonstrating that 
nucleation and anchoring activities of the centrosome do not depend on the same proteins 
(Mogensen et al. 2000). These appendages act as microtubule-anchoring sites, suggesting 
that ninein is involved in microtubule anchoring to the centrosome (Chretien et al. 1997; 
Mogensen 1999; Mogensen et al. 2000). Although both centrioles are capable of nucleating 
microtubules, only those nucleated by the mother centriole stay anchored due to the 
presence of ninein. The molecular mechanism of the transfer of microtubules is unknown. 
An analogy can be drawn with the nucleation of microtubules in budding yeast and the 
shuttling of Spc72p. A similar protein could cap microtubules minus ends and interact with 
proteins of the sub-distal appendages such as ninein therefore promoting microtubule 
anchoring. The current model by M. Bornens' group proposes that microtubules nucleated 
by the daughter centriole are either anchored by the mother centriole, or released into the 
cytoplasm depending on the intra-centriolar distance (Figure 1C, Piel et al. 2000; Bornens 
2002). If the distance is short enough, the microtubule will be transfered to the mother 
centriole, otherwise it will be released into the cytoplasm. The motor protein dynactin has 
also been implicated in the binding of microtubules to the centrosome, though it is not 
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currently known if dynactin is directly involved in this process, or if it transports anchoring 
molecules to the centrosome (Quintyne et al. 1999). 
Evidence suggests that microtubule release from the centrosome is an active 
mechanism (Ahmad et at. 1999). This activity is thought to be mediated by katanin, a 
protein with severing activity on microtubules both in vitro and in vivo (McNally and Vale 
1993; Hartman et at. 1998; Ahmad et at. 1999). The release of microtubules could also be 
the result of an activity mediated by the Kini subfamily of kinesin, which destabilises 
microtubules minus ends (Desai et at. 1999). 
D - The role of the centrosome in the formation and 
positioning of the mitotic spindle 
1) The centrosome is dispensable for spindle 
assembly 
For a long time, it has been thought that centrosomes were defining the spindle poles 
and were required for the establishment of a functional bipolar spindle. However, work 
performed in vitro using cytoplasmic extracts from Xenopus eggs clearly showed that a 
functional bipolar spindle could be established around chromatin-coated beads without 
centrosomes (Heald et at. 1996). It has been proposed that Ran-GTP causes the release of 
spindle pole proteins from a complex with importin a and 13  thereby promoting nucleation 
and stabilisation of microtubules (Gruss et al. 2001; Nachury et at. 2001; Wiese et at. 2001). 
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Ran-GTP activity is mediated through RCC-1, a guanine nucleotide exchange factor 
associated with the chromatin (Ohtsubo et al. 1989). Microtubule motor proteins, including 
cytoplasmic dynein and the BimC motor proteins, are also involved in bipolar spindle 
assembly (Sharp et al. 1999; Sharp et al. 2000). These proteins act together to establish a 
functional bipolar spindle. Ran-GTP also increases microtubule polymerisation through an, 
as yet, unknown mechanism (Kahana and Cleveland 1999). 
Acentrosomal spindles are also formed in higher plants, in some mammalian oocytes 
and in the acentrosomal Drosophila cell line 1182-4 (Debec et al. 1995). Moreover, when 
centrosomes are artificially removed from CV-1 and BSC-1 cells, they are still able to form 
a bipolar spindle (Maniotis and Schliwa 1991; Khodjakov et al. 2000; Hinchcliffe et al. 
2001). Furthermore, centrosomes can be artificially removed from the spindle pole without 
affecting focusing of microtubules (Nicklas et al. 1989). 
This raises the question why cells have centrosomes at their spindle poles if they are 
not required for the formation of the mitotic spindle. One view is that it ensures each 
daughter cell inherits one copy of the organelle so that other essential functions performed 
by the centrosome can be fulfilled. When present, the centrosome acts in a dominant way in 
the nucleation of microtubules and the organisation of a bipolar spindle, and the cell is able 
to build a bipolar spindle in a faster time than in acentrosomal cells, where no pre-formed 
organising centres are present. The number of centrosomes in a cell at the onset of mitosis 
determines the number of spindle poles. Cells containing a single centrosome or an 
unseparated doublet form a monopolar spindle while cells containing more than two 
centrosomes form multipolar spindles (Bajer 1982; Sawin et al. 1992; Mayer et al. 1999; 
Heneen 1975; Sluder and Rieder 1985). 
Thus, vertebrate cells have a redundant pathway of establishing a bipolar spindle and 
there are components not related to the centrosome stabilising microtubule minus ends. The 
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nuclear and mitotic Apparatus (NuMA) protein is able to stabilise and focus microtubules 
through a direct interaction (Merdes et al. 1996; Haren and Merdes 2002), In Xenopus laevis 
egg extracts, NuMA is required for assembly of the spindle pole and to maintain 
microtubule minus-end focusing (Merdes et al. 1996). NuMA can oligomerize and bind 
several microtubules inducing their tethering. Other proteins, such as 4.1R, may also be 
involved in the formation and the maintenance of the spindle pole. 
2) The 4.1 R protein is present at the centrosome 
The 4.1R proteins belong to a large protein family. These proteins arise from a 
single gene by alternative splicing, usage of three translation initiation sites and post-
translational modifications (Figure 4). These isoforms have apparent molecular weights 
ranging from 30 to 210 kDa and are widely expressed in many tissues (Granger and 
Lazarides 1984; Anderson et al. 1988) 
The 80kDa protein 4.1R (4.1R80) is a component of the membrane skeleton first 
described on the basis of its electrophoretic mobility in erythrocyte lysates (Ungewickell 
et al. 1979). The 4.1R'35 isoform is generated by usage of an upstream translation 
initiation codon. The protein contains an additional 209 amino-acid domain located in 
the amino-terminal part of the protein (compared to 4.1R80). 4.1R proteins have been 
located in several sub-cellular compartments where they have different biological roles. 
21 








AL T AL T A 	 AL L 	 1 
	




	 Spectrin Actin 
Pserine 
Figure 4: Schematic representation of 4.1R cDNA and proteins. 
The different domains of 4.1R protein (30kDa, l6kDa, lOkDa, 22-24kDa) were defined by partial 
chymotryptic digestion and functional analysis (Leto et al. 1984). Corresponding exons are shown. The 
amino-terminal 30kDa domain is encoded by exons 5-12. It binds transmembrane proteins such as band 
3, phosphatidyl serine (Pserine), Glycophorine C (GPC), p55 and calmodulin (CaM) (Hemming et al. 
1994; Pasternack et al. 1985). No specific binding sites were mapped in the l6kDa domain, encoded by 
exons 12-13. The lOkDa domain, known as the SABD (pectrinIActin-binding domain) encoded by 
exons 14-17, has a binding site for spectrin and actin and, in vitro, plays a critical role in nuclear 
assembly (Correas et al. 1986a; Correas et al. 1986b). The 22-24kDa domain (CTD: Carboxy-terminal 
domain), encoded by exons 17-21, interacts with NuMA (Mattagajasingh et al. 1999) and is involved in 
nuclear assembly as determined by in vitro experiments (Krauss et al. 2002). The additional 209aa 
domain present in 4. 1R'35 contains a binding site for Centrosomal P4.1-Associated Protein (CPAP). 
Phosphorylation sites for PKA or PKC are also shown (P circled). Adapted from Takakuwa (2000). 
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4.1R proteins are components of the centrosome, forming part of the 
pericentriolar material (Krauss et at. 1997b). More recently, CPAP (Centrosomal P4.1-
Associated Protein), a newly identified centrosomal protein associated with the y-tubulin 
complex, was shown to interact with 4.1R135 at the centrosome via its 209 amino acid 
domain (Hung et at. 2000). It has been postulated that 4.1R could act as an adapter to 
anchor the CPAP/y-tubulin complex at the centrosome (Hung et at. 2000). However, the 
role of the protein at the centrosome remains to be clarified. 4.1R is also present at the 
spindle pole where it interacts with NuMA, though a direct interaction with NuMA does 
not seem required for assembly of the protein at the spindle pole (Mattagajasingh et at. 
1999; Delhommeau et at. 2002). 
It has been suggested that 4.1R could be at the vicinity of the centrosome rather 
than a bonafide centrosomal component where it would associate to CPAP and to a yet 
unidentified-complex through its carboxy-terminal domain. This association would be 
required for 4.1R to localise to the centrosome and the spindle pole (Hung et at. 2000). 
4.1R could be a centrosomal component playing a structural role in the spindle pole 
architecture. It could promote or facilitate docking of NuMA at the spindle poles during 
mitosis ensuring a connection between the centrosome and the spindle pole. 
Alternatively, 4. 1R could mediate the interaction between the actin related protein Arp-1 
and NuMA, therefore establishing binding of NuMA to the dynein/dynactin complex 
during mitosis, as suggested by Clark and Meyer (Clark and Meyer 1999). 
It is not currently known whether the the alternate pathway of spindle formation 
based on self-organisation of microtubules and motor proteins is active in cells having 
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centrosomes or whether it works only when the centrosome is absent. This redundancy, if it 
exists, could be a way for the cell to increase the fidelity of chromosome segregation, which 
is in fine the role of the mitotic spindle. Although centrosomes might not be essential for 
segregating chromosomes they have other important roles in mitosis. They nucleate astral 
microtubules, which play a role in determining the position of the cleavage furrow through 
spindle positioning by interaction with the dynein motor protein (Busson et al. 1998; 
O'Connell 2000). Therefore, cells without centrosomes lack the ability to reposition the 
spindle as their shape changes during mitosis, leading to defects in cytokinesis as discussed 
below. 
E - Role of the centrosome during cytokinesis 
Recent studies have shown that the centrosome is required for progression 
through the cell cycle (Hinchcliffe et al. 2001; Khodjakov and Rieder 2001). When the 
centrosome is artificially removed, either by laser ablation or using a micro-needle, 
nearly half the cells fail to complete cytokinesis. The two daughter cells remain attached 
together by intracellular bridges containing chromatin or exit mitosis leading to the 
formation of binucleated cells (Khodjakov and Rieder 2001). These observations suggest 
that the centrosome plays a role in cytokinesis, though it is not required per Se, as half the 
cells complete a normal mitosis. The cells lacking centrosomes form an acentrosomal 
spindle and do not have astral microtubules. It often leads to an abnormal positioning of 
the spindle at the onset of anaphase (the long axis of the spindle is perpendicular to the 
long axis of the cell) and to failure of cytokinesis (Khodjakov and Rieder 2001). The 
central nervous system of Drosophila melanogaster larvae is an example of the 
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centrosome's role in spindle positioning, where neuroblasts divide asymmetrically to 
form another neuroblast and a smaller ganglion cell. This asymmetry is generated by the 
progressive disappearance of one centrosome and its astral microtubule triggering a shift 
of the spindle towards one side of the cell (Kaltschmidt et al. 2000). However, other 
studies using fly mutants showed that asymmetric divisions can occur without astral 
microtubules, suggesting the existence of a redundant process ensuring proper division in 
their absence (Bonaccorsi et al. 2000; Megraw et al. 2001). Thus, centrosomes might not 
play a direct role in cytokinesis, they rather organise and maintain the astral microtubule 
array to ensure proper cytokinesis. 
Another possibility would be that the centrosome activates the final stage of 
mitosis or releases the cell from an inhibitory mechanism such as a checkpoint. Such a 
checkpoint has been described in budding yeast. The cell remains in cytokinesis until the 
spindle pole body moves into the bud bringing together Teml-GDP (inactive) with Ltel, 
a guanine-nucleotide exchange factor located in the bud. This displacement leads to an 
active form of Temi (Teml-GTP) which activates the mitotic exit network (Bardin et al. 
2000; Pereira et al. 2000). Although the existence of such a checkpoint in animal cells 
has not yet been characterised, centriole movement has been described in some cell lines 
including HeLa, L929 and CHO. Piel and co-workers (Piel et al. 2001) showed that prior 
to cell cleavage, the mother centriole moves towards the intracellular bridge connecting 
the daughter cells. This displacement correlates with a narrowing of this bridge and 
microtubule depolymerisation in the bridge, suggesting again a link between centrosomes 
and cytokinesis. Moreover, when the movement of the centriole is impaired cytokinesis is 
defective (Piel et al. 2001). 
An alternative role of the centrosome during cytokinesis could be explained by 
the involvement of y-tubulin in the process. y-Tubulin has been located at the minus end 
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of microtubules forming the midbody and inhibition of y-tubulin function in mammalian 
cells or fission yeast led to cytokinesis failure (Julian et al. 1993; Shu et at. 1995; 
Hendrickson et at. 2001). 
Although the exact role of the centrosome in cytokinesis remains unclear it 
appears to play a crucial role in ensuring the fidelity of this process. The centrosome is 
also involved in other steps of the cell cycle, as several groups have reported its 
requirement for cells to progress from GI to S phase. 
F - The centrosome is required for the GuS 
transition 
When the centrosome is removed from CV-1 or BSC-1 cells during mitosis or S 
phase respectively, cells keep progressing through the cell cycle and complete mitosis, 
though a large increase in cytokinesis failure is observed (see above, Hinchcliffe et al. 
2001; Khodjakov and Rieder 2001). However, the acentrosomal daughter cell arrests in 
GI and does not enter S phase. Moreover, when the centrosome is dispersed using 
antibodies, cells cycle normally, suggesting that the transition from GI to S requires at 
least one factor normally associated with the centrosomes and independent of its 
structural integrity (Bobinnec et al. 1998). It is not currently known what centrosomal 
components are required for the cell to progress from GI to S. It is also unclear why 
removing the centrosome stops cell cycle progression. Is there a checkpoint associated 
with the centrosome or is the centrosome simply required for the process to occur? On 
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one hand, the checkpoint hypothesis is supported by the existence of the 1182-4 
acentrosomal Drosophila cell line, which progresses in the cycle normally. On the other 
hand, the fact that some enzymes and their substrates can be found at the centrosome 
suggests that it could coordinate molecular events required for the G1-S transition. 
G - Regulation of centrosome functions: anchoring 
of regulatory molecules, the role of AKAPs 
The centrosome acts as an anchoring site for molecules regulating cellular 
functions. A-kinase anchor proteins (AKAPs) target kinases and phosphatases to the 
centrosome and other cellular locations (see Diviani and Scott 2001 for review). AKAPs 
have at least two functional domains, one enzyme binding motif and a domain 
determining the cellular localisation of the proteins. To date three AKAPs have been 
identified at the centrosome: AKAP350 (also known as AKAP450 or CG-NAP), 
pericentrin, and AKAP 220 (Diviani et al. 2000; Reinton et al. 2000). AKAP350 binds 
Protein kinase A (PKA), PKCE, PKN, protein phosphatase 1, and protein phosphatase 2A 
(Schmidt et al. 1999; Takahashi et al. 1999; Takahashi et al. 2000). When located at the 
centrosome these enzymes influence centrosome separation and duplication. The 
targeting of AKAPs to the centrosome is presumably mediated through a 90 amino-acid 
sequence, called pericentrin AKAP450 centrosome targeting (PACT) domain, capable of 
targeting reporter protein to the centrosome (Gillingham and Munro 2000). The 
anchoring of enzymes to the centrosome through AKAPs is best characterised in the case 
of pericentrin. It anchors PKA at the centrosome through a unique motif of 100 amino 
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acids allowing its interaction with the PKA type II regulatory sub-unit (Diviani et at. 
2000). Pericentrin is targeted to the centrosome in a dynein-dependent manner and it has 
been shown that dynein is a substrate of PKA (Inaba et at. 1998; Young et at. 2000). 
Thus, the PKA asssociated at the centrosome could be involved in regulating dynein 
functions. 
A possible role for AKAPs would be to bring regulatory molecules close to their 
substrate to control the specificity of their functions. More generally, AKAPs are thought 
to integrate several signalling pathways by their ability to interact with proteins involved 
in signal transduction. 
III CENTROSOME CYCLE 
Each somatic cell contains a single centrosome that has to replicate once during 
each cell cycle. This occurs in a semi-conservative manner, ensuring that after mitosis 
each daughter cell receives a centrosome (Kochanski and Borisy 1990). Centrosome 
replication must be coordinated with other cellular events. For instance, the centrosome 
replication must be completed prior to mitosis to ensure equal distribution of the 
centrosomes to each daughter cell. The cell must control the replication process and stop 
overproduction of centrosomes when the cell cycle is slowed down to repair DNA 
damage, for example. Failure to stop the replication process leads to supernumerary 
centrosomes, to the formation of multipolar spindles and therefore contributes to genetic 
instability. 
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Figure 5: An overview of the centrosome cycle 
At the end of GI phase, the two centrioles lose their orthogonal orientation, maybe through the action of the 
SCF (Skp 1-Cull-F box) [®J. At the G 1-S transition, Cyclin E-Cdk2 phosphorylates nucleophosmin (NPM) 
[®a]. NPM leaves the centrosome and remains phosphorylated (NPM*), presumably through the action of 
Cyclin A-Cdk2 [®b], until mitosis. Cyclin E-Cdk2 also phosphorylates Mpslp, preventing its degradation 
by the SCF [®c, ®d]. These phosphorylation events and CaMKII activity [®1 lead to centriole splitting [®j. 
In C.elegans embryos ZYG-1 is involved in this process. Note that Cdk2 activities are under the control of 
E217 and p53. During S and 02 phases procentnoles form and elongate Il®]. Aurora A is recruited to the 
centrosome in late S phase [©]. In 02 phase, proteins such as ninein, Odf2, and e-tubulin are recruited to the 
pericentriolar material of centrosomes with the immature centrioles [®a]. At the end of G2 phase, the two 
centrosomes separate in a two steps process [®, ®J.  First, Nek2 kinase is activated by C-Napl [®a] 
triggering the physical dissociation of the two centrosomes [(]• Second, Aurora A kinase phosphorylates 
the motor protein Eg5 [©a] which will separate the two centrosomes. Cyclin B-Cdkl is phosphorylated by 
PIki kinase and is also required for Eg5 activity. In addition y-tubulin containing complexes are recruited at 
the centrosome prior the onset of mitosis in a Plkl and Aurora A dependent manner. NPM is recruited to the 
centrosome through the action of Cyclin B-Cdkl [©] and the tumor suppressor protein BRCA 1 localises at 
the centrosome until the end of mitosis IT, Mal. Aurora A is degraded in the early stages of GI phase [®a]. 
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A - The centrosome duplication 
A somatic cell in GI contains one centrosome with two centrioles. The first 
visible event of centrosome duplication is the splitting of the two centrioles which 
coincides with the loss of orthogonality (also known as disorientation) and occurs in late 
GI or early S phase (Figure 5 gives an overview of the centrosome cycle, Kuriyama and 
Borisy 1981). However, it has been reported that the two centrioles can separate as early 
as late telophase in some tissue culture cells (Mack and Rattner 1993; Piel et al. 2001). 
Currently, it is not known if the two centrioles are still linked together or if they split 
before the G1-S transition. 
Centriole duplication begins in early S phase by the formation of short daughter 
centrioles (procentrioles) perpendicular to the mother centriole and slightly separated 
from the two originals. The newly formed procentrioles will elongate and reach their full 
length during mitosis or the following G1 phase (Kuriyama and Borisy 1981; Lange et al. 
2000). Little is known about the molecular events of procentriole formation. New 
centriole assembly begins with the assembly of an amorphous structure (Figure 6, Dippell 
1968; Marshall et al. 2001). In Paramecium tetraurelia centrin and y-tubulin concentrate 
at the assembly site and a pre-pattern for the nine-fold symmetry is set before 
microtubule assembly (Ruiz et al. 1999; Beisson and Wright 2003). In Paramecium the 
elongation process requires y-tubulin, and in Tetrahymena and Drosophila y-tubulin 
might be required for stabilisation of centriolar microtubules (Ruiz et al. 1999; Beisson 
and Wright 2003). The role of centrin is not fully understood and will be discussed 
below. Once the precursor is formed microtubules begin to appear, first as a ring of nine 
single microtubules (formation of tubule A), subsequently converted into doublets 
(formation of tubule B) and triplets (formation of tubule Q. Studies in Paramecium 
tetrauretia and Chiamydornonas reinhardtii demonstrated that the formation of 
microtubules requires i, , and -tubulin (Figure 6). In Paramecium sm19 mutants (sml9 
encodes r-tubulin), y-tubulin mislocalises, indicating that 1-tubulin might tether y-tubulin 
to the basal body (Ruiz et at. 2000). E-Tubulin is required for the cohesion of the 
centriolar structure in the Paramecium basal body (Dupuis-Williams et at. 2002; Dutcher 
et at. 2002). In mammalian cells, E-tubulin is a component of the sub-distal appendages 
and is required for centriole duplication (Chang et at. 2003). &-Tubulin is required for the 
formation of tubule C of the Chiamydornonas basal body (Dutcher and Trabuco 1998; 
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Figure 6: Schematic representation of the centriole assembly pathway. 
The initial steps of centriole assembly are unknown (question mark). The required pre-pattern for centriole 
formation is represented by the nine branched star. Arrows indicate the entry point of the proteins involved 
in the assembly process and do not represent their time of action. Tubules A, B and C are indicated 
(adapted from Beisson and Wright 2003). 
The two centrosomes, defined as two discrete bodies of PCM, are first visible 
during S phase, although the exact timing of the transition from one to two centrosomes 
is unknown. At this stage the two centrosomes are not identical. The one with the mother 
centriole possesses cenexin/Odf2 and E-tubulin, whereas the other does not (Lange and 
Gull 1995; Chang and Stearns 2000; Nakagawa et at. 2001). 
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In G2 phase, the immature parental centriole acquires maturation markers such as 
e-tubulin, ninein and cenexin/Odf2 (Lange and Gull 1995; Chang and Stearns 2000; Piel 
et al. 2000; Nakagawa et al. 2001). At about the same time, the amount of y-tubulin at the 
centrosome increases three to five fold leading to an increase in microtubule nucleating 
activity (Khodjakov and Rieder 1999). 
In G2/early prophase, the two duplicated centrosomes separate into two distinct 
MTOCs in a two-step process. First, independently of the microtubules, cohesion 
between the two centrosomes is disrupted. Throughout the cell cycle, parental centrioles 
are connected through a proteinaceous structure. The centriole-associated protein, C-
Nap 1/Cep250 (entrosomal Nek2-associated protein I),  acts as an anchor protein 
between the proteinaceous structure and the centrioles (Fry et al. 1998; Mayor et al. 
2000). The phosphorylation state of C-Nap 1 regulates its association with the centrioles. 
At the onset of mitosis, the activity of Nek2 (Nima  related kinase 2) kinase prevails on 
phosphatase activity of protein phosphatase 1, and phosphorylation of C-Napl leads to 
the loss of cohesion between the centrosomes. The second step is the physical separation 
of the two centrosomes. They are separated by the action of plus-end directed motor 
proteins. One of them, Eg5, is recruited to the centrosome by the dynein/dynactin 
complex after phosphorylation by Cdkl (Blangy et al. 1995; Sawin and Mitchison 1995; 
Blangy et al. 1997). Each centrosome will be at the centre of the spindle poles and each 
daughter cell will inherit one centrosome after mitosis. The centrosome duplication is a 
complex process involving the action of many proteins. It is tightly controlled by 
regulatory proteins such as protein kinases, calcium binding proteins or E3 ubiquitin 
ligases. 
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B - The proteins regulating the centrosome cycle 
Centrosome duplication is controlled by the centrosome itself and extrinsic 
cytoplasmic factors. The intrinsic controls determine the number of daughter centrioles 
emerging at each cell cycle, whereas the extrinsic ones determine when the duplication 
starts in relation to nuclear events (i.e. DNA synthesis). 
Though centrosome duplication and DNA replication are usually initiated at the 
same time, several exceptions exist. L929 cells form procentrioles in GI, 4h before the 
beginning of DNA synthesis (Rattner and Phillips 1973; Hinchcliffe and Sluder 2001). 
Moreover, mouse embryonic fibroblasts lacking p53 can assemble multiple centrosomes 
before the onset of S phase (Fukasawa et at. 1996). The reasons why some cells initiate 
and complete centrosome replication in GI is not understood and is presumably due to 
differences in regulatory activities. It is also possible that early steps of centrosome 
replication occur well before DNA synthesis starts. The formation of the two 
procentrioles could be the physical manifestation of a process started in GI or even in the 
previous cell cycle. In S phase, cytoplasmic conditions are permissive for a complete 
cycle of centrosome reproduction. Artificial prolongation of S phase using hydroxy-urea 
in CHO cells allows multiple rounds of centrosome duplication without cell cycle 
progression. The same cells arrested in late GI with mimosin, or in G2 using a 
topoisomerase inhibitor, do not overduplicate their centrosome, demonstrating that at 
these cell cycle stages cytoplasmic conditions are not permissive for centrosome 
duplication (Balczon et at. 1995; Matsumoto et al. 1999). Mitosis does not support 
centrosome duplication but the mother and daughter centrioles can split and separate 
(Gallant and Nigg 1992). 
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Thus, temporal regulation of centrosome replication is under the control of 
cytoplasmic factors at specific cell cycle stages. It has emerged that phosphorylation and 
proteolysis, two key processes regulating cell cycle progression, are also responsible for 
the structural and functional transitions occurring during the centrosome cycle. 
1) The kinases regulating the centrosome cycle 
a) The role of CDK2 in the centrosome cycle 
The fact that centrosome replication events are correlated to cell cycle transitions 
motivated several studies investigating the role of cyclins and Qyclin dependent icinases 
(Cdk) in centrosome duplication. A first link between DNA synthesis and centrosome 
duplication came from studies demonstrating that Cdk2 is required for both events 
(Strausfeld et at. 1996; Hinchcliffe et al. 1999; Lacey et at. 1999). The Cdk2-cyclin E 
complex was identified as the regulator of centrosome duplication in Xenopus embryos 
whereas the Cdk2-cyclin A complex seems to have a predominant role in somatic cells 
(Hinchcliffe et al. 1999; Lacey et al. 1999; Meraldi et at. 1999). The Cdk2-cyclin E 
complex phosphorylates nucleophosmin NPMI1323 and stabilises levels of Mpslp kinase, 
both involved in centrosome duplication (see below, Okuda et at. 2000; Fisk and Winey 
2001). Cdk2 could have a direct effect on centrosome reproduction by phosphorylating 
centrosomal components and/or it could act indirectly, affecting pathways influencing 
centrosome duplication. 
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NPM/B23 is a substrate of Cdk2 
As mentioned above, nucleophosmin NPM/B23 is a substrate of Cdk2. 
Nucleophosmin was first identified as a nucleolar phosphoprotein with a possible role in 
ribosome biogenesis (Schmidt-Zachmann et at. 1987). Okuda and co-workers identified 
NPM/B23 as a constituent of the centrosome and a target of Cdk2-cyclin E (Okuda et al. 
2000). The association of the protein with the centrosome is dynamic. NPM/1323 
associates with the unreplicated centrosome and leaves the centrosome at the beginning 
of the duplication process. At the onset of mitosis the protein is again present at the 
centrosome (Zatsepina et al. 1999; Okuda et al. 2000). In vitro, the disappearance of 
NPM/B23 from the centrosome is mediated by the phosphorylation of Thr199 by Cdk2-
cyclin E (Okuda et al. 2000; Tokuyama et al. 2001). What happens in vivo is less clear, 
NPM/1323 could leave the centrosome upon phosphorylation or be degraded by an 
ubiquitin-dependent proteasome complex present at the centrosome whose activity is 
required for centrosome duplication (see below). Phosphorylation of NPM/B23 and 
dissociation from the centrosome are essential for the initiation of centrosome duplication 
as demonstrated by the use of non-phosphorylatable mutants and antibody micro-
injection which both prevent NPM/B23 from leaving the centrosome (or being degraded) 
and inhibit centrosome replication (Okuda et al. 2000). During S and G2 phases the re-
association of the protein with the centrosome is prevented, presumably through Cdk2-
cyclin A activity. During mitosis the protein re-associates with the centrosome, possibly 
through the action of Cdkl-cyclin B and each daughter cell receives an NPM/B23-bound 
centrosome. The role of this protein in the centrosome cycle remains unclear. 
Nucleophosmin NPM/1323 may be part of the molecular machinery licensing centrosome 
replication and could act locally to inhibit the duplication process when present at the 
centrosome. 
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Cdk2 plays a crucial role in the centrosome cycle at the GUS transition by 
licensing centrosome replication, restricting centrosome duplication to once per cell cycle 
and ensuring the coordination with DNA synthesis. However, Cdk2 is not the only kinase 
regulating the centrosome cycle. Other kinases involved in this process have been 
described. 
b) MPS1 is required for centrosome duplication 
The murine Mpslp (mMpslp, previously known as esk) is an ortholog of the 
Mpslp kinase of Saccharomyces cerevisiae, a protein involved in spindle pole body 
duplication and the spindle assembly checkpoint. It phosphorylates Spc98p, SpcllOp, 
and Spc42p, a SPB core component (Donaldson and Kilmartin 1996; Pereira et al. 1998; 
Friedman et al. 2001; Castillo et al. 2002). mMpslp localises to the centrosome 
throughout the cell cycle (Fisk and Winey 2001). The kinase activity of the protein is 
required for centrosome duplication since a kinase-dead mutant prevents centrosome 
replication (Fisk and Winey 2001). Moreover, over-expression of mMpslp in NIH 3T3 
cells arrested in S phase triggers centrosome reduplication. Cdk2-cyclin E activity is 
required for mMpslp-dependent centrosomal duplication and for maintaining the stability 
of the protein by protecting it from degradation (Fisk and Winey 2001). However, a 
recent report on the human ortholog, hMpslp, revealed a role in the spindle assembly 
checkpoint, but no evidence was found for a role in centrosome duplication (Stucke et al. 
2002). Moreover, the fission yeast ortholog of mMpslp, mph1, is also involved in the 
spindle checkpoint but not in SPB duplication. Furthermore, the Caenorhabditis elegans 
genome does not encode Mpslp but a unique kinase, encoded by the zyg-] gene, involved 
in centrosome duplication (He et al. 1998; O'Connell et al. 2001). Hence, the biological 
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function of Mpslp proteins in higher eukaryotes and their role in the centrosome cycle 
are still unclear and controversial. 
ZYG-1, a unique kinase involved in centriole duplication 
The zyg-] gene of Caenorhabditis elegans encodes a protein kinase which does 
not belong to any known kinase sub-family (Hanks and Hunter 1995). ZYG-1 associates 
transiently with the centrosome, essentially from anaphase to telophase. zyg-] mutants 
form monopolar spindles with a single centrosome, containing a single centriole. Cell 
cycle progression is not affected in these mutants, suggesting that ZYG-1 is essential in 
the initial steps of centriole duplication for daughter centriole formation and seems 
specifically involved in this process, unlike Cdk2 (O'Connell et al. 1998; O'Connell et al. 
2001). However, no substrates have yet been identified and the exact role of the protein 
remains unknown. 
The role of calcium and calmodulin-dependent kinases in the 
centrosome cycle 
Periodic calcium oscillations are observed in Xenopus laevis embryos, in 
particular at the GuS and G2/M transitions when centrosome duplication and centrosome 
separation occur respectively, suggesting that calcium may play a role in the centrosome 
cycle. Matsumoto and Mailer found that a transient increase of calcium concentration is 
required to initiate centrosome duplication in Xenopus egg extracts (Matsumoto and 
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Mailer 2002). This effect is mediated through the Calmodulin dependent protein kinase II 
(CaMKII), a protein previously described at the centrosome (Ohta et al. 1990). The mode 
of action of CaMKTI is not clear. Its target(s) are presently unknown, although a number 
of likely candidates are found at the centrosome, including calmodulin and the centrins 
(Li et al. 1999). 
Centrins (centrin 1 to 4) are EF-hand proteins localised at the centrosomes and 
belong to the calmodulin superfamily of calcium binding proteins. Centrin 2 localises to 
the centrosome, whereas centrin 3 localises to the PCM (Baron et al. 1992; Paoletti et al. 
1996; Laoukili et al. 2000). Depletion of the human centrin 2 in HeLa cells, and over-
expression of human centrin 3 in a two-cell stage Xenopus embryo lead in both cases to 
failure of both cytokinesis and centrosome duplication (Middendorp et al. 2000; 
Salisbury et al. 2002). In addition, a conditional mutation in cdc3], the yeast centrin 
gene, results in failure of the SPB to duplicate (Baum et al. 1986). Finally, 
phosphorylation of centrin by PKA during G2/prophase correlates with centrosome 
disjunction, and aberrant centrin phosphorylation was described in breast tumors with 
amplified centrosomes (Lingle et al. 1998; Lutz et al. 2001). All these data support a role 
for centrin 2 and 3 in centrosome duplication. It is, however, not known how these 
proteins act. In Spermatozopsis similis, centrins assemble in a fibrous structure, which 
emanates from the centriole (McFadden et al. 1987). Cdc31p, the yeast centrin protein, 
localises to a sub-structure of the SPB, called the half-bridge, bridging the original and 
nascent SPBs. Therefore, centrins could participate in the formation of a structure 
facilitating subsequent steps of centriole assembly. Alternatively, centrins, as Ca"-
binding protein, could act as regulators, modulating the activities of other proteins. 
W. 
Polo and polo-like kinases 
Protein kinases from the Polo family have been described in many organisms. 
Piki, a mammalian member of this family, regulates many cellular processes such as 
DNA damage checkpoint activation, regulation of the anaphase promoting complex, and 
centrosome duplication and maturation (Golsteyn et at. 1995; Kotani et al. 1998; Smits et 
al. 2000; Golan et al. 2002). Plkl associates with mitotic spindle poles until metaphase at 
which point it relocates to the midzone. 
When Plkl function is impaired by antibody microinjection, cells display 
duplicated yet unseparated centrosomes (Lane and Nigg 1996). It has been shown that 
Plkl phosphorylates cyclin B at the onset of mitosis therefore activating Cdkl 
(Toyoshima-Morimoto et al. 2001). HsEg5 is phosphorylated by Cdkl, suggesting that 
P1k! regulates HsEg5 activity and therefore centrosome separation (Blangy et at. 1995). 
In Drososphila Polo mutants, y-tubulin does not concentrate on centrosomes, but is 
scattered throughout the spindle, suggesting that the centrosomal kinase Polo is required 
for recruiting y-tubulin to the centrosome (Donaldson et al. 2001). 
Aurora A regulates centrosome replication 
Aurora A belongs to a family of serine/threonine kinases. It localises to the 
centrosome from the end of S phase, after centriole duplication, until early GI when the 
protein is degraded (Dutertre et al. 2002). Aurora A is not involved in the control of 
centrosome duplication since overexpression does not lead to centrosome overduplication 
(Meraldi et al. 2002). Inhibition of Aurora A leads to a failure in centrosome separation 
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both in Xenopus and Drosophila (Glover et al. 1995; Roghi et al. 1998). Eg5 has been 
shown to be phosphorylated by Aurora A presumably in order to trigger centrosome 
separation. In Drosophila, the enzyme phosphorylates theDrosophila-transforming acidic 
coiled-coil (D-TACC) protein allowing the recruitment of this protein to the centrosome 
(Giet et al. 2002). Moreover, in Drosophila cells with a delocalised Aurora A, y-tubulin 
and centrosomin are not detected at the centrosome, suggesting that Aurora A is required 
for the recruitment of these proteins at the centrosome (Berdnik and Knoblich 2002). 
2) Ubiquitin-mediated proteolysis and regulation of 
the centrosome cycle 
Increasing evidence suggests that ubiquitin-dependent proteolysis plays a role in 
the centrosome cycle. kp1-Cull-E box (SCF) and the anaphase promoting 
Qomplex/Qyclosome (APC/C) are two E3 ubiquitin ligase complexes involved in 
regulating the centrosome cycle. 
a) Role of the SCF E3 ubiquitin ligase in the centrosome cycle 
The first evidence for an involvement of SCF in regulating the centrosome cycle 
came from the observation that Skpl and Cull, two core components of the SCF, are 
localised at the centrosome (Freed et al. 1999; Gstaiger et al. 1999). Microinjection of 
antibodies against either of these proteins inhibits centriole separation. Moreover, the use 
of a proteasome inhibitor impairs centriole disorientation in vitro and prevents 
centrosome duplication when injected into Xenopus embryos (Freed et al. 1999). 
Furthermore, mutations or knock-outs of SCF components in Drosophila and mice result 
in supernumerary centrosomes (Nakayama et al. 2000; Wojcik et al. 2000). These data 
suggest a complex role of SCF in the centrosome cycle. It could act in centriole 
disorientation, which would be a pre-requisite for centrosome duplication, as well as in 
centrosome separation. 
b) The APC/C is involved in centrosome replication events 
The anaphase promoting complex/cyclosome has an important role in the 
metaphase to anaphase transition. It is also involved in the centrosome cycle even though 
it does not have a centrosomal localisation. It has recently been implicated in controlling 
the events at the GUS transition, by preventing the accumulation of cyclin A, which is 
required to trigger centrosome duplication in somatic cells (Meraldi et al. 1999). Recent 
studies demonstrated that the human Emil protein can inhibit the APC/C activity at the 
GuS transition, therefore stabilising cyclin A and triggering entry into S phase (Hsu et al. 
2002). A possible role of the APC/C would be to prevent premature centrosome 
duplication. 
Recently, Nek2 was shown to be a substrate for APC/C ubiquitination through a 
KEN box motif, involving the APC/C in the control of centrosome separation (Pfleger 
and Kirschner 2000). 
3) E21F is required for centrosome duplication 
In somatic cells, centrosome duplication and DNA replication are connected 
through the common requirement of Cdk2 activity but also through phosphorylation of 
the retinoblastoma protein and release of E2F transcription factor (Meraldi et at. 1999). 
E217 activates the transcription of Emil, promoting the accumulation of cyclin A (Hsu et 
al. 2002). Interestingly, both cyclin E and A genes are targets of E2F, which might 
explain the requirement of E2F for centrosome duplication. Alternatively, E2F could 
promote the transcription of genes encoding proteins involved in centrosome replication. 
The centrosome cycle is a mechanism under the control of many regulatory 
proteins. De-regulation of the cycle leads to supernumerary centrosomes, aneuploidy, 
genetic instability and cancer. 
C - Centrosome and cancer, deregulation of the 
centrosome cycle 
Many reports established a correlation between centrosomal abnormalities in 
structure and number, aneuploidy and cancer. However, it is not clear if centrosomal 
abnormalities are the cause or the consequence of tumorigenesis (Lingle and Salisbury 
2000). Abnormally duplicated centrosomes are found in tissues or cells carrying 
mutations in proteins implicated in recognition (BRCA1 and BRCA2) or in response to 
DNA damage (p53, p21, GADD45a), in protein degradation (Skp2) or in mitosis (Aurora 
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A). The role of some of these proteins in regulating centrosome duplication begins to be 
understood. 
The role of p53 in regulating the centrosome cycle 
The p53 gene is mutated in more than half of cancers and negatively regulates 
centrosome duplication. p53 is required for the transcription of the Cdk2 inhibitor 
p21/Waf-1 (el-Deiry et al. 1993; Harper et al. 1993). Therefore a lack of p53, and p21, 
leads to an increased Cdk2 activity and overduplication of centrosomes. Loss of p53 also 
results in an excess of Aurora A leading to cytokinesis failure and polyploidy (Meraldi et 
al. 2002). p53  is present at the centrosome throughout the cell cycle and is thought to 
regulate centrosome duplication through physical association with the centrosome, in a 
transcription-independent mechanism (Ciciarello et al. 2001; Tarapore et al. 2001). The 
molecular basis of this mechanism is currently unknown. p53 could modulate the activity 
of centrosomal proteins by direct interaction as previously described for the p53-trk A 
interaction (Brown et al. 2000). 
BRCA1, a suppressor protein involved in 
centrosomal functions 
Breast cancer suppressor protein I  (BRCA1) plays an important role in many 
cellular processes including transcription regulation, DNA damage repair and centrosome 
duplication. Mutations in BRCA] are associated with the development of familial breast 
and ovarian cancer. The BRCA1 protein localises to the centrosome during mitosis and 
binds 'y-tubulin in vitro when hypophosphorylated (Hsu and White 1998; Xu et al. 1999). 
BRCA1 interacts with many proteins involved in the centrosome cycle including p53 and 
Cdk2-cyclin A or E, suggesting a complex mechanism of action. When phosphorylated 
by Cdk2 (or other kinases), BRCA1 fails to interact with the centrosome, whereas the 
hypophosphorylated form causes centrosome amplification (Hsu et al. 2001). Moreover, 
the absence of BRCA1 results in centrosome amplification, suggesting that the protein 
could act as a repressor of centrosome duplication (Xu et al. 1999). Since BRCA1 is a 
regulator of transcription it could also influence centrosome duplication by regulating 
genes involved in the centrosomal replication process such as p21 (Hollander et al. 1999; 
Mantel et al. 1999). 
IV Research subject presentation - aims of 
thesis 
As described above, the GuS transition is the point where centrosome duplication 
begins. Moreover, the centrosome is required to progress from GI to S phases. Although 
progress has been made in understanding the role of the centrosome in these processes, 
the molecular events are still not fully understood. It is known that changes occur, both 
qualitatively and quantitatively, in centrosome composition. As described above, 
nucleophosmin NPMIB23 is located at the centrosome in GI phase and leaves it upon 
phosphorylation by Cdk2 in S phase. Another example is the phosphorylation of mMpslp 
at the GUS transition. 
To better understand the mechanism of centrosome duplication and the role of the 
centrosome at the GuS transition, we decided to investigate the overall changes 
occurring in the PCM between G  and S phase by comparing its composition at these two 
cell cycle stages. 
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MATERIALS AND METHODS 
All solutions were prepared using de-ionised water (Purite) and where 
appropriate, were autoclaved before use. Chemicals used were purchased from Sigma or 
Merck, unless noted otherwise. 
I 	Materials 
A - Cell culture 
1) Tissue culture cell lines 
HeLa JW cells were cultured in Dulbecco's modified Eagle's medium. HeLa S3, 
Jurkat, K562, HL60 cells, DT40 and DU249 chicken cells were cultured in RPMI 1640. 
All media were supplemented with 10% foetal calf serum, L-glutamine (2 mM) and 
antibiotics (penicillin and streptomycin 50 IU each). DT40 medium was also 
supplemented with 1% chicken serum. These cell lines were grown at 37°C in a 5% CO2 
humid atmosphere. 
Kel 
A6 Xenopus laevis cells were cultured at room temperature (22°C) in 65% 
Leibowitz L-15 media, 35% H20 supplemented with 10% fatal calf serum, L-glutamine 
(2 mM) and antibiotics (penicillin and streptomycin 50 IU each). 
2) Hybridoma culture 
Hybridoma cells were cultured in RPMI 1640 supplemented with 10% foetal calf 
serum, 10% condimed Hi (Roche), L-glutamine (2 mM), antibiotics (penicillin and 
streptomycin 50 IU each), hypoxanthine (100 MM), aminopterin (16 M) and thymidine 
(400 nM) at 37°C in a 5% CO2 humid atmosphere. 
B - Escherichia coil strains used during this work 
E. coli strains were routinely grown at 37°C in Luria Bertani (LB) medium. 
XL1-Blue cells were used for cloning and amplifying plasmid DNA. BL21(DE3) 
cells were used for protein expression. 
E. coli genotype: 
XL1-Blue: SupE44 hsd17 recAl endAl gyrA46 thi relAl lac, F'[proAB laqP 
1acZAM15 Tn]O (tel')] 
BL21(DE3): B F dcm ompThsdS (rB-MB-)  galL(DE3) 
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C - Peptides 
The peptide CSVTKGVVHQETEIA was synthetised by SIGMA, coupled to 
keyhole limpet hemocyanin using the N-terminal cystein, and used to immunise two 
rabbits. The sequence is located in the carboxy-terminal portion of Xenopus laevis 
4.1R135 (x4.1R'35) (residues 788 to 801). 
The peptide EPKELEELREKNESL is located in the tail domain of Xenopus 
D - Primers 
Name Sequence Comments 
XF2 TTCTAGAATGACTACAGAGAAGGGGTTATTA Xba I cloning site 
XF3 TTCTAGATTAAGCTATTTCTGTCTCTTGATG Xba I cloning site 
XF4 TTCTAGATACACAAAGACTGTAAAAGGTG Xba I cloning site 
XIF5 TTCTAGACTACTGGGTGGTGGTGGTACTAC Xba I cloning site 
XF6 GACCCAGAAGCAGACTGTGA Sequencing primer 
XF7 ACTTTATGCGAGGCCTTTGA Sequencing primer 
XF8 CATGGTGTAGACTATGTCAG Sequencing primer 
XF9 GGGAATAGACTCTGTGGATG Sequencing primer 
XF 10 GTCGTTTGTCCCATTCGCTG Sequencing primer 
XF1 1 AAACCGCCGAGCTATTTCTGTCTCTTGATG Sac II cloning site 
HCA66fwd CGGGGTACCATGGCAGAGATAATTCAGGA Kpn I cloning site 
HCA66rev CGCGGATCCTAAATGGCCAGTCTGATGCA BainH I cloning site 
HCA66dirl CGCGGCCGCCATGGCAGAGATAATTCAGGA Not I cloning site 
HCA66revl CCTCGAGTAkATGGCCAGTCTGATGCA Xho I cloning site 
HCA66- 1 CGCACTGCGCTTTCATCCAG Sequencing primer 
HCA66-2 AAGTGAGAGGATCATCTGTG Sequencing primer 
HCA66-3 GTCAGArTGCCAATACAAGC Sequencing primer 
HCA66-4 CAATGGCAGACAAACCTGGG Sequencing primer 
MCC-1 CTGCAGTGACCTGAACTCAG Sequencing primer 
MCC-2 TGCTCAATGTGCCTGTCCAC Sequencing primer 
MCC-3 TTCCCATCGCCAAGATTGCT Sequencing primer 
MCC-4 ATTGCTTTTACATTCCTCCA Sequencing primer 
MCC-5 GACCAGTCGGGGGATGAAZ\] Sequencing primer 
MCC-6 CTCCTCCTTCATGGCCATGA Sequencing primer 
MCC-7 GCCCAGGAGCAGGCCTACCT Sequencing primer 
Table 3: Primers used for cloning and sequencing 
E - Antibodies 
Antibody Source Working 
dilution 
Polyclonal anti Septin Dr. M. Kinoshita, Boston 1/200 IF, 1/300 lB 
Polyclonal anti 4.IR Dr. A. Baines, Canterbury 1/400 lB 
Polyclonal anti PCM-1 Dr. A. Merdes, Edinburgh 1gIml IF, lB 
Polyclonal anti Centrin-3 Dr. M. Bornens, Paris 1/100 IF, 1/200 lB 
Monoclonal anti Pericentrin Dr. 	A. 	Dammermann, 
Edinburgh  
1/100 IF 
Polyclonal anti y-Tubulin Dr. R. Heald, Berkley 1/100 IF 
Monoclonal anti y-Tubulin Sigma 1/100 IF, lB 
Monoclonal anti Lamin B1(clone L-5) Zymed Laboratories 1/500 lB 
Mononoclonal anti Porin Molecular Probes 1/200 lB 
Monoclonal anti a-tubulin (clone DM1A) Sigma 1/1,000 IF, lB 
Polyclonal anti 3-tubulin This study 1/30 IF, 1/50 lB 
Polyclonal anti PARP-1 NEB 1/500 lB 
Polyclonal anti HCA66 This study 1/100 IF, 1/300 lB 
Polyclonal anti MCC1 This study 1/100 IF, 1/300 lB 
Texas red and FITC conjugated antibodies for 
immunofluorescence 
Jackson Labs 1/200 
HRP-conjugated secondary antibodies for ECL Amersham 1/10,000 
Table 4: Antibodies used during this work 
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F - Common reagents and buffers 
Name Composition 
4x protein sample buffer (Laemli 250 mM Tris pH 6.8, 9.2% SDS, 0.2% Bromophenol blue , 40% 
buffer) glycerol, 1% 2-mercaptoethanol 
6x DNA loading buffer 0.25% bromophenol blue, 0.25% xylene cyanol FF, 15% Ficoll 
Type 400 (Pharmacia) in water 
Buffer A (for tubulin purification) 50 mM Imidazole/HCI, pH 7.2, 0.5 mM MgCl, 0.1 mM EGTA, 1 
mM 2-mercaptoethanol 
BRB80 80 mM PIPES pH 6.8, 1 mM MgCl2 , 1 mM EGTA 
BRB80-30% glycerol BRB 80 in 30% glycerol 
Cell lysis buffer for centrosome 1 mM Tris pH 8.0, 0.5% Nonidet (NP40), 0.5 mM MgCl,, 0.1% 
extraction 2-mercaptoethanol, 1 mM PMSF, 10 .tg/ml LPC, 10 	tg/ml 
aprotinin 
5X 	column 	buffer 	(for tubulin 0.5 M Pipes pH 6.9, 10 mM EGTA, 5 mM MgS041  10 mM DTT 
preparation purification)  
Coomassie blue solution 0.1% (w/v) Coomassie blue R250, 10% acetic acid, 50% ethanol, 
10% methanol 
CSF-XB XB + 10 mM K-HEPES pH 7.7, 50 mM sucrose, 5 mM EGTA 
pH 7.7 
Energy Mix (EM) 7.5 mM creatine phosphate, 1 mM ATP, 0.1 mM EGTA, 1 mM 
MgCl2  
Fixative for aster observation 50% glycerol, 10% formaldehyde (eventually 0.1 Itg/ml DAPI) in 
1X PBS 
Glycerol/PB 80 mm K-Pipes, 5 mM MgCl2, 1 mM EGTA, 1 mM GTP, 33% 
glycerol (v/v) 
GTE 25 mM Tris pH 8.0, 10 mM EDTA, 50 mM Glucose 
KPN 50 mM KC1, 50 mM Pipes pH 7.0, 10 mM EGTA, 1.92 mM 
MgCl2 , 1mM DTT, 100 juM PMSF, 20 jtM cytochalasin B, 1 
jig/ml LPC. 
Luria bertani medium (LB) 1% Bactot-tryptone, 0.5% Bacto-yeast-extract, 1% NaCl pH 7.4 
Microtubule resuspension buffer 0.1 M Na-Hepes pH 8.6, 1 mM MgCl2 , 1 mM EGTA, 40% 
(for rhodamine tubulin preparation) glycerol 
MMIR 100 mM NaCl, 2 mM KCI, 1 mM MgC12 , 2 mM CaC12, 0.1 mM 
EDTA, 5 mM HEPES pH 7.8 
PBS 65 mM Na2PO4, 8.8 mM KH2PO4, 1.37 M NaCl, 2.7 mM KC1 pH 
7.4 
PBS Tween (PBStw) PBS-0.1% Tween 20 
PEM 5 mM PIPES pH 6.8, 1 mM MgSO4, 1 mM EGTA 
lox Ponceau S solution 2% (w/v) Ponceau 5, 30% (w/v) trichioroacetic acid, 30% (w/v) 
sulfosalicylic acid 
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Protease inhibitor cocktail (LPC) leupeptin, pepstatin, chymostatin 10 mg/ml each in DMSO 
Protein electrophoresis buffer 25 mM Tris, 0.192 M Glycine, 0,1% SDS 
Separating gel buffer 1.5 M Tris base, 0.4% SDS, pH 8.8 
Stacking gel buffer 0.5 M Tris base, 0.4% SDS, pH 6.8 
Sucrose gradient buffer 10 mM K-PIPES pH 7.2, 1 mM EDTA, 0.1% 2-mercaptoethanol, 
0.1% Triton- X-100 
TAE 40 mM Tris-acetate, 1 mM EDTA 
TB 10 mM Pipes, 55 mM MnC121  15 mM CaCI7 , 250 mM KCI, pH 
6.7 
Transfer buffer Protein electrophoresis buffer in 20% Methanol. 
XB 100 mM KCI, 1 mM MgC12, 0.1 mM CaCl2 , pH 7.8 
Table 5: Common reagents and buffers 
II 	CELL BIOLOGY TECHNIQUES 
A - Transfection of HeLa JW cells. 
Transfections of plasmid DNA in HeLa JW cells were performed by precipitation 
of DNA with calcium phosphate. Briefly, 60 t1 of 2 M CaCl2 was added to 10 jtg DNA, 
diluted in 420 pJ dH20 with constant vortexing. 480 tl of 2X HEBS buffer (280 mM 
NaCl, 50 mM HEPES, 1.5 mM Na2HPO4, pH 7.15) was then added and the mixture was 
incubated for 20 minutes at room temperature. The DNA precipitate was then added to 
70% confluent HeLa cells for at least 9 hours. Then, the cells were washed with PBS and 
fresh medium was added. 
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B - Synchronisation of cells. 
Arresting Jurkat cells in S phase 
Typically, 2x109 Jurkat cells were arrested in S phase by inhibition of DNA 
polymerase 6 using a double aphidicolin block. 1 tg/mI of aphidicolin was added to the 
culture medium for 16 hours. The drug was washed off and the cells were grown for 9 
hours under normal conditions then a second block was performed for another 16 hours. 
The percentage of cells arrested in S phase was determined by FACS analysis (see 
below). 
Arresting HeLa S3 cells in prometaphase 
HeLa S3 cells were arrested in mitosis by adding nocodazole (200 ng/ml) for 24 
hours to the culture media. Cells were then fixed with —20°C cold methanol and their 
DNA stained with DAPI as described below. Efficiency of mitotic block was monitored 
by counting mitotic cells. 
C - Cell DNA content analysis by flow cytometry 
Cells were washed twice in cold PBS then fixed in ethanol 70%, then put at 4°C 
for at least 30 minutes. Cells were then washed in PBS and incubated for 30 minutes at 
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37°C in PBS containing 10 gg/ml of RNase A. Propidium iodide (40 [g/m1) was added 
to the cells which were then analysed by flow cytometry (FACSCalibur Beckton 
Dickinson). The data were then processed using CellQuest software from Beckton 
Dickinson. 
D - Immunofluorescence 
1) Fixation of the sample 
Two different methods have been used to fix cells grown on glass coverslips. 
Cells grown on glass coverslips were fixed in -20°C methanol for 10 minutes, 
rehydrated in PBS by three washes of 5 minutes and processed for staining as described 
below 
Alternatively, cells were fixed in 3.7% formaldehyde-PBS for 10 minutes. 
Unbound formaldehyde was quenched using 50 mM NH4CI in PBS. Cells were then 
permeabilized in PBS-0.2% Triton X-100 for 5 minutes, washed once with PBS and 
processed for staining as described below. 
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Staining of the sample 
Fixed cells were incubated in PBS-0.1% Tween 20 (v/v) (PBStw) containing 
0.5% fish gelatin for 5 minutes, then incubated with the primary antibody for 45 minutes 
at room temperature in a humidified chamber. After three washes of 3 minutes with PBS, 
cells were incubated as described previously with a secondary antibody, conjugated to a 
fluorescent dye (either FITC or Texas Red). Cells were then washed with PBS and the 
DNA was stained with DAPI (0.6 Itg/ml) for 3 minutes. 
Mounting and analysis of the sample 
Coverslips were rinsed in PBS and mounted on a drop of antifade mounting 
medium (Vectashield®,  Vector") placed on a microscope slide. 
Slides were examined on a Zeiss Axioskop2 fluorescence microscope. Images 
were captured using a Zeiss Axiocam camera and AxioVision software and imported 
into Adobe Photoshop 5.5. 
lmmunofluorescence on suspension cells 
Jurkat cells do not attach to glass coverslips. Therefore, to perform 
immunostaining they were washed twice in PBS by centrifugation and resuspension, 
then fixed in cold methanol for 10 minutes. Rehydratation, blocking and incubation with 
the antibodies (primary and secondary) as well as DAPI staining were done as described 
above. All these steps were done in a microtube. Finally, cells were centrifuged on a 
glass slide at 200 g for 4 minutes using a Cytospin (Shandon), mounted and analysed as 
described above. 
III BIOCHEMICAL TECHNIQUES 
A - Expression and purification of recombinant 
proteins. 
BL21(DE3) bacteria were transformed with the expression vector of interest as 
described below. Transformed cells were grown from a single colony in LB medium 
containing the appropriate selection marker at 37°C under shaking until 0D600 reached 
0.6. To induce the expression of the exogenous protein, IPTG (1 mM final) was added to 
the media, and cells were grown for at least two more hours. Bacteria were pelleted 
(3,500g, 4°C, 10 minutes) and washed twice in cold PBS containing 0.2 mM PMSF. The 
pellet was then frozen at —80°C for 16 hours. After thawing, the pellet was resuspended 
by sonication on ice, in cold PBS containing 0.2 mM PMSF. Cells were centrifuged at 
18,000g, 4°C for 15 minutes. The supernatant was stored at —20°C (PBS fraction) and the 
pellet resuspended by sonication on ice, in cold PBS containing 0.2 mM PMSF and 0.2% 
Triton X-100. After centrifugation (18,000 g, 4°C, 15 minutes), the pellet was 
resuspended by sonication and incubated for two hours at room temperature in a buffer 
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containing 8 M urea, 50 mM Na2HPO4, 0.2 mM PMSF (pH 7.6). The supernatant (Triton 
fraction) was stored at —20°C. The urea solution was spun at 18,000 g for 20 minutes at 
room temperature. The supernatant (urea fraction) and the pellet resuspended in dH20 
were stored at —20°C. 
An aliquot of each fraction was analysed by SDS-PAGE to determine which of 
them contained the recombinant protein. The gel was then stained for 1 hour with 
coomassie solution (0.1% (w/v) Coomassie blue R250, 10% (v/v) acetic acid, 50% (v/v) 
ethanol, 10% (v/v) methanol). Following a brief rinse in water, the gel was washed in a 
destaining solution (10% (v/v) methanol, 20% (v/v) acetic acid). When sufficient 
destaining was obtained, the gel was dried between two cellophane sheets. 
B - Purification of GST/His-tagged protein under 
denaturing conditions 
1) His tagged proteins 
1 to 2 ml of chelated sepharose slurry (Amersham) was washed twice with dH20 
and incubated for 5 minutes with a 0.1M NiSO4 solution. The slurry was centrifuged (2 
minutes, 200 g) and washed with dH2O several times. It was then equilibrated with the 
same buffer in which the protein was kept (in most cases 8 M urea, 50 mM Na2HPO41  pH 
7.6) and transferred into a Biorad-Econo column. Binding of the hexa-His-tagged protein 
to the nickel beads was performed by running the fraction containing the protein through 
the column. The flow-through was collected and stored at —20°C (flow-through fraction). 
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The column was washed with 20 ml of a solution containing 8 M urea, 50 mM Na2HPO4, 
pH 6, and the protein eluted with a solution containing 8 M urea, 50 mM Na,HP041  pH 
4.5. 
2) GST tagged proteins 
Bacterial pellets were resuspended in PBS containing 1% Triton X-100 and 0.5 
mM PMSF, sonicated 3 times for 20 seconds on ice and incubated for 30 minutes at 4°C 
with gentle agitation. Insoluble material in the lysate was then removed by centrifugation 
at 80,000 g for 30 minutes at 4°C. The supernatant was then incubated with imI washed 
glutathione sepharose (Amersham Pharmacia) for 30 minutes at 4°C with gentle 
agitation. Resin was recovered by centrifugation at 500 g for 5 minutes, and washed 5 
times with 10 ml PBS before transfer into a chromatography column and elution with 10 
mM reduced glutathione in 50 mM Tris pH 8.0 in 15 fractions of 1 ml. 
In both cases (His or GST) 10 jl of the fractions were run on a SDS-PAGE and 
the gel was stained with coomassie solution. 
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C - Purification of antibodies 
1) Affinity purification on a column 
Covalent binding of the antigen to the matrix 
10 to 20 mg of protein were incubated for 2 hours at room temperature with 500 
mg of BrCN-sepharose, pre-washed in 1 mM HCI. The binding efficiency of the protein 
to the matrix was assayed using the Bradford procedure (Bradford 1976, see below). The 
free groups remaining on the matrix were blocked using 0.1 M Tris pH 8 overnight at 
4°C. The excess ligand was washed with potassium acetate, pH 4.2, then 0.1 M Tris, pH 
8.6 three times. The slurry was then poured into a column and washed with PBS. 
Purification of the antibody 
To bind the antibody to the antigen, 1.5 ml of the serum was run twice through 
the above column. After two washes with PBS, the antibody was eluted in a solution of 
high salt/low pH (50 mM glycine, 500 mM NaCl, pH 2.2). 0.5 ml fractions were 
collected and the pH neutralised using 0.05 volumes of 2 M unbuffered Tris. Protein 
concentration was assayed according to Bradford. Antibody-containing fractions were 
pooled together. 
Affinity purification on a nitrocellulose membrane 
The recombinant protein was run on a SDS polyacrylamide gel and transferred 
onto a nitrocellulose membrane as described. The membrane was then stained with a 
Ponceau S solution and the area containing the protein cut out, destained and blocked 
overnight in PBS-0.1% Tween 20 (PBStw) containing 1% fish gelatin. The membrane 
was then incubated in blocking buffer for 4 hours at 4°C with the primary antibody then 
washed successively in PBStw containing 1% fish gelatin, PBStw and PBS. The 
antibody was eluted by incubating the strip in 400 IAI of elution buffer (200 mM glycine, 
0.5 M NaCl, pH 2.3) for 40 seconds. The acid was then neutralised by addition of 1.2 ml 
of phosphate buffer (500 mM Na2HP041  pH 9.0). This elution process was repeated 
twice. Tween 20 and gelatin were added to the eluate (final concentrations 0.1% and 1% 
respectively) which was then dialysed against PBStw at 4°C for 20 hours. 
Affinity purification on protein G 
In order to purify the monoclonal antibody produced by the hybridoma, 25 ml of 
filtered tissue culture supernatant were run through a protein G column previously 
washed in PBS. The column was washed three times with 100 mM Tris pH 8.0 and twice 
with 10 mM Tris pH 8.0. The antibody was then eluted at low pH in glycine solution as 
described above. Fractions were collected, pH neutralised and analysed using a 10% 
SDS-PAGE. Protein concentration was determined by Bradford assay. 
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D - Protein extraction from eukaryotic cells 
Two different methods were used to extract proteins depending of the cell type and the 
experiment. 
Standard protein extraction procedure 
lx iO adherent cells (HeLa JW, A6) were scraped off a tissue culture dish in 100 
.tl of lysis buffer (4X sample buffer + 0.1 mM PMSF) and boiled for 10 minutes. 
Concentrated extract 
As an alternative to the above method, in order to prepare very concentrated cell 
extract, cells (usually HeLa S3) were grown as described and washed twice in 1 volume 
of cold PBS. They were then washed in 50 ml of cold KPN buffer (50 mM KCI, 50 mM 
Pipes pH 7.0, 10 mM EGTA, 1.92 mM MgC12, 1 mM DTT, 100 AM PMSF, 20 AM 
cytochalasin B, 10 Ag/ml of leupeptin, pepstatin, chymostatin (LPC)) then in 1 ml of the 
same buffer. After centrifugation at 800 g, the cell pellet was frozen in liquid nitrogen. 
Cells were lysed by three cycles of thawing-freezing and ground using a mechanical 
pellet-pestle. The extract was then clarified by ultra-centrifugation at 120,000 g for 45 
minutes at 4°C. The soluble fraction was aliquoted and stored at -80°C. The protein 
concentration was determined using the Bradford procedure and was typically between 
30 and 45 Ag/Al. 
E - Determination of protein concentration 
Protein concentration was determined using the Bradford assay (Bradford 1976). 
Samples were incubated in Protein Assay Reagent (Bio-Rad) diluted 5 fold in dH20 for 
5 minutes. Absorbance at 595 nm was then determined in a spectrophotometer, and 
protein concentration determined by comparison to a BSA standard curve obtained under 
the same conditions. 
The protein concentration of cell extracts prepared in sample buffer containing 
SDS (but not 2-mercaptoethanol or bromophenol blue) was determined by BCA assay 
(Smith et al. 1985). imI of working reagent, made up from 100 parts of bicinchoninic 
acid solution and 2 parts of 4% copper (II) sulphate pentahydrate, was added to 50 ILl of 
sample and incubated at 60°C for 15 mm. Absorbance at 562 nm was then determined, 
and protein concentration determined using a BSA standard curve. 
F - Immunoblotting 
Most samples were run on the EC120 Mini Vertical Gel System (E-C Apparatus Co, 
Holbrook NY). Samples for mass spectroscopy were run on a Protean II xi cell with 1.0 
mm spacers (Bio-Rad). 
Gel electrophoresis (SDS-PAGE) 
The separating gel was made of a 30% acrylamide/bisacrylamide stock solution 
(Perven Biotech) (dilutions to different percentages were used depending on the 
resolution required), 0.25 volume separating gel buffer (1.5 M Tris base, 0.4% SDS, pH 
8.8), 0.1% ammonium persulfate (made freshly every week) and 1/20,000 volume 
TEMED. The solution was poured between two glass plates, overlaid with water-
saturated butanol and allowed to polymerise. The butanol was then discarded and the 
stacking gel made of 0.25 volume stacking gel buffer (0.5 M Tris base, 0.4% SDS, pH 
6.8), 5% acrylamide/bisacrylamide, 0.1% ammonium persulfate and 1/10,000 volume 
TEMED) poured on top of the resolving gel. 
Protein samples were loaded in sample buffer (62.5 mM Tris pH 6.8, 2.3% SDS, 
0.05% bromophenol blue, 10% glycerol, 0.25% 2-mercaptoethanol) and run on a SDS-
PAGE in protein electrophoresis buffer (MB: 25 mM Tris, 0.192 M glycine, 0.1% SDS). 
Minigels were run at 25 mA until the dye reached the bottom of the gel. Larger gels were 
run at 35 mA for 4.5 hours. 
Protein transfer on nitrocellulose and antibody 
incubation 
Minigels were blotted on a nitrocellulose membrane in transfer buffer (MB 
containing 20% methanol) at 20 V for 90 minutes. Transfer efficiency was controlled 
afterwards by staining proteins with a Ponceau S solution. After destaining using PBS, 
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the membrane was saturated overnight at 4°C with PBStw containing 5% (w/v) non-fat 
milk powder. The membrane was incubated with the primary antibody for 4 hours at 4°C 
(or room temperature depending on the antibody), washed 3 times 10 minutes with 
saturating solution and incubated for 1 hour at room temperature with the secondary 
antibody conjugated to horseradish peroxidase diluted 1/10,000 in saturating solution. 
3) Immunological detection of protein 
Using enhanced chemoluminescence 
5 ml of 100 mM Tris pH 8.5 containing 25 itl of 90 mM coumaric acid and 25 
of 250 mM luminol were mixed with 5 ml of 100 mM Tris pH 8.5 containing 3 Jtl of 
30% (w/w) H2021  incubated with the membrane for 1 minute then removed. The 
nitrocellulose membrane was wrapped in cling-film and placed in an autoradiography 
cassette to be exposed to an X-ray film for a different lengths of time (usually 10 
seconds, 2 minutes and 10 minutes). Films were developed in a Konica SRX-101A 
developer. 
For occasional re-use to allow re-probing, membranes were washed and kept at 
4°C in PBS for a few days or stored wet at 4°C wrapped in cling-film. 
Quantitative immunoblotting 
Quantitative immunoblotting was performed using ECL-Plus reagent as 
described by the manufacturer (Amersham Pharmacia Biotech). Quantification was 
performed using a STORM 860 phosphorimager (Molecular dynamics) and ImageQuant 
vi. 1 software (Molecular dynamics). 
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4) Stripping of nitrocellulose membrane 
Prior to incubation with a different antibody, membranes were incubated in 
stripping buffer (2% SDS, 62.5 mM Tris pH 6.7, 0.1 M 2-mercaptoethanol) for 30 
minutes at 60°C with agitation. Blots were then washed twice for 15 minutes with PBStw 
before blocking them again as described above. 
G - Dot Blotting 
A nitrocellulose membrane was placed into a blotting chamber. 6 jig of protein in 
50 p1 PBS were put onto the membrane for 30 minutes then the chamber was connected 
to a vacuum pump and the wells washed twice with PBS. The membrane was removed 
from the chamber and processed as described above. 
H - Preparation of recombinant protein for injection 
into rabbits. 
Several techniques were used to prepare samples 
Protein samples were run on SDS-PAGE as described. Gels were rinsed 3 times 
10 minutes in dH20 and stained with aqueous coomassie blue (0.1% Coomassie blue in 
25 mM Tris, 0. 192 M Glycine) for 1 hour at room temperature while shaking. The gel 
was destained for 3 times 10 minutes in Tris-glycine buffer (25 mM Tris, 0.192 M 
Glycine). The desired band was excised with a clean razor blade. The band was cut into 
smaller pieces, then ground to a fine powder using a ceramic mortar and pestle which 
had been pre-chilled at —80°C and contained a small amount of liquid nitrogen. Protein 
powder was stored at —80°C before being sent for injection into rabbits. 
Alternatively, when protein samples were pure enough, proteins were dialysed 
overnight at 4°C against PBS and stored at —80°C before being sent for injection into 
rabbits. 
Rabbits were immunised with 100-200 pg protein in a volume less than 250 p1. 
Rabbits were injected three times, over a period of 3 months, with the same amount of 
antigen and a small blood sample was taken from the rabbits for testing one week after 
injection 2 and 3. Rabbit antibodies were raised either by Eurogentec (Belgium) or by 
SAPU Diagnostics Scotland (Scotland). Prior to immunisation, pre-immune bleeds from 
all animals were screened by immunofluorescence staining on cultured cells to avoid use 
of animals that contained an immune titre against cellular structures. 
The mouse immunisation with 4.1C antigen was done by Dr. A. Merdes using 50 
jig of protein in 250 p1 total volume of PBS. The mouse was injected three times over a 
period of 1 months with the same amount of protein. 
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I - Purification of porcine brain tubulin 
The purification is based on cycles of polymerisation-depolymerisation of tubulin. 
Adapted from Williams and Lee (1982) and Sloboda and Rosenbaum (1982) 
Pig brains were carried from the slaughterhouse to the lab in ice-cold buffer A 
(50 mM Imidazole/HC1, pH 7.2, 0.5 mM MgCl,, 0.1 mM EGTA, 1 mM 2-
mercaptoethanol). Meninges from 5 brains of freshly slaughtered pigs were removed and 
brains were chopped into small pieces. Ice-cold buffer A at a ratio of 1 mi/ig of brain 
was added to brain pieces. Brains were homogenised in the presence of 1 mM PMSF 
using a blender. The suspension was centrifuged for 25 minutes at 8,000 g at 4°C. The 
supernatant was mixed with half volume of buffer A, pH 6.8 containing 12 M glycerol 
then, ATP and GTP were added to the mixture at a final concentration of 1 mM and 0.1 
mM respectively (polymerisation step). The mixture was then quickly warmed up to 
37°C for 30 minutes and split in 3 different rotors to be centrifuged as follows: 160,000 g 
for 35 minutes at 37°C in Beckman rotors type 45Ti and 70Ti; 1 hour at 80,000 g in 
Beckman rotor JA25.50 at 30°C. Pellets were resuspended, using a dounce-homogenizer, 
in ice-cold buffer A, pH 6.7, 1 mM EGTA. The suspension was incubated on ice for 30 
minutes then centrifuged at 4°C, 80,000 g for 30 minutes. A polymerisation step was 
performed as previously described and microtubules centrifuged for 45 minutes, 37°C at 
160,000 g. The pellet was ressuspended in ice-cold column buffer (0.1 M K-Pipes, pH 
6.8, 2 mM EGTA, 1 mM MgC12, 2 mM 2-mercaptoethanol) aiming for a protein 
concentration of 35 mg/mi. The mixture was dounce-homogenised as above and the 
material was frozen in liquid nitrogen and stored at —80°C. 
Mes 
Separation of tubulin from microtubule-associated proteins requires chromatography on 
a phosphocellulose column. 
To prepare the phophocellulose column (at least a day prior the tubulin prep) 500 
ml of ethanol were added to 20 g of dry Whatman p- 11 resin, gently stirred, and left to 
sediment. After removal of the ethanol, the resin was incubated with 500 ml of 0.5 M 
NaOH for 30 minutes at room temperature, to allow sedimentation. The supernatant was 
decanted and the resin washed several times with dH20 until the washing solution 
reached approximately pH 8. 50 ml of 0.5 M HC1 was then added to the resin, gently 
stirred and sedimented for 30 minutes at room temperature. Supernatant was poured off 
and replaced with fresh HCI, which was poured off after another 30 minutes. Then, the 
resin was washed with dH20 until the washing solution reached pH 5. The resin was then 
placed in 500 ml of 5X column buffer (0.5 M Pipes pH 6.9, 10 mM EGTA, 5 mM 
MgSO4, 10 mM DTT), pH titrated to 6.9 with NaOH and the mixture was left to 
sediment for few minutes at room temperature before decanting. The resin was washed 
with 1.5 1 of 1X column buffer (0.1 M Pipes pH 6.9, 2 mM EGTA, 1 mM MgSO4, 2 mM 
DTT), transferred to a 250 ml cylinder and mixed with buffer. The resin was allowed to 
settle for few hours, and after decanting of the supernatant, buffer was added to obtain 
1.2 times of the slurry volume. The slurry was poured into a 2cm x 45cm column in the 
cold room. The column was washed at high flow rate (>1.5 ml/minute) with 5 column 
volumes of lx column buffer. The last wash before running the column contained 0.1 
mMGTP. 
Frozen protein was thawed and loaded onto the column. 3 ml fractions were 
collected and an aliquot was run on a polyacrylamide gel to determine which fractions 
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contained the pure tubulin. The concentration of protein was determined, as described 
previously using a Bradford assay. Fractions showing a tubulin concentration above than 
1 mg/ml were pooled and [Mg"] brought to 1mM using MgSO4. Tubulin was flash-
frozen in small droplets and stored in liquid nitrogen. 
J - Labelling of tubulin with rhodamine 
According to Hyman and collaborators (Hyman et al. 1991) 
1) Producing polymerisation-competent tubulin 
The cycling procedure eliminates tubulin subunits that are not polymerisation-competent 
and produces a tubulin preparation suitable for in vitro assays. 
Fifty milligrams of tubulin were thawed in glycerol/PB buffer (80 mM K-Pipes, 5 
MM MgC12, 1 mM EGTA, 1 mM GTP, 33%(v/v) glycerol, pH 6.8). Microtubuies were 
polymerised at 37°C, 30 minutes, then layered onto a cushion of BRB80 buffer (80 mM 
PIPES pH 6.8, 1 mM MgC12, 1 mM EGTA) containing 60% (v/v) glycerol pre-warmed 
to 37°C. Microtubules were sedimented for 30 minutes at 190,000 g, 37°C, in a Beckman 
TLA 100 rotor. The supernatant was aspirated, the cushion interface was rinsed twice 
with dH20 and the cushion was then aspirated. The microtubuie pellet was broken down 
in ice-cold BRB80 and incubated at 0°C for 15 minutes. The volume of BRB80 was 
adjusted to yield a protein concentration 10 to 30 mg/ml, assuming half of the initial 
protein was polymerised. After centrifugation (60,000 g, 15 minutes), the tubulin present 
in the supernatant was repolymerised by incubation for 30 minutes at 37°C in the 
presence of 1 mM GTP and 15% glycerol. Microtubules were sedimented and 
resuspended in ice-cold BRB80 following the procedure described above. After a last 15 
minutes incubation at 0°C, the tubulin in the mixture was sedimented at 60,000 g for 15 
minutes at 0°C in a TLA100 rotor. Tubulin present in the supernatant was aliquoted and 
stored at —80°C or used for labelling. 
2) Labelling of tubulin with rhodamine 
GTP and glycerol were added to the tubulin in BRB80 (tubulin was now in 
glycerol/PB: 80 mm K-Pipes, 5 mM MgCl2,  1 mM EGTA, 1 mM GTP, 33% glycerol 
(v/v)). Tubulin was allowed to polymerise at 37°C for 30 minutes. Microtubules were 
layered onto a cushion of 0.1 M Na-Hepes pH 8.6, 1 mM MgCl2, 1 mlvi EGTA, 60% 
glycerol pre-warmed to 37°C, and sedimented in a Beckman SW41 rotor at 200,000 g, 
37°C, 50 minutes. The supernatant was aspirated and the cushion washed with 
resuspension buffer (0.1 M Na-Hepes pH 8.6, 1 mM MgCl2,  1 mM EGTA, 40% 
glycerol). Microtubules were resuspended by pipetting and vortexing in a minimal 
volume of pre-warmed resuspension buffer (100 to 200 	1/10 volume of 100 mM 
rhodamine (Molecular Probes) in DMSO was added to the microtubules and the mixture 
was incubated for 10 minutes at 37°C. The reaction was stopped and the pH lowered by 
addition of 2 volumes of BRB80 containing K-Glutamate and 40% glycerol (vlv). The 
mixture was loaded onto a 60% glycerol BRB80 cushion and centrifuged for 15 minutes 
at 60,000 g at 37°C. Prior to resuspension of the pellet in ice-cold BRB80, the 
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supernatant was removed and the cushion washed as described above. The mixture was 
incubated at 0°C for 15 minutes then cold-centrifuged for 15 minutes at 60,000 g. Two 
cycles of polymerisation depolymerisation were performed for the rhodamine-labelled 
tubulin. The final pellet was resuspended in BRB80, aliquoted, flash-frozen in liquid 
nitrogen and stored at —80°C. 
K - Preparation of cytostatic factor-arrested frog egg 
extract. 
Xenopus laevis egg extracts were prepared according to A. Murray (Murray 199]). 
Frogs were primed for ovulation by injection of 50 U of pregnant mare serum 
gonadotropin (PMSG) on day 1 and 25 U on day 3. Ovulation was induced on day 5 by 
injecting 150 U of human chorionic gonadotropin (HCG). Eggs were harvested on day 6 
by gentle massage of the frogs and collected in MIIVIR buffer (100 mM NaCl, 2 miVi KCI, 
1 mM MgC12, 2 mM CaCl2, 0.1 mM EDTA, 5 mM HEPES pH 7.8). Eggs were dejellyed 
in an XB solution containing 2% cysteine (100 mM KC1, 1 mM MgC121  0.1 mM CaCI,, 
pH 7.8) then washed in CSF-XB buffer (XB + 10 mM K-HEPES pH 7.7, 50 mM 
sucrose, 5 mM EGTA pH 7.7). After addition of protease inhibitors (LPC: leupeptin, 
pepstatin, chymostatin 10 tg/ml each) and 10 tg/ml cytochalasin B, the eggs were first 
compacted in a swinging bucket centrifuge (800 g, 4°C, 1 minute) and after removal of 
excess buffer, crushed by centrifugation (12,000 g, 4°C, 15 minutes). The cytoplasmic 
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layer was collected using a needle and syringe via side puncture. The extract was kept on 
ice to be used immediately or aliquoted and stored at —80°C. 
The quality of the extract was assayed by monitoring aster and spindle formation 
when incubated at room temperature with demembraned frog sperm nuclei. 10 p1 of 
freshly made extract was incubated for various periods of time (typically, 10, 30 and 60 
minutes) with sperm nuclei, energy mix (EM: 7.5 mM creatine phosphate, 1 mM ATP, 
0.1 mM EGTA, 1 mM MgC12) and rhodamine-labelled tubulin. 1 p1 of sample was 
spotted on a microscope slide on top of 4 p1 of fixative solution (50% glycerol, 3.7% 
formaldehyde, 0.1 pg/mI DAPI in 1X PBS). A coverslip was carefully placed on top of 
the fixed sample allowing visualisation by fluorescence microscopy. 
L - Centrosome related techniques 
1) Purification of centrosomes 
Centrosomes were purified according to Bomens, 1987 (Bomens et al. 1987). 
Briefly, 2x109 cells (either Jurkat or DT40), were grown as previously described. 1 h 
prior to harvesting, the cells were grown in the presence of 0.2KM nocodazole and 
1 jig/ml of cytochalasin D to depolymerise microtubules and actin, respectively. Cells 
were washed twice with cold PBS and once with cold 0.1X PBS-8% sucrose (w/v). 
After sedimentation (800 g, 5 minutes, 4°C), they were lysed in 25 ml of lysis buffer (1 
mM Tris pH 8.0, 0.5% Nonidet (NP40), 0.5 mM MgC121  0.1% 2-mercaptoethanol, 
protease inhibitor cocktail (PMSF 1 mM, 10 pg/ml LPC, 10 [tg/ml aprotinin). The 
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swollen nuclei and cell debris were sedimented at 2,000 g for 15 minutes and the 
supernatant filtered through a 100 m nylon mesh. The lysate was then incubated for 30 
minutes at 4°C in the presence of 10 mM K-FIEPES pH 7.2, 1 mM EDTA and 600 U of 
DNase I. The supernatant was overlaid on a discontinuous sucrose gradient (5 ml of 
70% sucrose (w/w), 3 ml of 50% sucrose (w/w), 3m! of 40% sucrose (w/w) in 10mM 
K-PIPES pH 7.2, 1mM EDTA, 0.1% 2-mercaptoethanol, 0.1% Triton- X-100) and 
centrifuged at 100,000g, 4°C for 1 hour. 0.5 ml fractions were collected from the 
bottom of the centrifuge tube. 
2) Aster formation assay 
Centrosome fractions were assayed for their ability to stimulate aster formation 
both in frog egg extracts and pure tubulin. 1 l of each fraction was incubated for 30 
minutes either at room temperature with 6 jd of concentrated mitotic frog egg extract 
containing energy mix or at 37°C with pure porcine brain tubulin in BR1380-30% 
glycerol (0.2v) containing 2 mM GTP. In both cases rhodamine-labelled tubulin was 
added to visualise microtubules. 1 l of sample was spotted onto a microscope slide on 
top of 4 itl of fixative solution (see above). A coverslip was carefully placed on top of 
the fixed sample, allowing visualisation by fluorescence microscopy. 
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Stripping of centrosomes 
To solubilise the pericentriolar material, purified centrosomes were incubated in 
1 M KI (prepared in PEM) at 4°C in the dark. The mixture was centrifuged at 120,000 g 
for 30 minutes at 4°C. The supernatant, containing the soluble material was then 
concentrated using a Centricon YM-10 device (cut-off of: 10 kDa; Millipore). The 
mixture was filtered through the device by centrifugation (5,000 g, 4°C) until almost all 
the liquid went through the membrane. The retained proteins were then recovered by 
inversion of the tube and a brief centrifugation at 200 g for 3 minutes. To remove all KI, 
they were then diluted in PEM, filtered through the device and recovered as described 
previously. Proteins were boiled for 5 minutes in protein sample buffer and stored at 
—80°C until loading on a polyacrylamide gel. 
Immunofluorescence analysis of centrosomal 
fractions 
5 Id of a centrosomal fraction were diluted in 300 l PEM buffer and loaded in a 
corex tube onto a PEM-15% sucrose cushion containing a glass coverslip, sitting on an 
adapter made of araldite®.  Centrosomes were sedimented by centrifugation (10,000 g, 
4°C, 15 minutes), then coverslips were immersed in methanol at —20°C for 6 minutes. 
Coverslips were rinsed three times for 3 minutes with PBS and blocked for 3 minutes 
with PBStw-0.5% fish gelatin. Primary antibody was diluted to a working concentration 
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in blocking solution and incubated for 30 minutes in a humid chamber at room 
temperature. The coverslips were rinsed twice in PBStw prior to incubation, as described 
above, with the secondary antibody diluted 1/100 in blocking solution. Coverslips were 
rinsed twice in PBS and incubated in 100% ethanol for two minutes. After drying, they 
were mounted on a drop of mounting medium (Vectashield®, VectorTM) placed on a 
microscope slide. Photometric quantification of immunofluorescence signals were 
performed from digital image files taken with a 40x/0.75NA lens. Mean pixel values of 
13x13 pixels areas were calculated using Adobe Photoshop 5.5 software. 
M - Silver staining of polyacrylamide gels 
Gels were fixed twice for 15 minutes in a 30% ethanol, 10% acetic acid solution. 
They were then sensitised for 30 minutes with a fixative solution containing 0.1% 
Na2S203 (w/v) titrated to pH 6.0. After three washes of 20 minutes in dH20 gels were 
incubated for 30 minutes in a 0.1% silver solution containing 0.01% formaldehyde. 
Excess of silver was removed by a brief rinse in dH20. The gel was developed using a 
solution of 2.5% Na2CO3 containing 0.02% formaldehyde. When sufficient staining was 
obtained the developing solution was discarded and the development stopped using 1% 
acetic acid. The bands of interest were cut using a clean razor blade and stored at -80°C. 
N - Sample preparation for mass spectrometry 
analysis 
Cut bands were thawed and incubated in 200 mM NH4HCO3, 50% acetonitrile 
(ACN) at 30°C for 3 times 30 minutes to remove the SDS. Proteins were then reduced by 
incubation in 20 mM DYT, 200 mM NH4HCO3, 50%ACN at 30°C for 1 hour. The DTT 
was then removed by three 5 minutes washes in 200 mM NH4HCO3, 50%ACN. 
Cysteines were then alkylated in 50 mM iodoacetamide, 200 mM NH4HCO3, 50%ACN 
at room temperature in the dark for 20 minutes. Bands were washed three times in 20 
mM NH4HCO3, 50% ACN then cut in small pieces using a clean scalpel, spun 2 minutes 
at 18,000 g and covered with ACN until they turned white. ACN was decanted and gel 
pieces were air-dried for 20 minutes. Gel pieces were swollen in 50 mM NH4HCO3 
containing 2.5 units of recombinant porcine trypsin (Promega). This solution was kept on 
ice for 30 minutes then transferred to 32°C for 18 hours. After digestion was completed, 
products were stored at —20°C. Samples were then given to the in-house (ICMB) mass 
spectroscopy facility for further processing and analysis by MALDI-tof (matrix-assisted 
laserdesorption/ionisation-time of flight) on a Voyager-DE STR-Biospectrometry 
workstation mass spectrometer (PerSeptine B iosystems). 
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IV NUCLEIC ACID TECHNIQUES 
A - Extraction of plasmid DNA from bacteria 
from a small volume of culture (mini-prep) 
1.5 ml of an overnight grown colony were spun 2 minutes at 10,000 g. The 
bacterial pellet was resuspended in 200 ld of GTE buffer (25 mM tris pH 8.0, 10 mM 
EDTA, 50 mM glucose) and the cells were lysed by adding 400 t1 of lysis solution (0.2 
M NaOH, 1% SDS). The bacterial debris and the chromosomal DNA were precipitated 
by addition of 300 tl of 3 M sodium acetate pH 5.3 and then pelleted for 15 minutes at 
18,000 g. The supernatant was collected and the plasmid DNA precipitated by adding 0.7 
volumes of isopropanol. After centrifugation (18,000 g, 15 minutes), the DNA pellet was 
washed in 70% ethanol and resuspended in 20 pJ dH20 containing 0.5 jig of RNase A. 2 
was analysed on a 1% agarose gel (usually after a restriction digest). 
from a large volume of culture 
When a larger amount and cleaner DNA was needed (e.g. for transfection 
experiments) we used the QIAFILTER MIDI-KIT. 100 ml of overnight culture were 
harvested and plasmid DNA isolated using the QlAfilter Plasmid Midi Kit (QIAGEN) 
Ii1 
according to manufacturer's instructions. The yield was determined by measuring 
absorption at 260 nm. 
For multiple plasmid DNA preparations of the same construct, columns were 
regenerated after use by passing through another volume of elution buffer, followed by 
one volume of 0.5x TE, 50% ethanol. Columns were stored dry at room temperature. 
B - Restriction digest of DNA 
Restriction digests were performed for at least 2 hours using enzymes from New 
England Biolabs. Reactions were performed in the buffer (eventually supplemented with 
1 mg/ml BSA) and at the temperature appropriate for the enzyme(s) used (usually 37°C). 
C - Agarose gel electrophoresis. 
Unless otherwise specified, all agarose gels were made of 1% agarose (Bioline, 
London) containing 0.3 ig/ml of ethidium bromide in TAE buffer (40 mM Tris-acetate, 
1 mM EDTA), and the electrophoresis was performed in the same buffer at 100 V. 
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D - Purification of DNA from agarose gels 
Electrophoresis was performed as described above. After visualisation using U.V. 
light, relevant bands were cut out of the gel using a clean razor blade and placed into a 
1.5 ml tube. DNA was extracted using a Qiagen Gel extraction kit according to 
manufacturer instructions. 
E - Blunting of 5' and 3' DNA overhangs 
When possible, restriction enzyme(s) were heat-inactivated and digest reactions 
were supplemented with 33 AM of each dNTP and 2.5 U of DNA polymerase I Klenow 
fragment (New England Biolabs). When it was not possible to inactivate the enzyme(s), 
DNA was gel-purified and resuspended in restriction digest buffer supplemented with 33 
/LM each dNTP and 2.5 U of DNA polymerase I Kienow Fragment (New England 
Biolabs). Fill-in was performed for 15 minutes at 25°C. Reactions were stopped by 
addition of EDTA to 10mM and heat-inactivated at 75°C for 20 minutes. 
va1 
F - Ligation of DNA 
Ligations were performed overnight at 16°C using 400 U of T4 DNA Ligase 
(New England Biolabs) in ligation buffer (50 mM Tris, 10 mM MgCl., 10 mM DTT, 1 
mM ATP, 25 tg/m1 BSA, pH 7.8) at a 3/1 molar ratio of insert/vector. For blunt-end 
ligations, purified vector was pre-treated with 5 U of alkaline phosphatase for 1 h at 
37°C. The reaction was stopped by adding 0.5 mM EDTA and heating at 65°C for 15 
minutes. The DNA was purified as previously described. 
G - Vector constructions 
1) pRSET-MCC821 and pRSET-MCC987 
The full-length cDNA clone of MCC1 (mutated in colorectal cancer 1) was 
obtained through the IMAGE consortium (IMAGE clone 4111706). DNA of this clone 
was digested by Pvu II and Nco I enzymes. The 821 bp and the 987 bp fragments were 
gel purified and cloned into pRSET-A previously cut by Pvu II and Nco I or only by Pvu 
II generating pRSET-MCC821 and PRSET-MCC97 respectively. In the PRSET-MCC987 
cloning orientation was verified by PCR using T7 and MCC4 primers located in the 
vector and the insert respectively. 
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Construction of pRSET-HCA66 and pRSET-
H CA6687366 
An HCA66 cDNA containing the whole open reading frame was generated by 
PCR using specific primers (HCA66fwd and HCA66rev; see Table 3), Taq DNA 
polymerase (Roche), and reverse transcription products from randomly primed Jurkat 
RNAs as a template. The PCR product was gel purified and ligated into pGEM-T® vector 
(Promega) as described. Accuracy of the insert sequence was verified by sequencing. 
The construct was then digested by EcoR I and Hind III and cloned into pRSET-C 
previously cut by the same enzymes. Boundaries were verified by sequencing. pRSET-
HCA6687366 was generated by cutting the full length cDNA (in pGEM-T®) by EcoR I and 
Hind III, gel purification and cloning into a pRSET-C vector previously cut by the same 
restriction enzymes. 
Construction of pCMV-HCA66myc 
An HCA66 cDNA containing the whole open reading frame was generated by 
PCR using specific primers (HCA66dirl and HCA66revl; see Table 3), Taq DNA 
polymerase (Roche), and pRSET-HCA66 as template. The PCR product was gel purified 
and ligated into pGEM-T® vector (Promega) as described. Accuracy of the insert 
sequence was verified by sequencing. The construct was then digested by Not I and Xho 
I and cloned into pCMV-Tag5A (Stratagene) previously cut by the same enzymes. 
Boundaries were verified by sequencing. 
Construction of pRSET-x4.1 R 
A x4.1R'35 cDNA containing the whole open reading frame was generated by 
PCR using specific primers (XF2-XF3; see Table 3) containing Xba I sites, Pfu turbo 
DNA polymerase (Stratagene) and pSP64T-x4.1R as a template (gift from R. Moon). 
PCR conditions were as described. The PCR products were run on a gel and purified as 
described. After purification, amplified DNA was cut by Xba I, purified again and cloned 
into pBluescript SK previously digested by Xba I thus generating pBS-x4.1R. The 
sequence of the insert was verified by sequencing as described. 
To generate pRSET-x4.1R, the pRSET-B vector was cut with BamH I and pBS-
x4.1R cut by Xba I. Both sites were filled-in using Klenow enzyme and ligated as 
described. Orientation of insertion was verified by PCR using T7 and XF7 primers. 
Boundaries were verified by sequencing. 
Construction of GST-x4.1 R135 
To generate GST-x4. 1R'35, the pGEX-4T-3 (Pharmacia) vector was cut by EcoR I 
and pBS-x4.1R cut by Xba I. Vector (pGEX-4T-3) and insert (x4.1R) were gel purified, 
filled-in using Kienow, dephosphorylated and ligated as described. Orientation of 
insertion was verified by restriction digest. Boundaries were verified by sequencing. 
H - Preparation of E. co/i competent for 
transformation by heat-shock 
E. coli cells (BL21(DE3) or XL1-Blue) were taken from a frozen glycerol stock 
and grown overnight at 37°C on LB agar plates. A single colony from this plate was 
inoculated into 2 ml LB and grown overnight at 37°C. 1 ml of this pre-culture was put 
into 500 ml LB containing 10 mM MgCl2  and the bacteria were grown with vigorous 
shaking at 18°C until 0D600 reached 0.25-0.7. Growth was stopped by placing cells on 
ice for 10 minutes. They were then harvested at 2,500 g for 10 minutes at 4°C. The pellet 
was resuspended in 80 ml of TB buffer (10 mM Pipes, 55 mM MnCl2, 15 mM CaCI,, 
250 mM KCI, pH 6.7) and cells were harvested again. They were then resuspended by 
swirling in 20m1 TB containing 7% DMSO and placed on ice for 10 minutes. Cells were 
then aliquoted, flash-frozen and stored at -80°C. 
I - Transformation of Escherichia coil strains. 
Supercoiled DNA (5 to 100 ng) or a ligation product was adsorbed on competent 
bacteria on ice for at least 30 minutes. Cells were heat-shocked at 42°C for 1 minute then 
incubated on ice for 2 minutes. Cells were grown for 45 minutes at 37°C in LB medium 
then plated on LB-agar plates containing the appropriate antibiotic. 
J - Sequencing 
Sequencing was performed using BigDye 0.0 kit (Applied Biosystems). 
250 ng DNA were incubated in a final volume of lOpi, containing 1.6 pmol of 
primer and 4 Al BigDye Terminator v3.0 Ready Reaction mix. The reaction was 
performed in a Biometra T3 Thermocycler. DNA was first denatured for 2 minutes at 
96°C, followed by 25 cycles of 30 seconds denaturation at 96°C, 15 seconds annealing at 
50°C, and 4 minutes elongation at 60°C. Reactions were then kept at 4°C. 
DNA was then precipitated by adding 50 of solution containing 1.5 itl of 3 M 
sodium acetate pH 4.6, 31.25 id ethanol and dH20. Tubes were then placed at -80°C for 
15 minutes before centrifugation at 18,000 g for 30 minutes at 4°C. Pellets were washed 
with 70% ethanol, centrifuged again for 10 min and dried for 1 hour at room 
temperature. Samples were then brought to the sequencing facility (ICABP) for loading 
onto an ABI Prism 377 DNA sequencer (Applied Biosystems). 
ABI sequence files were analysed using the Sequencher sequence analysis 
software (Gene Codes Corporation, Ann Arbor, MI, USA). 
K - Polymerase Chain Reactions 
PCR was performed in a Biometra T3 Thermocycler 
Except when specified all PCR was performed using 2U of Taq DNA Polymerase 
(Roche), 1 mM dNTPs and 25 pmoles of each primer in a PCR buffer (10mM Tris pH 
8.3, 1.5 mM MgC12, 50 mM KCI). Parameters were: denaturation for 3 minutes at 95°C 
followed by 30 cycles of 1 minute denaturation at 95°C, annealing 1 minute at Tm-3°C 
of the lowest melting temperature, polymerisation at 72°C for 1.5 mm/kb to amplify. 
Then, a last polymerisation step was performed at 72°C for 7 minutes. PCR products 
were kept at 4°C. 
L - RNA extraction and RT-PCR. 
1) RNA Extraction 
RNA was extracted from either HeLa JW or Jurkat cells as described by 
Chomczynski (Chomczynski and Sacchi 1987). HeLa JW cells were harvested with 
trypsin then washed with PBS. After centrifugation (800 g, 5 minutes), the cell pellet 
was resuspended in 1 ml of lysis buffer (4M guanidium thiocyanate, 25 mM sodium 
citrate, 0.5% sarcosyl, 150 mM 2-mercaptoethanol). 0.1 volume of sodium acetate (2 M, 
pH 4.0) and 1 volume of water-saturated phenol were added to the lysate and the mixture 
put on ice for 10 minutes. 0.2 volumes of chloroform were then added and the mixture 
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was centrifuged for 20 minutes at 4°C (5,000 g). RNAs present in the aqueous phase 
were precipitated with 1 volume of isopropanol (1 hour, -20°C) and washed with 70% 
ethanol. The RNA pellet was resuspended in water. The amount of RNA extracted was 
determined by spectrophotometry at 260 nm. 
2) First strand cDNA synthesis 
1 jtg of total RNA, 250 ng random primers and 2 mM dNTPs were incubated at 
65°C for 5 minutes then quickly chilled on ice for additional 5 minutes. Then, 40 U of 
RNAsin'M (Promega) and reverse transcription buffer (50 mM Tris pH 8.3, 75 mM KC1, 
30 mM MgCl2, 20 mM DTT) were added and the mixture was incubated for 5 minutes at 
25°C. 200 U of SUPERSCRIPTTM  RNase if reverse transcriptase (Invitrogen) were 
added and the tube placed at 42°C for 50 minutes. Heating at 70°C for 15 minutes 
stopped the reaction. 1/10 of the reverse transcription product was used for the PCR, 
performed as described above. 
RESULTS 
Many questions regarding the role of the centrosome at the GuS transition and 
the molecular events of centrosome duplication are yet unanswered. Moreover, little is 
known about the differences in the composition of the centrosome in mitosis compared to 
its composition in interphase (the recruitement of y-tubulin at the onset of mitosis is one 
example). We aimed to investigate these topics by purifying centrosomes to identify 
centrosomal proteins potentially involved in either of these processes, using mass 
spectrometry. 
We tried to purify centrosomes from different cell lines available in the 
laboratory. The different attempts made to isolate centrosomes from HeLa JW cells 
(fibroblast cell line, adherent) were unsuccessful, or too few centrosomes were 
recovered (<5x106 centrosomes from 2x109 cells). This very low yield was presumably 
due to the high level of intermediate filaments present in this cell type, therefore 
impairing the purification of centrosomes. In contrast, the use of Jurkat cells (T 
lymphoma, growing in suspension), a cell line with few intermediate filaments and a 
high nucleus/cytoplasm ratio, gave a high yield of purification (>4x108 centrosomes 
from 2x109 cells, see below). We therfore decided to use this cell line to isolate 
centrosomes (see below). 
FOR 
I 	Identification of cell cycle-dependent 
changes of the PCM 
A - Purification of centrosomes from Jurkat cells 
Centrosomes were isolated from Jurkat cells using a sucrose step-gradient as 
described in Materials and Methods (section III-L-1, see Figure 7 for a schematic 
representation of the isolation procedure). To identify centrosome-containing fractions, 
an aliquot of each fraction was separated by SDS-PAGE, transferred onto a nitrocellulose 
membrane, and probed with a 7-tubulin antibody. As shown in Figure 8, 7-tubulin was 
typically located in fractions 6 to 11, suggesting that centrosomes were present in these 
fractions. However, the presence of 7-tubulin did not imply that purified centrosomes 
were functional. Since it was important to determine whether isolated centrosomes 
remained functional (i.e. to know whether they were able to nucleate microtubules), small 
aliquots of fractions 6 to 12 were incubated with frog egg extract and tested for their 
ability to nucleate microtubules and form asters. Asters were typically observed in 
fractions 7 to 11, 8 to 10 being the fractions were most asters were observed (Figure 7). 
However, these asters could be formed either by direct nucleation of microtubules from 
the intact purified centrosome, or by non-functional centrioles that have recruited PCM 
proteins from the extract, thereby reconstituting a functional centrosome. To discriminate 
between these two possibilities, fractions 7 to 11 were incubated with porcine brain 

















Fractions where most asters were observed (ususally 8 to 10) were kept for subsequent 
experiments. 
The number of purified centrosomes per fraction was estimated by extrapolating 
the number of asters counted in 50 different fields of 0.28 mm2 each, observed under a 
fluorescence microscope. The volume sample in each field was appoximately 0.00 1 jil. 
From this we calculated that typically, 4 to 8x108 centrosomes were recovered from 
2x109 cells, representing -45% to 30% of the initial number of centrosomes. 
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Figure 8: Immunob lotting of sucrose gradient fractions. 
Jurkat whole cell lysate (WCL) and 10 Al of fractions 3 to 13 from a sucrose gradient were electrophoretically 
separated on a 10% polyacrylamide gel, blotted onto a nitrocellulose membrane and probed with various antibodies 
detecting proteins with different intracellular localisation. y-tubulin monoclonal antibody was used to detect 
centrosome-containing fractions, whereas porin and lamin BI monoclonal antibodies were used to detect 
mitochondria and nuclear lamina-containing fractions respectively. The membrane was then stripped to probe for 
PoIyADP Ribosyl Polymerase (PARP-1) protein. Immunological detection was performed using enhanced 
chemiluminescence. An estimation of the quantity of asters formed by incubating an aliquot of the fraction in frog 
egg extracts is shown (from - none, to ++ many); nd: not determined. 
++ 
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B - The fractions are highly enriched in centrosomes 
We assayed the purity of these fractions by performing several immunoblots, 
using antibodies against likely contaminants such as mitochondrial or nuclear proteins. 
The presence of mitochondria was tested using an antibody against porin, a 
transmembrane protein which forms pores in the outer mitochondrial membrane. A signal 
was detected in fractions 7 to 11, revealing the presence of mitochondria in the 
centrosome preparation (Figure 8). We also checked the presence of nuclear 
contaminants using antibodies directed against the lamina protein, lamin Bi, and against 
the nuclear protein Poly (ADP ribosyl) polymerase 1 (PARP-1). Lamin BI and PARP-1 
signals were detected in fractions 7 to 11, suggesting the presence of nuclear protein 
contaminants in the centrosome fractions (Figure 8). However, when comparing the y 
tubulin signal with porin, lamin Bi, and PARP-1 signals in the whole cell lysate and the 
centrosome containing fractions, it appeared that y-tubulin was highly enriched in these 
fractions. These results demonstrated that fractions 7 to 11 were highly enriched in 
centrosomes but not in mitochondria or nuclear components. 
C - Isolation of "Gi" and "S" centrosomes 
In order to compare the protein composition of centrosomes from cells in GI with 
those from cells in S phase, centrosomes were isolated from unsynchronised cells and 
cells arrested in S phase. 
Ell 
Three different methods were tested to arrest the cells in S phase: double 
thymidine block, hydroxyurea or double aphidicholin block. Time course and dose-
effect experiments demonstrated that the double aphidicholin block gave the highest 
number of cells arrested in S phase (-80% versus -65% for thymidine block and -60% 
for hydroxyurea). This method was therefore chosen to arrest the cells in S phase. 
1) A Jurkat cell population enriched in S phase 
Jurkat cells were blocked in the early stages of S phase using aphidicolin, which 
inhibits DNA polymerase 6 (see Materials and Methods). The blocking efficiency and 
cell cycle profile were determined using flow cytometry analysis (Figure 9A). Typically, 
-80% of cells were arrested in S phase after treatment compared to -25% in an untreated 
culture (Figure 9A). Treatment with aphidicolin diminished the proportion of cells in GI 
(-9% in the aphidicholin-treated population compared to -65% in the untreated cells) and 
decreased the proportion of cells in G2/M (-4% of the aphidicholin-treated cells 
compared to --10% of the untreated cells). However, the number of apoptotic cells 
slightly increased ('--9% of the aphidicholin-treated cells compared to -4% of the 
untreated cells). Thus, the aphidicolin treatment diminished by more than 7 times the 
number of cells in GI and increased, more than 3 times, the number of cells in S phase, 
allowing us to compare the unsynchronised population with the S phase-arrested 
population. 
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2) Centrosomes do not over-duplicate upon 
treatment of Jurkat cells with aphidicolin 
As described in the introduction, a prolonged arrest in S phase can trigger over-
duplication of the centrosome in some cell types. To test if the double aphidicolin block 
led to supernumerary centrosomes, aphidicolin-treated cells were stained for y-tubulin. 
Figure 9B shows a representative example of aphidicolin-treated Jurkat cells stained with 
an anti-y-tubulin antibody. We did not detect an increase in the number of cells with more 
than two y-tubulin foci when compared to the unsynchronised population, suggesting that 
Jurkat cells do not support centrosome over-duplication in these conditions. Therefore, 
centrosomes isolated from aphidicolin treated cells will not have gone through several 
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Figure 9: Jurkat cells arrest in S phase when treated with aphidicolin. 
Jurkat cells were treated with aphidicolin as described in Materials and Methods. A, left panel, DNA 
content determined by FACS analysis on untreated (Un.) and aphidicolin-treated (S) Jurkat cells. 
Segments Ml, M2, M3 and M4 delimit the area of the graph used to determine the number of cells in 
different cell cycle stages (Ml: GI phase cells, DNA content: 2n; M2: S phase cells, DNA content: 
>2n, <4n; M3: G2/M phase cells, DNA content: 4n; M4 apoptotic cells, DNA content <2n) . The right 
panel shows a quantification of the FACS results: percentage of GI, S. G2/M or apoptotic cells was 
determined by integration of the signal (count) in segments Ml, M2, M3 and M4 respectively. B, 
Immunofluorescence on aphidicolin treated cells: cells were stained for y-tubulin (red); DNA was 
stained with DAPI (blue). Bar 5 jsm. 
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Figure 10: linmunoblot of various centrosomal proteins on isolated 
centrosomes. 
"Gi" (Gi) and "S" (5) centrosomes were electrophoretically separated and blotted onto a 
nitrocellulose membrane which was probed with PCM-1, y-tubulin and ci-tubulin antibodies. 
Immunological detection was performed using ECL-Plus reagent. 
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3) Quantitative analysis of the presence of some 
known proteins at "Gi" and "S" centrosomes 
We isolated centrosomes from an unsynchronised culture of Jurkat cells, therefore 
mainly in GI, and from a population of cells arrested in S phase. To simplify, these 
centrosomes will be referred as "Gi" centrosomes and "S" centrosomes respectively. We 
first tested whether there was a quantitative difference in the presence of known 
centrosomal proteins in "GI" and "S' centrosomes. Fractions 8 to 10 were pooled, an 
aliquot was subjected to SDS-PAGE and transferred onto a nitrocellulose membrane, 
which was probed with various available centrosomal antibodies. We did not detect any 
significant differences in the amount of PCM-1 and y-tubulin present at the centrosome 
from unsynchronised or S phase cells (Figure 10). However, the detection method did not 
allow an accurate measurement of protein amount, and subtle changes could be missed. 
We therefore decided to compare the protein amount on "GI" and "S' centrosomes using 
immunofluorescence. Centrosomes were centrifuged onto coverslips, fixed and 
imrnunostained for various centrosomal proteins as described in Materials and Methods 
(Figure hA). As expected, intensity of a-tubulin signal was identical in both centrosome 
populations. While performing the immunostaining experiments on centrosomes, we 
noticed that fractions from aphidicolin-treated cells contained cellular debris, which were 
stained by the antibodies, whereas centrosomes from untreated cells did not. No 
differences were observed in the signal intensity of y-tubulin from "Gi" or "S' 
centrosomes, confirming the results obtained by immunoblotting (Figure 11, Table 6). 
We also tested the amount of centrin and pericentrin present in those centrosomes (Figure 
11, Table 6). In both cases, the amount of proteins detected did not change significantly. 
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Figure 11: Immunofluorescence of centrosomal proteins. 
A, Centrosomes purified from a culture mainly in Gi (Gi) or synchronised in S phase (S) of the cell 
cycle were spun down on coverslips and stained for several known centrosomal proteins. On the right 
hand side of each panel are four magnified areas showing centrosomes representative of the field. Bar 
20 ,um. B, Quantification of the signal observed in A. Values are expressed as arbitrary units (a. unit) 
and should not be compared between different proteins. Photometric quantification of 
immunofluorescence signals were performed from digital image files taken with a 40x/0.75NA lens. 
Mean pixel values of 13x13 pixels areas were calculated using Adobe Photoshop 5.5 software. 95 
Interestingly, PCM-1 signal in "5" centrosomes was -150% the signal observed in "Gi" 
centrosomes, suggesting that PCM-1 is recruited at the centrosome in S phase (Figure 11 
and Table 6). 
Signal intensity in G 	(a.u.) Signal intensity in S (% of GI signal) 
a-tubulin 100 ± 48.10 114.59 ± 26.59 
y-tubulin 100±31.12 110.70±36.66 
PCM-1 100±30.19 152.85±35.02 
cent in 100±41.40 114.81±36.58 
pericentrin 100 ± 33.09 100.08 ± 36.24 
Table 6: Quantification of the signal of various centrosomal proteins on "Gi" centrosomes and "S" 
centrosomes. Signal intensity in "Gi" centrosomes was set to 100 (au.: arbitrary units). Signal intensity in 
S centrosomes is expressed as a percentage of the corresponding Gi signal. Values should not be 
compared between different proteins. 
4) Stripped centrosomes do not nucleate tubulin 
We were interested in identifying changes occurring in the pericentriolar material 
of "GI" and "S' centrosomes. Treatment of centrosome fractions with potassium iodide 
(KI), a chaotropic salt, was described to dissociate the centromatrix and the PCM 
(Schnackenberg and Palazzo 1999). Stripping the centrosomes would also have the 
advantage to decrease the system complexity and then facilitate the analysis. In our hand, 
the soluble fraction represented approximately 40-50% of the total material as determined 
by protein quantification using a Bradford assay. This ratio is lower than the one obtained 
by Schackenberg and collaborator in Spisula solidissima centrosomes (Schnackenberg et 
al. 1998). The difference might result from differences in the composition or architecture 
of Spisula solidissima and human centrosomes. 
A time course of KI incubation was performed in order to determine how long the 
centrosomes should be treated to dissociate the soluble from the insoluble fraction 
(Figure 12). An aliquot of both fractions was separated by SDS-PAGE, then probed for y-
tubulin, a PCM component. The y-Tubulin signal in the insoluble fraction decreased 
gradually with increased time of treatment to become barely detectable after one hour, 
whereas the signal increased in the soluble fraction, indicating that the PCM was 
gradually removed from the centromatrix (Figure 12B). The stripping efficiency was 
estimated to be 95% after 1 hour of treatment. When these stripped centrosomes were 
incubated with pure tubulin no asters were observed (Figure 13), confirming the stripping 
efficiency. When incubated in frog egg extracts, stripped centrosomes nucleated tubulin, 
and asters were observed. Thus, stripping with KI removes the ability of the microtubules 
to nucleate tubulin. This ability was restored when centrosomes were incubated in egg 
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Figure 12: Stripping of centrosomes with 1(1. 
A, Schematic representation of centrosome stripping. Centrosome fractions were incubated with 1M KI at 
4°C in the dark and the soluble fraction was separated from the insoluble fraction by ultracentrifugation. B, 
Time course of centrosomes incubated with 1M KI. Fractions (insoluble pellet: P, Soluble: S) were 
immunobloted with an anti y-tubulin antibody. Immunological detection was performed using enhanced 
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Figure 13: Stripped centrosomes do not form asters in pure tubulin, but can be 
reconstituted in frog egg extracts. 
Centrosomes or KI-stripped centrosomes were spun down on coverslips and incubated either with pure 
tubulin or with either frog egg extract, then incubated to allow aster formation as described in Materials 
and Methods. To visualise microtubules, assays were supplemented with rhodamine-labelled tubulin. 
D - There are differences in the PCM composition of 
"Gi" and "S' centrosomes 
Centrosomes were purified from unsynchronised and S phase-arrested cells and 
treated for lh with 1M KI to separate the soluble and insoluble fractions. Before loading 
onto a gel, the soluble fraction was concentrated and the KI removed using a centricon 
device as described in Materials and Methods. Centrosome preparations were run in 
parallel on 6.8%, 9% and 12.5% gels to obtain maximum resolution of high and low 
molecular weight proteins (Figure 14). By comparing the PCM from two different "GI" 
and "S' centrosome preparations on each gel, several differences in protein amount of 
silver stained bands were noticed. Two bands (n° 2 and 5) showed a greater protein 
amount in the PCM from "01" centrosomes when compared with the PCM from "S' 
centrosomes. On the other hand, nine bands (n° 1, 3, 4, 6-11) showed a greater amount of 
protein in the PCM from "S' centrosomes. All these bands were cut out of the gel and 
analysed by MALDI-tof (matrix-assisted laserdesorption/ionisation-time of flight) mass 
spectrometry. Because one band may contain more than one protein it was sometimes not 
possible to identify unambiguously these proteins. This was the case for proteins of bands 




































Figure 14: There are differences in the soluble fraction of "Gi" and "S" 
centrosomes. Independent "Gi" (GI) and "S" (S) centrosome preparations were incubated in 1M 1(1, for 
ihour in the dark at 4°C, and the soluble fractions separated on 6.8%, 12.5% and 9% gels. Gels were silver 
stained, and bands enriched in either fractions (Gi or S) were cut out and processed for MALDI-tof mass 
spectrometry. Numbers 1 to 11 represent the different bands which were cut out of the gels. 
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Among the 8 proteins identified, only hsp73 (bands n° 6 and 10) was previously 
described as a component of the centrosome and shown to colocalise with pericentrin, 
although it is not a bona fide centrosomal protein (Brown et al. 1996a; Brown et al. 
1996b). Eukaryotic translation initiation factor 4a (band n° 8) is a very abundant protein 
in the cell and is likely to come from ribosomal contaminants of the preparation. The 
Epstein-Barr nuclear antigen 2 (EBNA-2) and the putative protein MGC:790 (band n° 11) 
are presumably nuclear contaminants. Pyruvate kinase (band n° 2 and 5) is a cytoplasmic 
enzyme involved in the metabolismn of phoshoenolpyruvate to pyruvate (the last step of 
glycolysis). The identity of the proteins present in band n° 3 is unclear: aminopeptidase is 
a cytoplasmic protease, and hnRNP L a nuclear protein which is probably also a nuclear 
contaminant. 
Septins (found in band n° 1) are guanine nucleotide binding proteins required for 
cytokinesis (see Kinoshita and Noda 2001 for review). As described in the introduction, 
the centrosome has been implicated in this process, therefore the presence of septin at the 
centrosome could explain its requirement for cytokinesis. Thus, we chose to investigate 
whether septin was a centrosomal protein and study its function at the centrosome. 
The identified proteins might have a role in regulating centrosome duplication 
and/or cell cycle progression. Among these proteins, two of them, HCA66 (band n° 9) 
and MCC1 (band n° 4 and 7), were linked to cancers (Kinzler et al. 1991; Wang et al. 
2002). Since defects of centrosome duplication can lead to supernumerary centrosomes 
and ultimately to cancer, HCA66 and MCC1 could be implicated in centrosome 
duplication events. We therefore decided to focus our attention on these two proteins in 
order to investigate their role in centrosomal events as well as in cell cycle progression. 
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± in Name MW MWcut Mowse Coverage Comments 
S (kDa) (kDa) Score 
1 + Septin 49 55 1.6x 104 n/a Role in cytokinesis. 
Glutamate 62 1 	lxi O n/a 
dehydrogenase 
2 - Pyruvate Kinase 58 60 2.Ix 109 28% 
3 + Aminopeptidase 52 62 6.7x 104 43% 
hnRNP L 64 2.3x 10 19% Nuclear protein 
4 + MCCI 100 105 4. lxi o 18% Mutated in colorectal cancer. 
BC007788 72 1.8x I o4 21% Eukaryotic translation 
initiation Factor 47 like 
5 - Pyruvate Kinase 58 60 5.2x10'' n/a 
6 + Hsp73 73 70 4x I 0 15% Described at the centrosome. 
7 + MCCI 100 95 1.5x 10" 20% see  
8 + Eukaryotic translation 50 50 lxi o 21% 
initiation factor 4a 
9 + HCA66 66 60 2.3x 105 20% Linked to hepato-carcinoma 
N-sulfotransferase 4 100 1.2x I 0 15% 
10 + Hsp73 73 70 3x107 23% see  
11 + MGC:790 102 105 3.6x 10'() 31% Putative nuclease 
EBNA-2 co-activator 100 4.8x10 29% Nuclear protein 
Table 7: Proteins identified by MALDI-tof mass spectrometry. The corresponding number 
of the band on the gels, band intensity variation between GI and S phases (± in 5), name and theoretical 
molecular weight of the proteins (MW) are shown. The approximate MW of the cut band is also shown 
(MW Cut). Highlighted in bold red are the cut sizes matching the theoretical sizes. The Mowse score is a 
scoring method used for peptide-mapping based on counting the number of measured peptide masses that 
correspond to calculated peptide masses present in the Mowse database allowing the identification of the 
protein (Pappin et al 1993). The percentage of coverage (Coverage) is also shown. n/a: not annotated. 
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1) Is septin a centrosomal protein? 
Septins form a family of conserved proteins implicated in a variety of cellular 
functions. Septins are involved in cytokinesis (Kinoshita and Noda 2001). In Drosophila 
melanogaster they are transported to the cleavage furrow by pavarotti, a plus end motor 
protein (Adams et al. 1998). An immunoblot was performed to confirm the presence of 
septin in the centrosome preparations (Figure iSA). As shown on Figure 15A, the 
antibody recognised several septins, all of them enriched in the "S" fraction compared to 
"Gi", confirming the presence of septins in the centrosome preparations. Since a protein 
present in these fractions could be a contaminant and, therefore not be associated with the 
centrosome, or associated with the centrosome in an unspecific manner, we decided to 
test the localisation of septin in Jurkat cells by immunofluorescence. In these cells, septin 
did not colocalise with the centrosomal marker y-tubulin, suggesting that septin is not a 
centrosomal protein (Figure 1513). However, a centrosomal staining could be obscured by 
a strong cytoplasmic background staining, therefore we performed immunofluorescence 
experiments on isolated centrosomes to determine whether septin was located at the 
centrosome. "Gi" and "5" centrosomes were co-stained with an anti-septin antibody and 
an anti o-tubulin antibody (Figure 15C). In both fractions, only a minority of 
centrosomes (--4%, n=205) were positive for septin staining. These results suggest that 
septin is not a bonajide protein, although present in the centrosome fractions. 
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Figure 15: Septin, a centrosomal protein? 
A, The pericentriolar material of centrosomes purified from unsynchronized cells (Gi lane) or cells 
arrested in S phase (S lane) were loaded together with protein extract from HeLa and Jurkat cells and 
probed with an anti-septin antibody. Immunological detection was performed using enhanced 
chemiluminescence. Black arrows indicate different isoforms detected by the antibody. Red arrow 
indicates a septin of the same molecular weight as the one identified by MALDI-tof. B, Methanol-
fixed Jurkat cells immunostained with antibodies against y-tubulin (red) and septin (green). Arrows 
point towards centrosomes. DNA was stained with DAPI (blue). Bar: 5 14m. C, Immunofluorescence 
using anti-a-tubulin (red) and anti-septin (green) antibodies on isolated centrosomes. Arrows point to 
centrosomes. 	 105 
No differences in septin signal intensity were observed between "Gi" and "S' 
centrosomes, suggesting that the increase of septin signal intensity observed by 
immunoblotting did not result from a recruitment of septin at the centrosome at the onset 
of S phase. However, the fact that septin was detected in only 4% of the centrosomes, 
suggested that the protein could associate transiently with the centrosome. Since no 
differences were noted in septin signal between "Gi" and "S' centrosomes, it is likely 
that this association occurs in G2 or M phases of the cell cycle. 
2) Characterisation of the MCC1 protein 
The MCC] (mutated in colorectal cancer 1) gene is located on chromosome 5q21 
and was found mutated in several colorectal cancers (Kinzler et al. 1991). The MCC1 
protein is 829 amino acids long and has an apparent molecular weight of -100 kDa. The 
protein has a short region similar to the G protein-coupled m3 muscarinic acetylcholine 
receptor and contains several regions which have a high probability to form coiled-coil 
structures (Kinzler et al. 1991). MCC1 has been localised in the cytoplasm of NIH3T3 
cells and has been proposed to play a role in the signaling pathway negatively regulating 
the GuS transition, since overexpression of MCC blocks cell cycle progression from GI 
to S phase (Matsumine et al. 1996). 
We obtained the full-length human MCC1 cDNA from the IMAGE consortium 
(clone IMAGE n° 4111706) and expressed two portions of the protein in bacteria 
(MCC987: amino acids 180 to 510, MCC821: amino acids 523 to 797). The expressed 
polypeptides were subsequently used to immunise rabbits. Serum from one rabbit 
immunised with MCC821 failed to detect any protein of the expected molecular weight 
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when used on immunoblot, and gave a staining reminiscent of intermediate filaments, 
suggesting a keratin contamination during the immunisation procedure (data not shown). 
A different antibody, raised against MCC987, recognised a 100 kDa protein likely to be 
MCC1 when used in immunoblotting experiments (Figure 1613). Immunofluorescence on 
HeLa cells using the same antibody stained the nucleus in interphase cells (Figure 16A). 
Speckles were also observed in the nuclei of stained cells. In metaphase cells, the protein 
was found associated with the chromatin. No centrosome signal was observed either in 
interphase or metaphase cells. To determine whether MCC1 was a centrosomal protein 
"Gi" and "S" centrosomes were immunostained with an anti a-tubulin antibody and our 
MCC1 serum. We did not observe any MCC1 staining, suggesting that MCC1 does not 
localise to the centrosome (Figure 16C). Hence, the MCC1 protein does not seem to be a 
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Figure 16: Characterisation of the MCC1 protein. 
A, Methanol-fixed HeLa cells were stained either with pre-immune serum or with our anti-MCC1 
serum (green). DNA was stained with DAPI (blue). Pictures were all taken at the same exposure. Bar 
20 1Am. B, HeLa whole cell lysates were separated by SDS-PAGE, blotted and probed either with the 
pre-immune serum (pre-immune) or the anti-MCC1 serum (Anti-MCC1). Immunological detection 
was performed using enhanced chemiluminescence. C, Centrosomes were stained with anti-a-tubulin 
antibody (red) and anti-MCC1 serum (green). 
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3) Characterisation of the HCA66 protein 
The HCA66 gene is located on chromosome 17q11 and the HCA66 protein 
(accession number NP_060898.1) has recently been identified as an antigen in 
hepatocellular carcinomas, using human autoimmune sera (Jenne et al. 2001; Wang et al. 
2002). The predicted protein sequence of HCA66 comprises 597 amino acids, with a 
theoretical molecular weight of 66 kDa. Database searches revealed highly homologous 
sequences from ESTs in mouse, Drosophila, Anopheles, and yeast (see Figure 17). 
Alignment of the HCA66 protein sequence from different species showed that the amino-
terminal half of HCA66 (aa 1-202) is the most conserved region within the protein (61% 
homology between yeast and human), suggesting that this region plays a crucial role for 
the function of the protein (Figure 17). The HCA66 protein contains several TPR (1etra 
rico peptide repeat) motifs involved in protein-protein interactions. No other motifs were 
found using motif prediction software, and no functional data on HCA66 have been 
reported. 
We have generated a cDNA clone encoding the full-length protein by reverse 
transcription of Jurkat cell RNA and PCR as described in Materials and Methods. We 
then expressed a recombinant portion of the protein (amino acids 86-365) in bacteria and 
raised an antibody in rabbits. 
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Busies xAEIrQERIxDRLPILEQLERIoLFssAx;xAxrxxAaDLsYK;QRR4FKED;;M;vQYsILLELIRRRRTR-;GsrxKo.x 84 
Mouse MA8IIQIRI8DRXP8LIQLERI0LFAIIXAXIK1CAIDLITKIKRRLLKEDFIIVQY8IILLBLIQRRRAR-IKr4FKKD8I 84 
A.Oabie MSKLVILRRRQAIRE,ECMKHLNLFTDAEIQSIKNK8HYHDFXIERRTKRL8DFINTIAT8C1VFHLLLQRRQK-Llih$AEW8L 84 
Drosophila MA8FIAKMQ$RLLPITIQMKNrSVF?ADQVREIVSRRERLFLXINXSHQSITDTLDFIL!8KHMM1IVDKEKK-MHVKLTO- -L 82 
6.Cerevisiae MSK_TtR!YL8QCIPIMDDLVEKOLFTXNZVSLIMKKRTDF8NSLNS8OS3INDTIKXINTES*VNKLRAXRCKSILQVKXTNILS 84 
85_au INIVMRVQGVFQRAAKWKDDVILWLS8VAFCUWATKRLIK 	VFSAMLAXIS NKPALWIMAAXWIX8D SLS SEARQLF 165 
Mouse IT 	VE8VQOVFG8A5kXWKDDVLWL8TZVFCKXWGTKHLX- - - IFSAMLAIISNXPALWIMAAXWEMZD-RLSSIARQLF 165 
A.Gapbie CQIIQRVRVLTKRAMARFAAITRVWTHFLQ!CQMRRFFEO8- - _VLDQKLOTIODKPKAWI.CAIEWEYRQ-AN!IAARAXHTM 165 
Drosophila KktIATRIMRLXREALAKFNHDRRLWSNWIKFSRX_ SNPVEVAG- - -I 	xMLLTI 0DSPDLWVDAALWLIF!RLIDRVKDIL 163 
8.Cerevisiae  168 
ff5_an LRALRFMPICPXLTKITFRMILMXAEKLRKZX8IFERASXDVE --- NP--DTSIIILKO --- ILAWI ITKNIVSI IXOAIFNVSL 242 
Mouse LffALRFIPZCPKLTQITFRMILM8AEXLRKIICQXFEXAAMDMG --- 	P--D8P8IILKe --- ILARIITKIIISKIXOANFIVSL 242 
A.Gaabie Lff0LQRIpICRELaIOFIoIaLEEoKIcVvExAal8xQGLVVKuIaPPLDEPQzLELExALxTAQVVYRI- -FE1CDMRFTEQL 248 
Drosophila L8GLQRIPDSEALNKCFFDIMLXEAALASNI-RNLAE4LSEQ -------DIXL8RVEA --------VT8$IMANITQLDTFVKL 232 
B.Carevisiae QNGLRPNPDVPXLWYCTVKFILNPITXLINR-IX-VMQLINER --------- ELDMQ ---- N---EQKffN-QAPDEEXS8LQV 234 
	
85_au 	L_IXAQLPDFAKDLXIITDDLQALIDDPLWD1VARRILII8fT_I -------- -IPXAKAVEV0 --- KI8RCCAVT 313 
Mouse L_AIAQLFDFAXDLJtffITDDLQALIkDDPLWWD1VARRILEIIP,I---------PVKAKAVEMO---IIIIJtCCAVT 314 
A.05_bie 	8.XELKI8CPLSNALARQAVAIMRE4DQEAMWHLLAKLILIG --------------- DAFVMXIAEQKPH --- ELARCLAVT 315 
Drosophila Lx MC EDiQ8LT0KLQRMIIDDMQEK?PREP0LWDLLAQRILROFHLGDLWDIIPAi:XKSRsVNGRlLX$iIQLCVTVT 317 
S.Cerevisiae 	PS D8MKDKLNZLPEADISVLONAEN-PALR00IALTIFDV ---------------------CMICTLGKH ------------1 285 
Human 85AVKTLPTEAMWXCyXTFCLIRPKKSNsGFLR0KRLIffTVFRKA8ELKLLSICQIXLSVSLLCTNFLR8__ALEVAVA0 396 
Mouse 	E5AVffALPiEAMWKCrITFCLERFsKKTjSVPLRGQRLIRMLAFRKAIELKLLsIVQ!KQWIDLLLRQDLFK8_ -ALQVAEAO 	397 
A.Gembie KIAVERLPKKM*SLC IDTMLQLNIJLEEII- IDEKAXRKALAGAFXAALI DDLLDIDKLL!LXLLLNNSNPNI8LVMKVZ NKOL 399 
Drosophila K5AVEELQTEMWNMTLDAMLALNDGX ---PILXQCLADALQAG$RSQLMGVKu1.ATLRXMLCTAPSGfl8----AAVTZL 395 
S.Cerevisiae 	INK&XOAISDSXKNIILNKRTLNYLF ---- 8L*!IXLYDEFLDL8RDYLIN--HVLFWXNDMTDLSLRK ---- DLPELYL 360 
85_an 	ILFRDUOTMW- -QLxLovLxIfrU_PD;AxL;sEAFvxLKPvc-LPLwIl--wAsw.xoaxt:--T:AVFXXALLAVIGA:@v 474 
Mouse xLPxD.vTMw--QTxLQVLxDxI1-PDVuMRFEEArAnLKPvc-LPLwz-wAEwfxsAK--TAX?XxAIIAVt43AV 475 
A.Oa.bie 	IQTPA$VDVWItAYLffXQILQEVGA_DILIRTFRXALNLPERVs5LVLWKQMFQ1TI8RPAT__LxQLP8RAIDQEP-DIN 480 
Drosophila IALlCNDSVEM8$LLL4IZ4IPLIYELFNXXQKSM0SIAL- - PLWRIVILTTRTRQDLOARffLDIITGLACKAAW- PIFO 477 
8.Cerevisiae 	KVMIDIjLN_--IRTMPV8KLDI-DQLQLSVKXT4A*ISKLDS -----A.VXSLKNETRSTLD--NY-LKXMNAEDOP -----428 
Human 	Z.ffNIC1LDWA1R0Q--TXXAIIAVFX 	RPFrVDFFffKMIFIKEQ*SCNMA---III8*TIRALRITG DDLWMDTMKZ 554 
Mouse ILKEKTLDWATRIGI_ -TXKARAVFK RP?VIFFRXMKQFIKEQrPCKMVk---LRI*rIRALRIVa IDLWMDTIKI 555 
A.Ga.bie 562 
Drosophila 	ELR8DTLRTLWQ8RS- VEEARKstAKLAILPPKlf~L 
A 
LZROkVWLZIlAAACDQASLktWRMCTDFMACTrGKIQPRVWVETLAF 560 
8.Cerevisiae --RYXILDLIISKL -----------------------------------------------------------------------440 
55_an I
%T




A.Gabie 	 606 
Drosophila R - -OIAXjISLLRALS:LIPQYVAAFEAIRALAXVQASI 	602 
8.Cerevisiae 	----------------------------------------------440 
Figure 17: Sequence comparison between human, mouse, Anopheles gambie, Drosophila melanogaster, 
and Saccharomyces cereviswe HCA66 proteins realised with ClustaiX. 
Key to Clustal symbols, - amino acid fully conserved, - strong group fully conserved, STA, NEQK, NHQK, QHRK, MILV, 
MIL, HY, FYW 	. - weaker group fully conserved CSA, ATV, SAG, STNK, STAR, SGND, SNDEQK, NDEQHK, NEQHRK, FVLIM, 
HFY. Colouring of Clustal alignment, Blue: A F I L M V W, Purple: E D, Green: N 0 S T, Yellow: P, Orange: G, red: K R, 







By immunoblot, the serum and the affinity purified antibody recognised mainly a 
60 kDa protein (Figure 18A). To confirm that the -60 kDa protein was indeed HCA66, 
we cloned the HCA66 open reading frame into an eukaryotic expression vector 
containing a myc tag and transfected it into HeLa cells. As shown on Figure 18A, the 
tagged protein recognised by the anti-myc antibody had an apparent molecular weight of 
-.60 kDa migrating at the same position than the HCA66 signal. This suggests that our 
serum detects HCA66. Immunofluorescence microscopy on HeLa cells gave a staining 
pattern for HCA66 that was very peculiar. In interphase, the protein was mostly located 
in the nucleus. Speckles were also observed in the nuclei of interphase cells, suggesting 
the association of the protein with some structure such as Cajal bodies or nuclear bodies 
(Figure 18B and 18C). The nucleolar staining observed with the serum (Figure 18B) was 
seen only weakly with the affinity-purified antibody. 
Figure 18: Characterisation of the 
anti HCA66 serum. 
A, Immunoblotting on HeLa whole cell 
lysate using the pre-immune serum (pre-
immune), the anti HCA66 serum and the 
anti HCA66 serum affinity purified over a 
HCA66 column (aff. purified) (Left panel). 
Whole cell lysate from HeLa cells 
transfected with HCA66-myc or control 
cells were separated by SDS-PAGE, 
transferred and probed with an anti-myc 
antibody (Right panel). Immunological 
detection was performed using enhanced 
chemiluminescence. 
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Figure 18 continued 
B, Methanol-fixed HeLa 
cells were stained either 
with pre-immune serum 
or with anti HCA66 
serum (green). DNA was 
stained with DAPI (blue). 
Pictures were all taken at 








Figure 18 continued 
C, Co-staining of pericentrin and HCA66 using the HCA66 affinity purified antibody. White arrows 
point to centrosomes. Bar 20 ,um. 	 113 
This was the only notable difference between the crude serum and the affinity-purified 
antibody. Upon entry into mitosis, HCA66 seemed to redistribute and associate with the 
centrosome / spindle pole as determined by co-staining with the centrosomal protein 
pericentrin (Figure 18C). Moreover, weak staining was still present at the chromatin 
periphery, suggesting that the protein is associated with the surface of the condensed 
chromosomes (Figure 18B and 18C). The centrosomal/spindle pole staining seemed most 
intense at metaphase (Figure 1813). Upon the onset of anaphase, the protein began to 
dissociate from the centrosome/spindle pole and was no longer associated with it in late 
anaphase/telophase (Figure 1813). 
To determine whether HCA66 was associated with the centrosome, 
immunblotting was performed on "GI" and "S' centrosomes. As shown in Figure 19A, a 
60 kDa band corresponding to HCA66 was detected by our antibody in GI and S 
fractions. An —80 kDa band was also detected in both fractions. To determine whether 
there was more HCA66 in "Gi" than "S" centrosomes, the signal intensity was 
normalised to tubulin signal intensity (in S fraction, a doublet of (X-tubulin was 
reproducibly obtained and the signal of both bands was added to determine the tubulin 
amount). Intensity of signal in "5" centrosomes was —1.75 ± 0.22 times higher compared 
to the HCA66 signal in the Gi fraction. To confirm this result and determine whether 
HCA66 was a centrosomal protein or was present in the fraction without being associated 
with the centrosome, we performed immunostaining experiments on isolated centrosomes 
(Figure 1913). As shown in Figure 19B, a signal was detected in both "Gi" and "5" 
centrosomes. Moreover, quantification of the signals showed that staining in "Gi" 
centrosomes (12.3 ± 4.3) was —2.3 times weaker than staining in "5" centrosomes (27.33 








62.0 - 	__ 	












ItI U 10 
Figure 19: HCA66 is a centrosomal protein. 
A, Quantitative immunoblotting (using ECL Plus) on "G 1" and "S" centrosomes using anti-HCA66 
serum. Two proteins were detected with the antibody (black and red arrow, top panel). The signal of 
the 60 Wa protein was quantified over a-tubulin (middle panel). Numbers indicate the ratio of 
HCA66 signal over a-tubulin (arbitrary unit) B, Immunofluorescence on "Gi" and "S" centrosomes 
using the anti HCA66 serum. Pictures were taken with the same exposure. Higher magnification of 
representative centrosomes are shown. Bar 10 pm. C, Quantification of the signal observed in B. 
115 
These results strongly suggest that (1) HCA66 is indeed at the centrosome and (2) 
present in higher amounts in S centrosomes, suggesting a recruitment at the centrosome 
at the onset of S phase. 
Interestingly, when used for immunoblotting experiments, our anti-a-tubulin 
antibody recognised two bands in "S" centrosomes (see Figure 17, see also Figure 10). 
The differences between the two bands might reflect differences in post-translational 
modifications of the tubulin (i.e. acetylation and/or glutamylation and/or 
phosphorylation) occurring at the G1/S transition. The ratio between the two bands was 
variable in different centrosome preparations (compare Figure 10 with Figure 17). In 
every case, the whole tubulin signal from both bands was taken into account when 
quantification of the signal was required. 
E - Purification of centrosomes from cells in mitosis 
We also wanted to compare the protein composition of "Gi" centrosomes with the 
centrosomes of mitotic cells, therefore we attempted to isolate centrosomes from cells 
arrested in mitosis. We were not able to arrest Jurkat cells, HL60 or K562 cells (myeloid 
and erythro-leukemic cell lines respectively, chosen for the same reasons than Jurkat 
cells) in mitosis using microtubule depolymerising drugs such as nocodazole or colcemid, 
suggesting that these cells lack the spindle check-point. To bypass this problem, we tried 
to reconstitute a functional centrosome from DT40 (a chicken B lymphoma cell line) salt-
stripped centrosomes and concentrated extract from Hela S3 cells in interphase or 
arrested in prometaphase (>75% mitotic cells; Hi kinase activity of the extract was 
tested, data not shown). This would have the advantage to discriminate between the 
116 
protein recruited to the reconstituted centrosome (of human origin) from the one present 
in the unsoluble fraction (of chicken origin). Although, we were able to reconstitued a 
functional centrosome on coverslips (data not shown), we were unable to resolublise the 
KI-unsoluble fraction in the extract and could not compare the composition of 
centrosomes from cells in mitosis with centrosomes purified from cells in other cell cycle 
stages. 
In the past, various centrosomal proteins were described to localise in a broad, 
crescent-shaped area of the spindle pole when cells entered mitosis or meiosis. In 
particular in acentriolar spindles of mouse oocytes, centrosomal proteins such as 
pericentrin were found in a large "cap-like" region associated with minus ends of spindle 
microtubules (Doxsey et al. 1994). This staining was reminiscent of the distribution of a 
microtubule binding protein that stabilises the spindle pole, NuMA (Merdes et al. 1996). 
We were interested to determine, whether direct binding between centrosomal proteins at 
the microtubule ends existed in the mitotic spindle. We therefore investigated 4. 1R, a 
protein that had previously been shown to localise to the centrosome and the spindle pole, 
and that was found to interact with NuMA (Krauss et al. 1997b; Mattagajasingh et al. 
1999). 
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II 	4.1 R a multi-faceted protein 
The centrosomal localisation of 4.1R protein was first determined by electron 
microscopy and immunolocalisation (Krauss et al. 1997b). However, this study did not 
determine which 4.1R isoforms were located at the centrosome. So far, only the 4.1R'35 
isoform has been located to the centrosome using immunofluorescence (Hung et al. 
2000). 
A - Is 4.1 R a centrosomal protein? 
We decided to investigate which of the 4.1R isoforms was present at the 
centrosome. We performed immunoblotting on purified centrosomes from Jurkat cells 
using an anti 4.1R antibody directed against the carboxy-terminal domain of the protein 
and recognising 4.1R'35 and 4.1R8° (generous gift of Dr. A. Baines (Scott et al. 2001)). 
As seen on Figure 20, Jurkat cells expresses the 80 and 135 kDa isoforms of 4.1R. To 
our surprise, the antibody did not detect any band in the centrosome fraction suggesting 













Figure 20: 4.1R is not detected on the centrosome. 
Whole cell lysates from HeLa (HeLa WCL) and Jurkat (Jurkat WCL) cells and purified centrosomes from 
Jurkat cells were immunoblotted with an anti-4.IR antibody (generous gift of A. Baines) and an anti-
PCM-1 antibody. Immunological detection was performed using enhanced chemiluminescence. 
B - Characterisation of polyclonal antibodies raised 
against 4.1 R 
We decided to raise antibodies against the Xenopus laevis 4.1R135 isoform 
(x4.1R135). cDNA encoding amino acids 222 to 531 (4.1M) and 530 to 801 (4.1C) of 
x4.1R'35 (Figure 21) were expressed in bacteria, purified and used to immunise rabbits 
(4.1M: rabbits 1044 and 1045; 4.1C: rabbits 1046 and 1047). 
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Figure 21: The different polypeptides used to raise antibodies against 4.1R. 
Schematic representation of the two main isoforms of the 4. 1R protein, 4. 1R'35 and 4. 1R80, and the 
different polypeptides (fusion proteins 4. 1M, 4. 1C, GST-full-length or synthetic peptide) used to raise 
antibodies against the Xenopus laevis isoforms of the protein. CPAP and NuMA interaction domains are 
shown. 
120 
Sera from rabbits immunised with the same antigen gave the same results, 
therefore only sera 1044 and 1047 are described thereafter. As shown in Figure 22A, 
both sera reacted against the recombinant full-length protein by immunoblot. However, 
in whole cell lysate from HeLa cells none of the sera recognised a protein of the 
expected molecular weight (i.e. 80 kDa or 135 kDa). Instead, serum 1044 detected a 
37 kDa protein, whereas serum 1047 detected a 50 kDa protein (Figure 22A). These 
antibodies were used by immunofluorescence on HeLa cells. As shown on Figure 2213, 
serum 1044 gave a diffuse cytoplasmic staining in interphase and mitotic cells, although 
some staining of the spindle could also be seen. Serum 1047 gave a diffuse cytoplasmic 
staining both in interphase and mitotic cells (Figure 2213). 
Neither of these two antibodies detected a centrosomal isoform of 4.IR and 
therefore they could not be used for our experiments. Another antigen was chosen to 
raise antibodies against a centrosomal isoform of 4. 1R. 
A GST fusion of x4.1R'35 was expressed, purified and used to immunise two 
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Figure 22: Characterisation of the different anti-4.1 polyclonal antibodies. 
A, 4. 1R135 His-tagged fusion protein and HeLa whole cell lysates (HeLa WCL) were run on a 7.5% 
polyacrylamide gel, blotted and incubated with sera 1044, 1047 and the respective pre-immune sera 
(P1 serum). B, Methanol-fixed HeLa cells stained with sera 1044, 1047 and the respective pre-
immune sera. An interphase and a metaphase cell are shown. C, 4. 1R135 His-tagged fusion protein and 
HeLa whole cell lysates (HeLa WCL) separated by SDS-PAGE, blotted and incubated with serum 
1632 and the respective pre-immune serum (PT serum). Serum 1632 was also used by immunoblotting 
on isolated centrosomes (centr.). 0, Methanol-fixed HeLa cells stained with serum 1632 and the 
respective pre-immune serum. An interphase and a metaphase cell are shown. Arrows point to 
centrosomes. Immunological detection in A and C was performed using enhanced 
chemiluminescence. Bars in B and D, 20 jim. 	 122 
Our serum detected the full-length recombinant protein (His6-tagged) when used 
on immunoblot (Figure 22C). In HeLa whole cell lysates, serum 1632 reacted with a 
major band corresponding to a protein of apparent molecular weight of -210 kDa. The 
sera also detected another protein of -440 kDa although with a weaker reactivity 
(Figure 22C). These two proteins might be different isoforms of the 4.1R protein. As 
expected, when used by immunostaining the serum gave a clear centrosomal staining 
both in interphase and mitotic HeLa cells (Figure 22D). To determine which of the two 
proteins was localised at the centrosome, we performed an immunobloting experiment 
on isolated centrosomes. As shown in Figure 22C, the 1632 antibody only detected the 
210 kDa band. Taken together these results suggest that a 210 kDa isoform of the 4.1R 
protein is located at the centrosome. 
C - A mouse polyclonal antibody recognising 4.1 R 
We also tried to isolate a hybridoma clone producing a monoclonal antibody 
against the centrosomal/spindle pole isoform(s) of 4.1R. 
The 4.1C construct was used to immunise a BALB/c mouse. The mouse bleed 
showed a typical 4.1R staining in chicken DU249 cells along with a centrosomal 
staining in interphase and mitotic cells (Figure 23A). 
When used in immunoblotting experiments the bleed recognised two proteins of 
135 and 80 kDa in HeLa whole cell lysates and of 145 and 135 kDa in chicken DT40 
whole cell lysates (Figure 2313). In order to isolate a monoclonal antibody, a hybridoma 
of B cells from the immunised mouse and myeloma cells was made by Dr A. Merdes. 
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However, we were not able to isolate a stable clone expressing an antibody with the 




MW DT40 HeLa 








Figure 23: Characterisation of an anti-4.1R mouse polyclonal antibody. 
A, Chicken DU249 cells were stained with mouse anti-4.1R serum. Cells in interphase and in metaphase 
are shown. The corresponding DNA staining with DAPI is shown. Note the plasma membrane staining at 
the sites of cell-cell contact, and the centrosome staining (arrows). Bar 20 Am. B, DT40 and HeLa whole 
cell lysates (WCL) blotted and probed with the mouse anti-4.1R serum. Immunological detection was 
performed using enhanced chemiluminescence. 
D - 13-tubulin and 4.1 share a structural homology 
Since the results we obtained with our antibodies were unsatisfactory, we raised 
an antibody against a synthetic peptide of the last 14 amino acids of x4.1R135 (amino 
acids 788 to 801; see Materials and Methods). Two rabbits (1781 and 1782) were 
immunised and both gave a positive immune response to the peptide, as seen on dot blots 
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(Figure 24A), whereas the reactivity against a control peptide from Xenopus NuMA was 
very low (Figure 24A). The two sera were further characterised by immunoblotting and 
immunostaining on tissue culture cells, and both gave identical results. For this reason, 
only serum from rabbit 1782 is described hereafter. When used on HeLa cells by 
immunofluorescence, the antibody stained a structure reminiscent of microtubules in 
interphase and the mitotic spindle in mitosis (Figure 2413). Moreover, when cells were 
treated with nocodazole, a microtubule depolymerising drug, staining with the anti-4. 1R 
serum was restricted to the centrosomal area (Figure 24C), whereas the pre-immune 
serum did not detect any centrosomal signal. Double immunofluorescence with our 
serum and an anti a-tubulin antibody confirmed that the peptide antibody against 4. 1R 
stained indeed the microtubule network (Figure 24D). These results suggested that 4. 1R 
could be associated with microtubules, which would be consistent with previous 
observations (Correas and Avila 1988). Alternatively, the observed pattern may be due to 
a cross-reactivity of the antibody with tubulin or a microtubule associated protein. To 
discriminate between these two possibilities, we performed additional experiments. 
When immunoblots were performed, the serum showed a strong response 
against a recombinant full-length x4.1R'35, whereas the pre-immune serum did not. 
Moreover, the serum predominantly reacted against a 55 kDa band in whole cell lysates 
from Xenopus laevis A6 cells and recognised pure brain tubulin, suggesting a cross-
reactivity of the antibody with tubulin (Figure 25). 
125 
1782 	DNA 	Merge 
4. 1R Cntrl 




1782 0 	Metaphase 
C 
Tubulin+ 
Pre-immune Nocodazole  
1782 	Tubulin+ 
serum Nocodazole 
Li 	 Tubulin 	1782 	Merge 
Interphase 
Metaphase 
Figure 24: A serum raised against a 4.1R C-terminal peptide stains the 
microtubule network. 
A, A 4. 1R peptide (4. 1R pept.) and a control peptide (cntrl pept.) of the tail domain of Xenopus NuMA 
were transferred onto nitrocellulose membranes using a dot-blotter and the membranes were probed 
either with pre-immune sera or immune sera from rabbits 1781 and 1782. B, Methanol-fixed HeLa cells 
were incubated with the 1782 serum (red) and DAPI to stain DNA (blue). Examples of a cell in 
interphase and a cell in metaphase are shown. C, HeLa cells treated with nocodazole and stained with an 
anti-tubulin antibody and either pre-immune serum or 1782 serum. D, Double immunostaining of HeLa 
cells with a monoclonal anti-tubulin antibody (green) and 1782 serum (red). DNA is stained with DAPI 
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Figure 25: 1782 serum raised against a 4.1R C-terminal peptide recognises tubulin. 
Polyacrylamide gels containing recombinant full-length 4.1R protein (lane 4.1R), protein extracts from 
Xenopus A6 cells (lane extr.), and purified bovine brain tubulin (lane tub.) were stained with a coomassie 
blue solution (Coomassie), or blotted onto nitrocellulose and probed with rabbit pre-immune serum 1782, 
or serum 1782. * indicates a degradation product of the recombinant 4.IR protein reacting with our 
serum. Immunological detection was performed using enhanced chemiluminescence. 
Identical properties were observed in the sera from both rabbits, suggesting that 
the detection of tubulin was due to a cross-reactivity with the 4.1R epitope, rather than 
due to independent antibody titres against two proteins, as occasionally occurring in 
auto-immune sera. However, in order to distinguish between these two possibilities, we 
affinity purified the serum on recombinant x4. 1R'35 protein. Immunofluorescence and 
immunoblotting experiments showed that the reactivity against tubulin was preserved in 
the anti-4.1R antibody (Figure 26A, B), indicating that the same antibody cross-reacted 
both with 4.1R and tubulin. Consistently, serum that was affinity purified on pure brain 
tubulin also recognised the recombinant x4.1R'35 protein by immunoblotting (Figure 
26A). To our surprise, these affinity-purified antibodies were both specific for the 1-
tubulin isoform, since they did not recognise recombinant a-tubulin expressed in 
bacteria (Figure 26A). 
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Figure 26: Anti-4.1R antibodies cross-react with 0-tubu1in. 
A, Coomassie staining of a protein gel loaded with full-length 4. 1R protein (4. 1R), brain tubulin (Tub.), 
Xenopus egg extracts (Extr.), and GST-tagged recombinant u-tubulin (GST u-Tub) or -tubulin (GST 
n-Tub), respectively. Note the increased molecular weight of the recombinant forms of tubulin after 
addition of the GST-tag. Identical gels were blotted and probed with 4. 1R peptide antibodies, 
previously affinity purified from brain tubulin (left) or recombinant 4.1R (middle). * denotes the 
position of a degradation product of 4.1R. Immunological detection was performed using enhanced 
chemiluminescence. B and C, The same affinity purified antibodies were used for immunofluorescence 
staining of HeLa cells. Interphase and metaphase cells are shown. Affinity purified antibody over 4. 1R 
is shown in B, and affinity purified antibody over tubulin is shown in C. DNA was stained using DAPI 
(blue). Bars in B and C, 2014m. 	 128 
An alignment of the 4. 1  peptide sequence with a- and 13-tubulin sequences 
revealed 29% identity within amino acids 183 to 196 of 13-tubulin, but no significant 
similarity with a-tubulin (Figure 27). The specified region is located at the end of helix 
5 in 3-tubulin, and is exposed to the outer surface of the microtubule polymer (Nogales 
et al. 1999). 
helix 5 	 sheet 6 helix 6 
-tubulin 177 VSTAVVEPYNSILTTHTTLEHSDCAFMVDNEAIYDICRRNLDIE 220 
3-tubulin 175 VSDTVVEPYNATLSVHQLVENTDETYCIDNEALYDICFRTLKLT 218 
4.1R peptide 	 SVTKGVVFIQETEIA 
Figure 27: 4.I11 peptide and 3-tubulin share some homology. 
Alignment of the C-terminal 4.1 R peptide with amino acids 177 to 236 of u-tubulin and the corresponding 
region in 3-tubulin (amino acids 175 to 234). The positions of -helices and 3-sheets in tubulin are 
indicated. Identical amino acids are highlighted in red. 
Although the degree of similarity between the 4.1R peptide and 3-tubulin is 
weak, our results open the possibility that the antibody cross-reactivity reflects a 
structural homology between the helix 5 of the 3-tubulin molecule and amino acids 788 
to 801 of x4.1R'35. 
Although these antibodies reacted against an isoform of 4.1R located at the 
centrosome, we could not use them as a tool to study the biological function of this 
protein, because the tubulin cross-reactivity largely obscured the centrosome specific 
4.1R staining. 
Table 8 summarises the different attempts and strategies we used to raise an 
antibody against 4.1R'35 
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Name Antigen Type Immunoblot Immunofluorescence 
1044 Amino 	acids 
222 to 531 	of 
Rabbit 
Polyclonal 
x4.1R '35 (4.1M)  
-37 kDa protein Diffuse cytoplasmic. 
1045 
1046 Amino 	acids 
530 to 801 	of 
Rabbit 
Polyclonal 
x4.1R'35 (4.1C)  
-50 kDa protein Diffuse cytoplasmic. 
1047 
1631 GSTx4.IR'35 Rabbit 
 Polyclonal 
-210 kDa and -140 










-135 kDa and 80kDa 
proteins 




-200 kDa protein Centrosomes (metaphase- 
 telophase). 
1781 Amino 	acids 




13-Tubulin Microtubules, and 
centrosomes. 1782 
Table 8: Antibodies raised using different 4.1R antigens. The molecular weight (or the name of the 
protein when identified) recognised by immunoblot are shown. The pattern observed by 
immunofluorescence is described. 
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DISCUSSION 
The goal of our study was to identify centrosomal proteins potentially involved in 
the initiation of centrosome duplication or the control of the GuS transition by the 
centrosome. Proteins from the pericentriolar material of "Gi" and "S' centrosomes were 
separated using one-dimensional gels (ID-gels) and analysed by MALDI-tof mass 
spectrometry. Eight proteins were found differentially localised between "Gi" and "S" 
centrosomes. 
Changes occurring at the GuS transition can be both qualitative and quantitative. 
Using a ID-gel protein separation technique did not allow us to distinguish qualitative 
changes occurring in the PCM (for instance, phosphorylation events mediated by cdk2-
cyclin A or E), limiting us to quantitative modifications. However, by using this 
technique, we were able to identify several new proteins, which might have a role in 
centrosome function or centrosome duplication, and decided to concentrate our efforts in 
investigating these proteins. A way to see qualitative changes such as phosphorylation of 
specific proteins of the PCM would have been to perform two-dimensional 
electrophoresis (2D-gel) analysis. Although we attempted to use this technique, we soon 
realised that significantly more cell material would have to be processed to allow 
detection of protein spots in two dimensions, exceeding the capacity of our facility. 
We chose to compare an unsynchronised population of cells with a population 
arrested in early S phase. The unsynchronised population, although mainly in Gi, 
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contained 25% of cells in S phase (Figure 9). This high proportion of cells in S phase 
made the detection of small quantitative changes harder. It might also explain why we 
found only 1.75 times more HCA66 at the PCM of "S centrosomes by immunoblotting 
and an average of 2.3 times more by immunofluorescence, since a quarter of the "Gi" 
centrosomes were actually "S' centrosomes. Therefore, the unsynchronised population of 
cells should possess more HCA66 than a 100% GI population. Thus, it is likely that the 
S/G1 ratio of HCA66 was underestimated and that there is more HCA66 at the "S" 
centrosome than observed. 
In our screen, we did not find NPM/1323 which is described to leave the 
centrosome at the beginning of S phase upon phosphorylation by cdk2 (Okuda et al. 
2000, see Introduction). At least two possibilities can explain this. Firstly, differences in 
expression of the protein might have been too weak to be detected, or were masked by 
the presence of other proteins of a similar molecular weight. Secondly, it is possible that 
cells were blocked at a stage before NPM/1323 left the centrosome. Indeed, aphidicolin is 
an inhibitor of DNA polymerase 8, an enzyme involved in the initiation step of DNA 
replication. Therefore, cells were blocked at the very beginning of S phase, possibly prior 
to the separation of NPMIB23 from the centrosome. Immunoblotting experiments using 
an anti-NPMIB23 antibody would allow us to determine whether the protein was still 
located at the "S" centrosome. 
Similarly, other changes in the protein composition of the PCM from "S" 
centrosomes might not have been detected due to the very early stage of S phase the cells 
were blocked in, which may explain the relatively small number of differences detected. 
As mentioned above, we could not detect qualitative changes, which also accounts for 
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this small number of differences. It is possible that the use of another technique to arrest 
the cells later in S phase would have given different results, and perhaps more candidates. 
The comparison of the PCM composition in the other cell cycle phases (i.e. G2 
and mitosis) would also have been of great interest. The attempt we made to compare the 
composition of the PCM between interphase and mitotic cells have so far been 
unsuccessful because the cell system used here, Jurkat cells, could not be arrested in 
mitosis using standard procedures of microtubule depolymerisation. Attempts to bypass 
this problem, by reconstituting a functional centrosome from potassium iodide-stripped 
DT40 centrosomes and concentrated extract from interphase or mitotic HeLa S3 cells, 
were unsuccessful due to the insolubility of salt-stripped centrosome in the extract. 
The eight proteins we found when comparing the PCM composition of "Gi" and 
"S" centrosomes all belong to different classes of protein. The nuclear proteins (Mccl, 
EBNA-2 and may be hnRNP L) and the one associated with the translational machinery 
(Eukaryotic translation initiation factor 4(x) were presumably contaminants. Among the 
proteins identified, only one, hsp73, was previously described as a centrosoma! protein 
(Brown et al. 1996a). Pyruvate kinase is an enzyme of glycolysis, septin has been 
implicated in cytokinesis (see Kinoshita and Noda 2001 for review) and HCA66 is an 
uncharacterised protein linked to an hepatocarcinoma (Wang et al. 2002). 
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Hsp73 is recruited at the centrosome at the 
beginning of S phase 
Hsp73 is a molecular chaperone produced in increasing amounts after a thermal 
stress to repair or replace proteinaceous components. It has been shown that hsp73 
facilitates the recovery of the centrosomal structure after heat-shock. Furthermore, hsp73 
is present at the centrosome throughout the cell cycle in unstressed cells (Brown et al. 
1996a). Other chaperones such as tailless complex olypeptide-1 (TCP-1) or hsp90 were 
also described at the centrosome (Brown et al. 1996b; Lange et al. 2000; de Career et al. 
2001). Molecular chaperones have been proposed to facilitate the movement of proteins 
from and to the centrosome as well as to promote spatial changes in the organisation of 
the PCM which occur during centrosome duplication (Andersen 1999). This would be 
consistent with the recruitment of hsp73 at the beginning of S phase, which would be 
required to modulate centrosome assembly. Alternatively, hsp73 could be required to 
stabilise centrosomal proteins throughout the cell cycle and at the time of centrosome 
duplication. This stabilisation effect was previously described in Drosophila, for hsp90, 
where it is required for polo kinase activity (de Career et al. 2001). 
A centrosomal role for pyruvate kinase? 
We identified pyruvate kinase (bands n°2 and n°5) as a potential centrosomal protein. 
Quantitatively, there is less pyruvate kinase in the "S' fraction than in the "GI" one. Being 
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centrally located at the minus-ends of the microtubules the centrosome could also serve as a 
"meeting place", bringing regulatory molecules close to their substrate to control the 
specificity of their functions. Thus, pyruvate kinase could be at the centrosome only to 
phosphorylate its substrates and may not play a role in centrosome duplication or cell cycle 
progression per Se. Moreover, one can not exclude that this protein was merely a 
contaminant of the centrosome preparation. However, enolase, another enzyme of the 
glycolytic pathway, was also described at the centrosome and more recently a 
phosphorylated form of glycogen synthase kinase-3 was located at the centrosome, and the 
spindle pole (Johnstone et al. 1992; Wakefield et al. 2003). Taken together, these data point 
towards a role at the centrosome for several enzymes involved in the glucose metabolism. 
The particular case of septin 
Septin was identified in band n° 1 along with glutamate dehydrogenase (Table 6 and 
Figure 14). As mentioned in the introduction, centrosomes are required for the completion 
of cytokinesis through a yet undetermined mechanism. Septin is also involved in 
cytokinesis, therefore presence of septin at the centrosome could provide an explanation for 
the requirement of the centrosome for cytokinesis. Although present in the centrosome-
enriched fraction from GI and S cells, we detected a centrosomal septin signal by 
immunofluorescence on purified centrosomes only in very few cases (4%). The same results 
and signal intensity (data not shown) were obtained for "Gi" and "S' centrosomes by 
immunofluorescence. Therefore, the differences observed in the silver stained gel and by 
immunoblotting may be due to soluble septin contaminating the centrosome fractions. It is 
also possible that the 4% of centrosomes with associated septin do not come from GI or S 
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phase cells, but instead from G2 or mitotic cells which are present at this low percentage in 
both the "Gi" and "S phase centrosome preparations. Presence of septin at the centrosome 
might also be an artefact due to the isolation procedure, since we did not observe any Jurkat 
or HeLa cells with a centrosomal septin signal by imunofluorescence. No staining was 
observed when the cells were treated with aphidicolin or submitted to the same osmotic 
shock as in the centrosome purification procedure (data not shown). 
The second protein identified in the same gel band as septin was glutamate 
dehydrogenase. Since we had no antibodies against this protein, we were unable to verify its 
centrosomal localisation. Therefore we can not rule out that glutamate dehydrogenase is a 
contaminant rather than a specific centrosome component. 
HCA66, a novel centrosomal protein 
We identified HCA66 as a centrosomal protein recruited at the beginning of S 
phase. The protein was previously identified in patients with hepatocarcinoma (Wang et al. 
2002). As described in the introduction, defects of the centrosome cycle can lead to genetic 
instability and cancer. The fact that HCA66 is recruited at the centrosome at the beginning 
of S phase, at the initiation of the centrosome cycle, and that HCA66 was linked to a 
carcinoma, make it an attractive candidate that may play a role in centrosome duplication. 
In HeLa cells, HCA66 is detected at the centrosome from prophase until early anaphase. 
Why is HCA66 not detected at the centrosome in interphase cells, although the protein is 
present at "Gi" and "S' (and presumably "G2") centrosomes, as shown by our 
immunofluorescence data on isolated centrosomes? The signal may be too weak compared 
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to the cytoplasmic background staining, therefore not allowing the detection of the protein at 
the centrosome. Alternatively, the epitopes might be accessible in the purified centrosomes 
but not in the cell. 
The HCA66 protein is not solely located at the centrosome and has several sub-
cellular localisations. HCA66 is also located in the cytoplasm and in the nucleus. It might 
either reflect a difference of function according to the cellular localisation or the existence of 
different pools of HCA66, as described for other centrosomal proteins, such as y-tubulin and 
centrin (Moudjou et al. 1996; Paoletti et al. 1996). These different localisations were also 
described for the 4.1R proteins. Cell fractionation would allow us to determine whether the 
ratio of cytoplasmic/centrosomal HCA66 undergoes any changes during the cell cycle, such 
as described for y-tubulin. Our immunofluorescence data suggest that part of HCA66 
shuttles between the chromatin and the spindle pole. At the beginning of mitosis, part of the 
chromatin-associated HCA66 seems to leave the chromatin and associates with the 
centrosomes (Figure 18). The association of HCA66 with the chromatin is very peculiar. 
The protein seems associated with the surface of condensed chromosomes. To test whether 
additional HCA66 protein was bound to the condensed chromatin but inaccessible to our 
antibodies, cells were treated with hydrochloric acid after fixation (data not shown). 
Immunofluorescence on chromosome spreads would allow us to determine whether the 
protein is associated with the surface of specific chromosomes. 
The localisation of HCA66 at the centrosome and in the nucleus reflects a property also 
found for other proteins. Several other proteins, including NPM/B23, nuclear antigen 14, 
topoisomerase ha and 4. 1R have been described both at the centrosome and in the nucleus 
(Schmidt-Zachmann et al. 1987; Ramos-Morales et al. 1998; Okuda et al. 2000; Krauss et 
al. 1997a; Krauss et al. 1997b; Barthelmes et al. 2000; Pfannenschmid et al. 2003). 
Since there are currently no functional data on HCA66 and no known motifs, suggesting a 
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function, it is difficult to propose a biological role for this protein. It is conserved form yeast 
to human, suggesting an important biological function. HCA66 might be involved in cell 
cycle progression at the GuS transition, previously shown to be centrosome dependent 
(Hinchcliffe et al. 2001; Khodjakov and Rieder 2001), or in centrosome duplication or 
formation of the mitotic spindle. More experiments are required to determine the function of 
HCA66. Depletion of HCA66 by siRNA would enable us to answer some of these questions 
and understand the role of this protein (Elbashir et al. 2001). 
Other questions to be addressed include whether HCA66 could act as a licensing 
factor for centrosome duplication in the same way as NPM/B23. For example, the 
recruitment of the protein at the beginning of S phase could trigger centrosome duplication. 
Would over-expression of HCA66 trigger multiple rounds of centrosome duplication? How 
is the cyclic accumulation of HCA66 to the centrosome regulated? Phosphorylation events 
triggered by cdk2/cyclin A and E could regulate the recruitment of HCA66 at the 
centrosome. The use of a specific inhibitor of cdk2/cyclin A and E would help to answer this 
question. 
138 
PCM-1 is recruited to the centrosome in S 
phase 
We showed that the amount of PCM-1 protein was -4.5 times higher in "S' 
centrosomes compared to "GI" centrosomes. The recruitment of PCM-1 to the centrosome 
at the beginning of S phase might reflect its role in recruiting other pericentriolar proteins 
from the cytoplasm to the centrosome, at the time of centrosome duplication when new 
PCM is required, as previously proposed (Dammermann and Merdes 2002). 
As mentioned in the introduction, centrin and y-tubulin concentrate at the assembly site of 
the new centriole. However, we did not detect any changes in the amount of centrin and y-
tubulin between "GI" and "S" centrosomes. This suggests that either cells were arrested 
before this event happens, or the amount of additional protein recruited is so small that the 
difference was not detected by immunoblotting or immunofluorescence on isolated 
centrosomes. Another explanation would be that no additional centrin and ?-tubulin are 
recruited to the centrosome but that there is a change in the spatial distribution of these 
proteins within the centrosome. In the case of y-tubulin, this hypothesis is supported by A. 
Khodjakov's results who showed that centrosomal y-tubulin level is constant in interphase 
and that y-tubulin is recruited to the centrosome at the onset of mitosis (Khodjakov and 
Rieder 1999). 
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4.1 R at the centrosome? 
The centrosomal localisation of 4. 1R protein was first determined by electron 
microscopy and immunofluorescence in CaSki and W138 cells (human epithelial cell line 
and human normal lung fibroblast respectively, Krauss et al. 1997b). Other groups also 
detected the 4.1R protein at the centrosome, using indirect immunofluorecence (Hung et al. 
2000; Perez-Ferreiro et al. 2001a). Hung and collaborators detected 4.1R'35 at the 
centrosome of lymphoid T cells, although they failed to detect the protein on purified 
centrosomes by immunoblotting. None of these studies determined precisely which 4.1R 
isoforms were located at the centrosome. Moreover, the antibodies used in these previous 
studies might also detect other 4.1 protein family members which are highly homologous to 
4.1R. One of them is 4.1G, which is also known to localise to the centrosome and to the 
spindle pole (Hoover and Bryant 2000; Delhommeau et al. 2002). Finally, more recently, 
4. 1R was identified as a centrosomal component of K137 cells (a T lymphoma cell line) by 
liquid chromatography, followed by mass spectrometry (J. Andersen, personal 
communication). Thus, it seems established that 4.1R is a centrosomal protein. However, the 
4.1R isoforms present at the centrosome have not yet been identified. Since the published 
literature on the localisation of 4.1R is unclear and sometimes controversial, we decided to 
investigate this topic. 
Using an antibody reacting specifically against 4.1R135 and 4.1R80 in Jurkat cells, but not 
against 4.1G (Scott et al. 2001), we did not detect any of these isoforms in the centrosome 
preparation. This result suggests that 4.1R8° and 4.1R'35 are not the 4.1R isoforms present at 
the centrosome of Jurkat cells, although we can not exclude that these isoforms are present 
in small quantities below the detection level. Interestingly, 4.1R80 and 4.1R135 isoforms do 
not associate with the centrosome but with microtubules when over-expressed in Jurkat 
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cells, suggesting the absence of these isoforms from the centrosomes of Jurkat cells (Perez-
Ferreiro et al. 2001a). However, these results have to be taken with caution. The cellular 
localisation of 4.1R isoforms is very complex. It has been found that an exogenously 
expressed isoform (4.1R80) in COS-7 cells localised in more than one sub-cellular 
compartment (plasma membrane, nucleus and centrosomes) (Gascard et al. 1998). The 
sorting of the protein to different cellular localisations is likely to be regulated by different 
post-translational modifications. During our attempts to produce an antibody against 4. 1R'35, 
the serum 1632 gave a centrosomal staining in all the cell types we tested (HeLa, A6 and 
Jurkat). Since this antibody was raised against the full-length 4.1R'35 protein it might react 
against other isoforms of 4.1R. The antibody recognised a 210 kDa centrosomal protein 
which might correspond to the 4.1R isoform located at the centrosome. However, so far the 
definite proof that this antibody is indeed recognising 4.1R isoforms, and not other 4.1 
family members, is missing. A clear answer would be given by immunoprecipitating the 210 
kDa protein and identifying it by mass spectrometry. 
4.1R and microtubules 
Several studies reported an association of 4. 1R with microtubules, suggesting a role 
of 4.1R in maintenance of microtubule architecture (Correas and Avila 1988; Perez-Ferreiro 
et al. 2001a). Both 4.1R'35 and 4.1R8° isoforms can associate with microtubules as 
demonstrated by immunofluorescence and in vitro binding analysis (Perez-Ferreiro et al. 
2001a). Interestingly, when overexpressed in Jurkat cells, 4.1R isoforms associate with 
microtubules, whereas ectopic overexpression in COS-7 cells disorganises the microtubule 
network. Thus, as suggested by other studies (Kontrogianni-Konstantopoulos et al. 2000; 
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Kontrogianni-Konstantopoulos et al. 2001), different cell types respond differently to the 
expression of the same 4.1R isoform, suggesting that functional activities of 4.1R proteins 
are cell type regulated. 
We demonstrated a cross-reactivity of antibodies against epitopes in both 4.1R and 
13-tubulin. These data indicate a similarity of the 4.1R carboxy-terminus with a short region 
in 3-tubu1in, which is further supported by the sequence alignment of the 4.1R C-terminal 
peptide with the helix 5 region of 13-tubulin. Our experiments show that after 
depolymerisation of microtubules, the 4.1R staining is restricted to the centrosome. This 
suggests that the antibody can detect both 13-tubulin and the centrosomal isoform(s) of 4.1R 
protein, but under normal conditions, the centrosomal signal is hidden by the high 
abundance of microtubule filaments in the cytoplasm. We did not detect any plasma 
membrane staining with this antibody, which might indicate that the epitope is masked in the 
plasma membrane or that the isoforms recognised by the antibody are not present in the 
plasma membrane. 
What is the biological significance of the similarities between the 4.1R carboxy-
terminus and 13-tubulin? The localisation of 4.1R protein to the centrosome may suggest a 
role in microtubule organisation. Microtubules are nucleated from the pericentriolar 
material, but many of them are subsequently released into the cytoplasm (Keating et at. 
1997). It is not clear how the anchoring and release of microtubules at the centrosome is 
regulated. One possibility would be that a protein such as 4.1R is involved in microtubule 
release. With its carboxy-terminal end showing similarity to 13-tubulin, 4.1R could mimic 
microtubule ends and compete for the binding to centrosomal components, thus 
disconnecting microtubules from the centrosomal surface. This idea is supported by recent 
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findings from Perez-Ferreiro and collaborators (Perez-Ferreiro et at. 2001a; Perez-Ferreiro 
et at. 2001b). These authors report that over-expression of 4.1R in COS-7 cells disturbed 
microtubule organisation, and that microtubules no longer radiated from a single 
pericentriolar focus, although centrosomal markers such as pericentrin or y-tubulin remained 
unaltered. Given the multitude of 4.1 isoforms and their varying sub-cellular localisation in 
different cell types (reviewed in Takakuwa 2000), the 4.1 protein could contribute to the 
modulation of the microtubule network by releasing microtubules from nucleation sites, and 
therefore contribute to the various cell shapes and properties of many differentiated cells. 
The binding of 4.1R to NuMA, as reported by Mattagajasingh and collaborators 
(Mattagajasingh et al. 1999), could provide an additional level of regulation to control 
microtubule behaviour. Whereas only small amounts of a NuMA splice variant are found at 
the centrosome during interphase (Tang et at. 1994), the majority of NuMA localises near 
the centrosome in mitosis. In contrast to NuMA, the protein 4.1R appears to be a 
constitutive resident of the centrosome throughout the cell cycle, binding to the protein 
CPAP (Hung et at. 2000). Therefore, the protein 4.1R could provide a docking site on the 
mitotic centrosome for NuMA protein complexes that are transported towards the spindle 
poles by dynein/dynactin (Merdes et at. 2000). Similar to interphase cells, the NuMA-4.1R 
interaction in mitosis might affect processes such as microtubule release from the 
centrosome (Mastronarde et at. 1993). 
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CONCLUSIONS 
Centrosome duplication and the control of the GuS transition are two important 
processes whose defect can ultimately lead to cancer. Therefore, the identification of 
centrosomal proteins involved in these two processes is of primary importance. 
In this work, we identified several potential candidates, involved in the centrosome 
cycle that are differentially localised at "GI" and "S" centrosomes. The characterisation of 
these proteins and the elucidation of their role at the centrosome will be the next step 
towards understanding the molecular mechanisms of the centrosome cycle. 
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Appendix 1: Sequences 
Sequence of HCA66 cDNA (accession number: NM_O 18428) with the ATG and stop codon 
indicated in red. 5' and 3' untranslated regions (UTR) are in blue. 
GCTGTTGAGAAGCTACCCGCGGGGTTGTAGACCTCGGACCTCATGGCAGAGATAATTCAGGA 
ACGCATAGAAGATCGGC TC CCGGAATTGGAACAGC TGGAGCGCATTGGACTGTTCAGTCATG 
CGGAGATTAAGGC TATCATTAAGAAGGC TTCCGATC TAGAGTACAAAATCCAGAGAAGAACC 







GAGGAAGGAGAAGGAAGAATTTGAAAAAGCCAGTATGGATGTGGAGAATCC TGATTATTC TG 
AAGA1ATCCTTAAGGGCGAGTTGGCATGGATCATCTACAAAAATTCTGTAAGCATAATTAAA 
GGTGCAGAATTTCACGTGTCACTGCTTTCGATTGCACAGCTATTTGACTTTGCCAAAGATCT 
ACAAAAAGAGATTTATGATGACCTTCAGGCTCTACACACAGATGATCC TC TCACTTGGGATT 
ATGTGGCAAGGCGAGAATTAGAGATTGAGTCACAGACAGAAGAGCAGC C TACAACGAAACAA 
GCCAAAGCAGTGGAGGTCGGC CGGAAGGAGGAGAGGTGCTGTGCTGTGTATGAAGAGGCAGT 
GAAGAC TC TGCCAACAGAGGC CATGTGGAAGTGTTACATCACCTTTTGCTTGGAATGATTTA 
CTAAGAAGTCAAATAGTGGGTTCC TTAGAGGGAAGAGGTTGGAAAGAACCATGACTGTATTC 
AGGAAGGCACATGAACTGAAGC TTCTGTCAGAATGC CAATACAAGCAGTTGAGTGTTTCGTT 
174 
GC TGTGTTATAAC TTCC TGAGGGAAGC TCTGGAAGTGGCAGTAGCTGGAACTGAATTGTTTA 
GAGACTCTGGGACAATGTGGCAGC TGAAGCTGCAGGTGCTGATCGAGTCAAAGAGC CC TGAC 
ATAGCCATGCTTTTTGAAGAAGCCTTTGTGCACCTGAAACCCCAGGTTTGTCTGCCATTGTG 
GATTTCC TGGGCAGAGTGGAGTGAAGGTGCCAAAAGCCAAGAAGACACTGAGGCAGTCTTTA 




TCTGATCTTTGGATGGATTATATGAAAGAAGAATTGAACCACC CCC TTGGTAGACC TGAGAA 
CTGTGGACAGATC TACTGGCGAGCGATGAAAATGTTGCAGGGAGAGTCAGCAGAGGCATTTG 
TAGC TAAACATGC TATGCATCAGACTGGCCATTTATGAAGATGAAGAATACCGTCC GC TTTG 
TGAAATAGTATTGCAAGCCAGCCCCGTGGGCAAATTTGTATTGAGTCCATCTGTAATTTGCT 
CAGTGATGGCAGACAAGATGGCTGTCTGGTTTTGAGACACACAC TTTAATTTTATGTTAAC T 
TGTTAAATCTTTTTAAAAATTAAAAAATTTTTATGATTGAAAAAAAAA 
175 




LMHAEKLRKEKEEFEKASMDVENPDYSEEILKGELAWI IYKNSVS I IKGAEFHVSLLS IAQL 
FDFAKIJLQKE IYDDLQALHTDDPLTWDYVARRELE I ESQTEEQ PTTKQAKAVEVGRKEERCC 
AVYEEAVKTLPTEANWKCY I TFCLJERFTKKSNSGFLRGKRLERTMTVFRKAHELKLL SECQY 





cDNA encoding Xenopus laevis 4.!R'35 sequence (accession number: M20621) with the 
ATG and stop codon indicated in red. 5' and 3' untranslated regions (UTR) are in blue. 
CGGGATTTGGGCGCGTCACGTGACGGGAGTTGAAGCGCGGGAAGCTGGTAGCCGACCCGAAA 





CAAGACCAAAAGGATGTTGATGAGGGTTTGGGAGAGCAGC TAGAGGATGATGTTTTTC TAAA 
GGCCCCTATTGCAGCTCCAGAGCCTGAACTTCGAACTGACCCATCACTAGACCTTCATTCCT 
TAAGTAGTGCAGAACC CAGCCAGCACAAGAGGAACAGAAAGAAGACCAAGAC CCAGAAGCA 
GACTGTGAGGACGTGGAAGGCAAGGAACCAATAAAAAAACCTGAAGGAGAATCAAAGGCCTC 
GCATAAAGTAGTTAGGCGCTCTCCCAACATGCGCTGCAAAGTCACACTTCTCGATGACACTG 






ATGGTGTAGAC TATGTCAGTGAATTTAAAC TCAGTCCAAATCAAACAAAAGATC TTGAAGAG 
AAGGTTGGGGAGC TTCATAAGTCATATAGATC TATGACTCC TGCTCAGGCTGACCTGGAATT 










CCA7AGAAAGAC TCCAGGGC CAAGAGTAGAGGAAATGCCCAAAAAGACAGAGGAGAAGC CCA 




GGCCAGGTCCAGAC TGGGACAGATGGGCC TCCACTAGTGMAAACACAGACCGTCACCATC TC 




CAGGAGATGGAGACC TTGATCATGACCAGGTC TTAGTTCAAGC TATTAAAGAAGCAAAGGAG 





TGAAATGGC TTC C CATATCAGAATGAATTC 
178 
Protein sequence of Xenopus laevis 4. 1R'35 (accession number: AAA49695) 
MTTEKGLLAEAESPPQDQKQEGEEEVESCTTQPVVGSGDKDPETEQSQES PSTTS PSTRKSK 
DRHSQGKGLSRLFS SFLKRPKSQVSSDEKEVELLGEKGQDQKDVDEGLGEQLEDDVFLKAPI 
APEPELRTDPSLDLHSLSSAETQPAQEEQKEDQDPEADCEDVEGKEPIKKPEGES}CJSHKV 




RPGEQEQYESTIGFKLPSYKAAKKLWK\TCVEHHTFFRLTSTES I PKHRFLSLGSTFRYSGRT 




TVKGGI SETL IEKRIVITGDGDLDHDQVLVQAIKEAKEQHPDMSVTKGVVHQETEIA 
179 
cDNA sequence of MCC1 (accession number: M62397) with the ATG and stop codon 








TAAAATGTGGCAGAAGGGACCAAGCAGTGGATATTGAGCC TGTGAAGTC CAAC TC TTAAGC T 
CCGAGACCTGGGGGACTGAGAGCCCAGCTCTGAAAAGTGCATCATGAATTCCGGAGTTGCCA 
TGAAATATGGAAACGACTCCTCGGCCGAGCTGAGTGAGCTCCATTCAGCAGCCCTGGCATCA 




C TCAGAAC TGCGATCAGAAC TCAGCCAGAGCCAACACGAGGTCAACGAGGAC TCTCGAAGCA 
TGGACCAAGACCAGACCTCTGTCTCTATCCCCGAAAACCAGTCTACCATGGTTACTGCTGAC 
ATGGACAACTGCAGTGAC CTGAAC TCAGAAC TGCAGAGGGTGCTGACAGGGCTGGAGAATGT 
TGTC TGCGGCAGGAAGAAGAGCAGC TGCAGCC TCTCCGTGGCCGAGGTGGACAGGCACATTG 
AGCAGCTCACCACAGCCAGCGAGCAC TGTGAC CTGGC TATTAAGACAGTCGAGGAGATTGAG 
GGGGTGCTTGGCCGGGACCTGTATCCCAACCTGGCTGAAGAGAGGTCTCGGTGGGAGAAGGA 








ACAGAACGGC TGAATAGCCGGATTGAGCACCTCAAATC C CAAAATGAC C TCC TGACCATAAC 
CTTGGAGGAATGTAAAAGCAATGCCGAGAGGATGAGCATGC TGGTGGGAAAATACGAATCCA 
ATGCCACAGCGCTGAGGCTGGCCTTGCAGTACAGCGAGCAGTGCATCGAAGC CTACGAAC TC 
CTCCTGGCGCTGGCAGAGAGTGAGCAGAGCCTCATCCTGGGGCAGTTCCGAGCGGCGGGCGT 
GGGGTCCTCCCCTGGAGACCAGTCGGGGGATGAAAACATCACTCAGATGCTCAAGCGAGCTC 
ATGACTGCCGGAPIGACAGCTGAGAATGCTGCCAAGGCCCTGC TCATGAAGC TGGACGGCAGC 
TGTGGGGGAGCCTTTGCCGTGGCCGGCTGCAGCGTGCAGCCCTGGGAGAGCCTTTCCTCCAA 
CAGCCACACCAGCACAACCAGCTCCACAGCCAGTAGTTGCGACACCGAGTTCACTAAAGAAG 
ACGAGCAGAGGCTGAAGGATTATATCCAGCAGC TCAAGAATGACAGGGC TGCGGTCAAGC TG 
ACCATGCTGGAGCTGGAAAGCATCCACATCGATCCTCTCAGCTATGACGTCAAGCCTCGGGG 
AGACAGCCAGAGGC TGGATCTGGAAAACGCAGTGCTTATGCAGGAGCTCATGGC CATGAAGG 
AGGAGATGGCCGAGTTGAAGGCCCAGCTCTACCTACTGGAGAAAGAGAAGAAGGCCCTGGAG 
CTGAAGCTGAGCACGCGGGAGGCCCAGGAGCAGGCCTACCTGGTGCACATTGAGCACCTGAA 

















Protein sequence of MCC1 (accession number: AAA52069) 
MNSGVAMKYGNDS SAELSELHSAALASLKGDIVELNKRLQQTERERDLLEKKLAKAQCEQ SH 
LMREHEDVQERTTLRYEERITELHSVIAELNKKIDRLiQGTTI REEDEYSELRSELSQSQHEV 
NEDSRSMIJQDQTSVSI PENQSTMVTADMDNCSDLNSELQRVLTGLENVVCGRKKSSCSLSVA 
EVDRHI EQLTTASEHCDLAIKTVEE IEGVLGRDLYPNLAEERSRWEKELAGLREENESLTAN 




QMLKRHDCRKTAENAAKALLMKLDGSCGGAFAVAGC SVQ PWE SLS SNSHTSTTS STAS SOD 
TEFTKEDEQRIKDYIQQLKNDRAAVKLTMLELES IHIDPLSYDVKPRGDSQRLDLENAVIJMQ 
ELMANKEEMAELKAQLYLLEKEKKALELKLSTREAQEQAYLVHI EHLKSEVEEQKEQRNRSL 
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The protein 4.1 R is an isoform of a larger family of 4.1 proteins. It is known as a component of 
the plasma membrane skeleton, but it is also found at the centrosornes in interphase and mitosis. 
To investigate the properties of the carboxy terminal region of protein 4.1R, we raised 
antibodies against a peptide representing the last 14 amino acids of 4.1R. These antibodies 
crossreact with an epitope in beta-tubulin and stain the microtubule network by immuno-
fluorescence. Furthermore, sequence comparison of the carboxy terminal 4.1 R peptide sequence 
with tubulin reveals homology with a region at the end of helix 5 in beta-tubulin, but not 
alpha-tubulin. A potential function of the 4.1 R carboxy terminus in regulating the formation of 
microtubule networks is discussed. 	 f' 2002 Elsevier Science Ltd. All ritghts reserved. 
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INTRODUCTION 
The protein band 4.1 has been identified about 
thirty years ago as a major constituent of the 
membrane skeleton in erythrocytes (Fairbanks 
et al., 1971). It has been named according to its 
electrophoretic mobility on protein gels of erythro-
cyte ghosts, and it has been characterized as 
a binding partner of other membrane skeleton 
elements, including spectrin and actin. Closely 
related isoforms of 4.1 exist in other cell types, 
encoded by at least four different genes in humans: 
4.1R in red blood cells and most other tissues, 4.1N 
in central and peripheral neurons, 4.113 in brain, 
and 4.1G which is generally expressed throughout 
the body (for an overview, see Hoover and Bryant, 
2000). Further variability is generated by alterna-
tive splicing; e.g. the gene coding for 4.1R contains 
21 exons which can be arranged in a multitude of 
splice variants (Takakuwa, 2000). 
In a search for interactors of 4.1R, components 
of the mitotic spindle pole including NuMA (pro-
tein of the nucleus and mitotic apparatus, 
Mattagajasingh ci al., 1999) and the novel centro-
somal protein CPAP (centrosomal protein 4.1-
associated protein, Hung ci' al., 2000) have been 
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identified. These findings were further supported by 
localization studies, demonstrating that a signifi-
cant amount of 4.1R localizes to centrosomes both 
during interphase and mitosis (Krauss et al., 1997). 
The exact role of protein 4. 1 R on the centrosome is 
not clear. Mattagajasingh et al. (1999) suggested 
that 4.1R may be crucial for the organization of the 
mitotic spindle. In support of this, Clark and 
Meyer (1999) suggested that 4.1R might be part of 
a complex that binds to NuMA and the actin-
related protein Arpl, an interaction that has pre-
viously been shown to be important for spindle 
formation (Merdes et al., 1996, 2000). 
To investigate the role of 4.lR in the mitotic 
spindle in more detail, we raised antibodies against 
a peptide sequence in the C-terminal domain of this 
protein. In this report, we demonstrate that anti-
bodies against this region cross-react with beta-
tubulin and that the 4. 1 R carboxy terminus shares 
sequence similarities with a region in beta-tubulin 
oriented towards the outer surface of polymerized 
microtubules. 
MATERIALS AND METHODS 
Generation of antibodies against 4.1 R 
A peptide containing the carboxy-terminal amino 
acid sequence SVTKGVVHQETEIA of 4.IR in 
1065-6995/02/5-sec front matter 	 ' 2002 Elsevier Science Ltd. All rights reserved. 
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Xenopus laevis was synthesized by Sigma/Genosys 
(Cambridge, England), including an additional 
amino-terminal cysteine residue for coupling of 
the peptide to keyhole limpet hemocyanine. The 
coupled peptide was injected into two rabbits for 
immunization, followed by five additional injec-
tions to boost the immune response. Serum was 
collected on day 77 after immunization. The 
serum was affinity purified either over a tubulin 
affinity column, made of phosphocellulose-purified 
bovine brain tubulin, coupled to CNBr-activated 
Sepharose 4 Fast Flow (Amersham Pharmacia, 
Uppsala, Sweden), or over nitrocellulose western 
blot strips containing a single protein band of the 
full-length recombinant 4.lR protein. 
The recombinant 4.lR protein was generated in 
bacteria; for this purpose the cDNA of clone 
pXFPO!SP64T encoding full-length Xenopus 4.1 R 
(a gift from Dr Randall Moon, University of 
Washington, Seattle, U.S.A.; Spencer ci al., 
1990) was PCR-amplified using Pfu polymerase 
(Stratagene, La Jolla, California, U.S.A.) and 
primers at the extreme end of the 4.IR 
coding region, and cloned into the BamHl 
site of pRSET-B (Invitrogen, Groningen, The 
Netherlands) after blunting with Kienow fragment. 
The integrity of the sequence was verified by 
sequencing. The cloning in pRSET-B added an 
amino-terminal hexa-histidine tag to 4.IR that was 
used to purify the protein over nickel-sepharose. 
Antibodies were tested by probing dot 
blots of the 4.1R peptide or a control pep-
tide of the tail domain of Xenopus NuMA 
(EPKELEELREKNESL), using 6 ig peptide/well. 
They were further tested by immunoblotting of cell 
extracts, purified 4.1 R, or tubulin on nitrocellulose. 
Cell extracts were made from cultured Xenopus A6 
kidney cells, homogenized and boiled in protein 
gel loading buffer containing sodium dodecyl sul-
fate, or from Xenopus laevis eggs, as described by 
Murray (1991). 
A different antibody was raised in a mouse, 
immunized with a hexa-histidine tagged 4.lR 
fusion protein containing the carboxy-terminal 271 
amino acids of Xenopus 4.1R. This fusion protein 
was obtained by Pstl digest of pXFPOISP64T, 
cloning of the resulting 1100 bp fragment into 
pRSET-B, expression in E.coli BL-21, and 
purification over nickel-sepharose. 
Cloning and expression of recombinant alpha and 
beta-tubulin 
Clones for alpha and beta-tubulin eDNA were 
provided by Dr. Don Cleveland (La Jolla, 
California, U.S.A.; see Cowan ci al., 1983; Lopata 
et al., 1983). The original cDNAs in pBR322 were 
amplified by PCR using primers at the extreme 5' 
and 3' ends of the coding region, and cloned 
into pGEX 4T2 (Amersham Pharmacia, Uppsala, 
Sweden). The pGEX 4T2 vector added an amino-
terminal glutathione-S-transferase tag that was 
used for subsequent purification of the bacterially 
expressed fusion proteins over glutathione affinity 
columns. 
Cell culture and microscopy 
HeLa cells, chicken DU249 cells, and Xenopus A6 
kidney cells were cultured in DMEM, RPMI 1640, 
or 66% strength L-15 medium, respectively. All 
culture media were supplemented with lO% fetal 
calf serum, L-glutamine, penicillin and strepto-
mycin (all reagents from Gibco BRL, Paisley, 
Scotland). Cells were grown on glass coverslips 
and fixed in methanol at -20'C for 10 mm, 
re-hydrated in phosphate-buffered saline, and 
labelled with antibodies against tubulin (DM1 
alpha, Sigma, St Louis, Missouri, U.S.A.) or pro-
tein 4.1. As secondary antibodies, Texas Red-
coupled horse anti-mouse (Vector Laboratories, 
Burlingame, California, U.S.A.) and FITC-coupled 
donkey anti-rabbit were used. DNA was stained 
using 4',6'-diamid1no-2-phenylindole (DAPI). In 
some samples, microtubules were depolymerized 
with 25 tIM nocodazole for 45 min at 4°C. Samples 
were viewed and documented with a Zeiss 
Axioskop 2 and a Zeiss Axiocam digital camera, 
using software from the manufacturer (Carl Zeiss, 
Oberkochen, Germany). 
RESULTS 
A polyclonal antibody against the carboxy-
terminal 271 amino acids of 4.1R was raised in 
a mouse, showing the typical plasma membrane 
skeleton staining along cell-cell contacts in cultured 
cells (Fig. 1) that has been documented previously 
in the literature (Lue ci' al., 1994). Besides, a clear 
staining of the centrosomal region is visible, both in 
interphase and mitotic cells. This finding is consist-
ent with earlier work by Krauss ci' al. (1997). 
Because 4.1 R has been reported to interact with 
NuMA, and because isoforms of NuMA were also 
found at the centrosome in interphase and mitosis 
(Tang ci' al., 1994), we attempted to characterize 
this interaction in more detail by raising new 
antibodies, directed specifically against the NuMA 
binding site of 4.1R. 
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Fig. 1. Polyclonal antibodies against 4.1 R stain the plasma membrane at the sites of cell-cell contact, and the centrosomes during 
interphase and mitosis. Chicken hepatoma DU249 cells were stained with mouse anti-4.1 R serum in interphase (A) and mitosis 
(B). The corresponding DNA staining with DAPI is shown on the right. Arrows indicate centrosome staining, arrowheads 
indicate the plasma membranes at cell-cell contact sites. Bar in B (right). 20 pm. 
This binding site was mapped to exons 20 and 21 
of 4.IR (Mattagajasingh et al., 1999), represented 
by the carboxy-terminal 60 amino acids of our 
Xenopus 4. 1 R isoform. Because of the high conser-
vation of the last 14 amino acids within this region 
(93% identity between human and Xenopus 4. 1 R), 
we assumed a functional importance and raised 
antibodies against a synthetic peptide of this 
sequence. Two rabbits were immunized and gave 
positive immune responses to the 4.1R peptide, as 
seen on dot blots (Fig. 2). Both sera showed only 
background reactivity against a control peptide 
from Xenopus NuMA (Fig. 2). 
The sera were further tested by immunoblotting, 
and both gave identical results. For this reason, 
only serum 1 is described in the following: Whereas 
the preimmune serum did not contain any recog-
nizable titer, the immune serum showed a strong 
reaction against recombinant 4. 1 R, containing the 
sequence of the immunizing peptide at its carboxy-
terminal end. In whole cell extracts of Xenopus A6 
kidney cells, however, the serum predominantly 
reacted against a protein band at 55 kDa, suggest-
ing tubulin. In a separate lane, loading of pure 
brain tubulin indicated that this 55 kDa band 
represents tubulin. Furthermore, immunofluor-
escence labelling of cultured HeLa cells showed a  
filamentous staining pattern reminiscent of micro-
tubules (Fig. 3A,D). Double immunofluorescence 
with a specific antibody against tubulin confirmed 
that the peptide antibodies against 4.lR stained 
indeed the microtubule network (Fig. 3B, C, E, F). 
This staining could be completely eliminated by 
treatment of the cells with nocodazole: Fig. 3G and 
H show that the niicrotubule network was com-
pletely depolyrnerized, and that the staining with 
4.1R antiserum was now restricted to the area of 
the centrosomes, whereas pre-immune serum failed 
to detect any centrosomal signal (Fig. 31, J). 
Because identical properties were observed in the 
immune sera from both rabbits, we believed that 
the detection of tubulin by immunoblotting and 
immunofluorescence was due to a crossreactivity 
with the 4.lR epitope, rather than due to an 
independent antibody titer against tubulin, as 
sometimes accidentally appearing in a rabbit 
serum. However, to distinguish between these two 
possibilities, we affinity purified serum from recom-
binant 4.1 R protein. As shown by immunoblotting 
and immunofluorescence (Fig. 4A, B), the reac-
tivity against tubulin was still preserved in the 
anti-4.IR antibody, indicating that the same anti-
body crossreacted with both 4.lR and tubulin. 
Consistently, serum that was affinity purified from 
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Fig. 2. Serum against a 4.1 R C-terminal peptide recognizes tubulin. Protein gels containing recombinant full-length 4.1 R (lane 
4.1 R), extract of Xenopus A6 cells (lane extr.), and bovine brain tubulin (lane tub.) were stained with Coomassie. or blotted onto 
nitrocellulose and probed with rabbit pre-immune serum, or serum alter immunization with it peptide representing the 
C-terminal 14 amino acids of Xenopus 4.1 R. The asterisk on the anti-4. I R immunoblot indicates a degradation product of the 
recombinant 4.1 R protein that reacts strongly with our serum. On the right, dot blots of the 4. I R C-terminal peptide and a 
control peptide of the tail domain of Xenopus NuMA are shown. These were probed with pre-immune sera, as well as immune 
sera from two different rabbits. 
phosphocellulose-purified brain tubulin also recog-
nized 4.1R protein by immunoblotting (Fig. 4A, 
Q. To our surprise, the antibodies only recognized 
the beta-tubulin isoform, but not alpha-tubulin. 
This was verified by immunoblotting against 
recombinant fusion proteins, containing alpha or 
beta-tubulin tagged with glutathione-S-transferase 
(Fig. 4A). 
Finally, an alignment of the 4.1 R peptide 
sequence with alpha and beta-tubulin using Cl usia! 
W software (EBI, I-Iinxton, U.K.) revealed 29 
identity with amino acids 183 to 196 in beta-
tubulin, but no significant similarity in alpha-
tubulin (Fig. 5). The specified region is located at 
the end of helix 5 in beta-tubulin, and is exposed 
to the outer surface of the microtubule polymer, 
according to the structural analysis by Nogales 
et cii. (1998, 1999). Although the degree of simi-
larity between the 4.1R peptide and beta-tubulin is 
weak and only restricted to a very short region, the 
specificity of the antibodies for beta-tubulin and 
the accessibility of the epitope for immunofluor-
escence labelling support the idea that the antibody 
crossreactivity is directed against this area of the 
tubulin molecule. Conventional BLAST analysis 
which uses higher stringency for alignment failed to 
detect this similarity. 
DISCUSSION 
We demonstrate here a crossreactivity of anti-
bodies against epitopes in both 4.1R and 
beta-tubulin. These data indicate a similarity of the 
4.lR carboxy terminus with a short region in 
beta-tubulin, which is further supported by the 
sequence alignment of the 4. 1 R C-terminal peptide 
with the helix 5 region of beta-tubulin. Our experi-
ments with nocodazole show that after depolymer-
ization of microtubules, the immunouluorescence 
staining with the 4. 1 R antibody is restricted to the 
cenirosome. This suggests that the antibody can see 
both tubulin as well as protein 4.1 R in the cell, but 
under normal conditions, the centrosomal 4. 1 R 
signal is obscured by the high abundance of micro-
tubule filaments in the cytoplasm. Plasma mem-
brane staining was not detected with this antibody, 
which might indicate that the extreme carboxy-
terminus of 4.1R is masked in the plasma 
membrane skeleton. 
What is the biological significance of the simi-
larities between the 4. 1 R carboxy terminus and 
beta-tubulin? The partial localization of 4.1 R to the 
centrosome may suggest a role in microtubule 
organization. Microt ubules are nucleated from the 
pericentriolar material, but many of them are sub-
sequently released into the cytoplasm (Keating 
et al., 1997), potentially by the action of a micro-
tubule severing factor, katanin (Hartman et al., 
1998). It is not clear how the anchoring and release 
of microtubules at the centrosome is regulated in 
detail. One possibility would be that a protein such 
as 4.1 R is involved in microtubule release. With its 
carboxy terminal end showing similarity to beta-
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Fig. 3. Peptide antibodies raised against 4. I R stain microtubules. (A) and (D) show single immunofluorescence of the 4. 1 R 
peptide antiserum in HeLa cells during interphase (A) and mitosis (D). Double immunofluorescence with the same serum 
and monoclonal anti-tuhulin antibody is shown during interphase in (B. C) and during mitosis in (E, F). (U) to (J) show 
HeLa cells treated with nocodazole. (H) and (J) show anti-tubulin staining. (G) and (I) show immunofiuorescence with 4.1 R 
peptide antiserum, or with pre-immune serum from the same rabbit, respectively. Bar in (F), 20 irn same magnification in 
(A) (J). 
compete for the binding to centrosomal compo-
nents, thus disconnecting microtubules from the 
centrosomal surface. 
This idea is supported by recent findings from 
Perez-Ferreiro et al. (2001). These authors report 
that overexpression of 4. 1 R disturbed microtubule 
organization, and that microtubules no longer 
radiated from a single pericentriolar focus, 
although centrosomal markers such as pericentrin 
or gamma-tubulin remained unaltered. Moreover,  
the carboxy-terminal region of 4. 1 R had the maxi-
mum capacity of interfering with microtubule 
organization in their experiments. Given the multi-
tude of 4.1 isoforms and their varying subcellular 
localization in different cell types (Takakuwa, 
2000), the 4.1 protein could contribute to the 
modulation of the microtubule network by releas-
ing microtubules from nucleation sites, and there-
fore contribute to the various cell shapes and 
properties of many differentiated cells. 
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.1R tub. extr. GST-a GST-)3 	4.111 tub. extr. GST-a GST-f3 	4.1R tub. extr. GST-(X GST-)3 
R 	 ' 	 ( 
wajd It ~F k~ 7*0 
Fig. 4. Anti-4. I R antibodies cross-rcact s ith beta-tubulin. (A) shows Coomassie staining of a protein gel loaded ssith full-length 
4.1R protein (4.11Z), brain tubulin (tub.). Xr'nopus egg extract (extr.), and GST-tagged recombinant alpha-tubulin (GST-u) or 
beta-tubulin (GST-3), respectively. Note the increased molecular weight of the recombinant forms of tubulin after addition of the 
GST-tag. Identical gels were blotted and probed with 4.1 R peptide antibodies, previously affinity purified from recombinant 4.1 R 
(middle), or brain tubulin (right). The same affinity purified antibodies were used for immunolluorescence staining of 1-leLa cells; 
affinity purified antibody from 4.1 R is shown in (B), and affinity purified antibody from tubulin is shown in (C). Asterisks in (A) 
denote the position of a degradation product of 4.1 R. Bar in (C), 20 pm. 
helix 5 	 sheet 6 	helix 6 	 helix 7 
a-tubulin 177 VSTAVVEPYNSILTTHTTLEHSDCAFMVDNEAIYDICRRNLDIERPTYTNLNRLISQIVS 236 
l-tubulin 175 VSDTVVEPYNATLSVHQLVENTDBTYCIDNEALYDICFRTLKLTTPTYGDLNHLVSATMS 234 
4.1R peptide 	 SVTKGVVHQETEIA 
Fig. 5. Alignment of the C-terminal 4.1 R peptide with amino acids 177 to 236 of alpha-tubulin (identical in mouse, humans, 
chicken, and Xenopus), and the corresponding region in beta-tubulin (amino acids 175 to 234). The positions of alpha-helices and 
beta-sheets in tubulin are indicated. Identical amino acids are highlighted in bold typescript. 
The binding of 4.1R to NuMA, as reported by 
Mattagajasingh et al. (1999), could provide an 
additional regulatory element to control micro-
tubule behaviour. Whereas only small amounts of a 
NuMA splice variant are found at the centrosome 
during interphase (Tang et al., 1994), the majority 
of NuMA localizes near the centrosome in mitosis. 
In contrast to NuMA, the protein 4.1R appears 
to be a constitutive resident of the centrosome 
throughout the cell cycle, binding to the protein 
CPAP (Hung, 2000). Therefore, the protein 4.lR 
could provide a docking site on the mitotic centro-
some for NuMA protein complexes that are trans-
ported towards the spindle poles by dynein/ 
dynactin (Merdes ci' al., 2000). Similar to  
interphase cells, the NuMA-4. 1 R interaction in 
mitosis might affect processes such as microtubule 
release from the centrosome (Mastronarde et at,, 
1993), or poleward flux of tubulin polymer, as 
proposed by Sawin et at. (1992). 
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